#chr	start	end	ref	obs	genotype	quality	gene	variant_type	coding_and_splicing	1000g	ExAC	gnomAD	dbSNP	ljb2_phylop	ljb2_mt	ljb2_sift	ljb2_pp2hvar	esp6500si_ea	cosmic64	RepeatMasker	OMIM	ClinVar	ihdb_hom_80	ihdb_het_80	ihdb_wt_80	ihdb_allsys	classification	validated
chrX	2715425	2715425	A	G	hom	222	XG			0.61	0.61	0.61	rs112841345 [];					0.6383					0.1875	0.05	0.7625	68		
chrX	2724760	2724760	T	C	hom	222	XG	nonsynonymous SNV	XG:NM_001141919:exon8:c.T392C:p.L131P,	0.97	0.97	0.1	rs111382948 [];	0.1390		0.3400	0.0000	0.9975					0.95	0	0.05	141		
chrX	2726396	2726396	A	G	hom	212	XG			0.96	0.96	0.96	rs6567645 [];										0.4375	0	0.5625	46		
chrX	2729552	2729552	-	A	hom	214	XG			0	0	0											0.3375	0.0125	0.65	41		
chrX	2733109	2733109	T	G	hom	222	XG			0.72	0.72	0.72	rs5939124 [];										0.775	0.0375	0.1875	76		
chrX	2733210	2733210	G	A	hom	222	XG			0.71	0.71	0.71	rs5939125 [];										0.7875	0.0375	0.175	78		
chrX	2733276	2733276	G	A	hom	222	XG			0.91	0.91	0.91	rs5939339 [];										0.975	0	0.025	94		
chrX	2733641	2733641	A	G	hom	222	XG			0.75	0.75	0.75	rs3672 [];										0.8625	0.025	0.1125	89		
chrX	2733668	2733668	G	A	hom	222	XG			0.74	0.74	0.74	rs3671 [];										0.7625	0.0375	0.2	78		
chrX	2733845	2733845	-	TACACACACACACACA	hom	157	XG			0	0	0								198			0.0125	0	0.9875	1		
chrX	2733863	2733863	-	CACACACACACACACC	hom	214	XG			0	0	0								198			0.4625	0	0.5375	46		
chrX	2748051	2748051	T	C	hom	110	GYG2			0.75	0.75	0.75	rs57068689 [];										0.35	0	0.65	35		
chrX	2748253	2748253	G	C	hom	222	GYG2			0.93	0.93	0.93	rs55640257 [];					0.9941					0.4375	0	0.5625	95		
chrX	2748292	2748292	C	G	hom	222	GYG2			0.67	0.67	0.67	rs6641656 [];										0.35	0.0125	0.6375	83		
chrX	2774478	2774478	A	G	hom	222	GYG2			0.98	0.98	0.98	rs5939132 [];										0.4375	0	0.5625	46		
chrX	2777985	2777985	C	T	hom	222	GYG2	nonsynonymous SNV	GYG2:NM_001184702:exon7:c.C716T:p.A239V,GYG2:NM_001184704:exon6:c.C251T:p.A84V,GYG2:NM_001079855:exon7:c.C716T:p.A239V,GYG2:NM_001184703:exon8:c.C809T:p.A270V,GYG2:NM_003918:exon8:c.C809T:p.A270V,	0.63	0.63	0.63	rs2306734 [];	-0.3340	0.0004	0.3300	0.1450	0.7483					0.625	0.075	0.3	111		
chrX	2779570	2779570	A	G	hom	222	GYG2	nonsynonymous SNV	GYG2:NM_001184702:exon8:c.A845G:p.H282R,GYG2:NM_001184704:exon7:c.A380G:p.H127R,GYG2:NM_001079855:exon8:c.A845G:p.H282R,GYG2:NM_001184703:exon9:c.A938G:p.H313R,GYG2:NM_003918:exon9:c.A938G:p.H313R,	0.63	0.63	0.63	rs2306735 [];	-3.1280	0.0000	0.4300	0.0010	0.7206					0.5375	0.075	0.3875	98		
chrX	2800295	2800295	G	C	hom	222	GYG2			0.81	0.81	0.81	rs211660 [];										0.9125	0.0375	0.05	88		
chrX	2823402	2823402	C	T	hom	222	ARSD			0.05	0.05	0.05	rs11538097 [];										0.05	0.075	0.875	12		
chrX	2832661	2832661	A	T	het	14.2	ARSD			0	0	0	rs111318153 [];										0	0.4625	0.5375	61		
chrX	2832742	2832742	G	C	het	7.8	ARSD			0.76	0.76	0.76	rs211648 [];	-1.5460	0.0000	0.0300	0.0000	0.6253					0.525	0.35	0.125	122		
chrX	2832771	2832771	C	T	het	225	ARSD			0.0012	0.0012	0.0012	rs78142040 [];										0	0.8	0.2	110		
chrX	2832787	2832787	A	G	het	225	ARSD			0	0	0	rs73632954 [];	-0.1320	0.0002	0.5200	0.0030						0	0.8	0.2	110		
chrX	2832860	2832860	G	A	het	225	ARSD			0	0	0	rs73632955 [];										0	0.3375	0.6625	54		
chrX	2832871	2832871	A	G	het	225	ARSD			0	0	0	rs115343387 [];										0	0.3375	0.6625	37		
chrX	2832881	2832881	-	AT	het	217	ARSD			0	0	0	rs72264262 [];										0	0.3375	0.6625	37		
chrX	2832937	2832937	A	G	het	141	ARSD			0	0	0								1640			0	0.3375	0.6625	37		
chrX	2833534	2833541	TTACGCCC	-	het	60.5	ARSD			0	0	0											0	0.05	0.95	8		
chrX	2833551	2833551	A	T	het	31	ARSD			0	0	0	rs114724695 [];										0	0.1125	0.8875	17		
chrX	2833552	2833552	C	G	het	22	ARSD			0.01	0.01	0.01	rs115030126 [];										0	0.1125	0.8875	17		
chrX	2833580	2833580	A	G	het	18.1	ARSD			0.0036	0.0036	0.0036	rs112594989 [];										0	0.275	0.725	46		
chrX	2833749	2833749	T	C	het	120	ARSD			0	0	0	rs112924969 [];										0	0.15	0.85	22		
chrX	2833752	2833752	C	T	het	121	ARSD			0	0	0	rs115063380 [];										0	0.125	0.875	18		
chrX	2835831	2835831	C	T	het	94	ARSD			0.07	0.07	0.07	rs75490251 [];										0	0.3375	0.6625	55		
chrX	2835863	2835863	G	T	het	225	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C845A:p.A282D,	0.08	0.08	0.08	rs78034736 [];	1.3380	0.9429	0.0000	0.9930						0	0.8125	0.1875	112		
chrX	2835964	2835964	G	A	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C744T:p.F248F,	0	0	0	rs73632972 [];										0	0.825	0.175	112		
chrX	2836041	2836041	A	T	het	199	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T667A:p.F223I,	0	0	0	rs67272620 [];	-1.3810	0.0000	0.6900	0.0060						0	0.8	0.2	99		
chrX	2836047	2836047	C	T	het	148	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.G661A:p.G221S,	0.06	0.06	0.06	rs67359049 [];	0.3830	0.1782	0.1400	0.9430						0	0.8	0.2	99		
chrX	2836060	2836060	G	A	het	174	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C648T:p.A216A,	0.07	0.07	0.07	rs113318393 [];										0	0.8125	0.1875	103		
chrX	2836084	2836084	C	G	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.G624C:p.A208A,	0.07	0.07	0.07	rs73632973 [];										0	0.8125	0.1875	106		
chrX	2836138	2836138	G	A	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C570T:p.P190P,	0.07	0.07	0.07	rs73632974 [];										0	0.8125	0.1875	105		
chrX	2836181	2836181	A	T	het	75	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T527A:p.M176K,	0.09	0.09	0.09	rs73632975 [];	1.1320	0.1479	0.0300	0.2480						0	0.8125	0.1875	117		
chrX	2836184	2836184	C	T	het	93	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.G524A:p.G175D,	0.08	0.08	0.08	rs73632976 [];	1.3940	0.9369	0.0100	0.8830						0	0.8125	0.1875	113		
chrX	2836211	2836211	A	T	het	148	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T497A:p.L166Q [1(large_intestine)]; 	0.09	0.09	0.09	rs73632977 [];	1.1320	0.5142	0.0300	0.9300		298990 [1(large_intestine)]; 				0.0125	0.8125	0.175	110		
chrX	2836238	2836238	G	A	het	182	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C470T:p.S157F,	0.08	0.08	0.08	rs73632978 [];	0.3710	0.4682	0.0400	0.1040						0.0125	0.8125	0.175	97		
chrX	2836283	2836283	A	G	het	23	ARSD			0.05	0.05	0.05	rs115556892 [];										0	0.0875	0.9125	17		
chrX	2836285	2836285	T	C	het	30	ARSD			0.05	0.05	0.05	rs114112932 [];										0	0.0875	0.9125	18		
chrX	2836349	2836349	G	C	het	36	ARSD			0.03	0.03	0.03	rs111614007 [];										0	0.2625	0.7375	29		
chrX	2836373	2836373	A	G	het	114	ARSD			0.02	0.02	0.02	rs113026716 [];										0	0.3375	0.6625	37		
chrX	2945389	2945389	C	T	hom	222	ARSH	nonsynonymous SNV	ARSH:NM_001011719:exon7:c.C1072T:p.R358C,	0.003	0.003	0.003	rs146832237 [];	1.3280	0.8254	0.0100	1.0000	0.0028					0	0	1	1		
chrX	3227120	3227120	T	A	hom	222	MXRA5			0.04	0.04	0.04	rs184208316 [];							25			0.05	0.0125	0.9375	6		
chrX	3228411	3228411	G	A	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon7:c.C7833T:p.A2611A,	0.73	0.73	0.73	rs1635233 [];					0.6443					0.525	0.0625	0.4125	82		
chrX	3228891	3228891	A	G	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon7:c.T7353C:p.T2451T,	0.61	0.61	0.61	rs1635235 [];					0.5760					0.4875	0.075	0.4375	73		
chrX	3235724	3235724	C	T	hom	222	MXRA5	nonsynonymous SNV	MXRA5:NM_015419:exon6:c.G5998A:p.G2000S,	0.7	0.7	0.7	rs1635242 [];	1.3990	0.0004	0.5600	0.1640	0.6452					0.525	0.0625	0.4125	83		
chrX	3238167	3238167	T	G	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon5:c.A5559C:p.P1853P [1(stomach)]; 	0.48	0.48	0.48	rs1635245 [];					0.5706	150754 [1(stomach)]; 				0.4125	0.075	0.5125	70		
chrX	3238733	3238733	G	A	hom	222	MXRA5	nonsynonymous SNV	MXRA5:NM_015419:exon5:c.C4993T:p.P1665S [1(stomach)]; 	0.45	0.45	0.45	rs1974522 [];	0.3450	0.0059	0.0800	0.1320	0.5706	150756 [1(stomach)]; 150755 [1(stomach)]; 				0.425	0.0875	0.4875	70		
chrX	3239545	3239545	C	T	hom	222	MXRA5	nonsynonymous SNV	MXRA5:NM_015419:exon5:c.G4181A:p.G1394D,	0.72	0.72	0.72	rs1726199 [];	-0.2410	0.0000	1.0000	0.0000	0.6451					0.5375	0.0625	0.4	82		
chrX	3240343	3240343	G	A	hom	222	MXRA5	nonsynonymous SNV	MXRA5:NM_015419:exon5:c.C3383T:p.A1128V,	0.53	0.53	0.53	rs1635246 [];	-1.5190	0.0004	0.3800	0.0020	0.5718					0.425	0.0875	0.4875	72		
chrX	3241050	3241050	G	A	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon5:c.C2676T:p.S892S [1(stomach)]; 	0.53	0.53	0.53	rs1635247 [];					0.5716	150761 [1(stomach)]; 				0.425	0.075	0.5	71		
chrX	3241256	3241256	T	C	hom	222	MXRA5	nonsynonymous SNV	MXRA5:NM_015419:exon5:c.A2470G:p.I824V,	0.74	0.74	0.74	rs5983119 [];	0.0250	0.0000	1.0000	0.0000	0.6449					0.55	0.075	0.375	87		
chrX	3241284	3241284	A	G	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon5:c.T2442C:p.S814S [1(stomach)]; 	0.48	0.48	0.48	rs1635248 [];					0.5709	150762 [1(stomach)]; 				0.425	0.075	0.5	70		
chrX	3241317	3241317	T	C	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon5:c.A2409G:p.P803P,	0.74	0.74	0.74	rs1635249 [];					0.6454					0.5625	0.0875	0.35	88		
chrX	3241791	3241791	G	A	hom	222	MXRA5	synonymous SNV	MXRA5:NM_015419:exon5:c.C1935T:p.D645D,	0.48	0.48	0.48	rs1635250 [];					0.5703					0.425	0.075	0.5	70		
chrX	3264455	3264455	G	A	hom	57	MXRA5			0.2	0.2	0.2	rs7052556 [];										0.025	0.0125	0.9625	3		
chrX	3523092	3523101	ACACACACAC	-	hom	214	PRKX			0	0	0								432			0.2375	0.1	0.6625	33		
chrX	3524493	3524493	T	C	hom	203	PRKX			0.98	0.98	0.98	rs6420576 [];							2386			0.9125	0	0.0875	89		
chrX	3526665	3526665	-	CA	het	184	PRKX			0	0	0											0	0	1	0		
chrX	3592725	3592725	G	A	hom	222	PRKX	synonymous SNV	PRKX:NM_005044:exon2:c.C249T:p.P83P,	0.48	0.48	0.48	rs10871864 [];					0.5740					0.4875	0.0875	0.425	87		
chrX	3592847	3592847	C	T	hom	222	PRKX			0.95	0.95	0.95	rs7880937 [];					0.8893					0.3875	0.0125	0.6	69		
chrX	3735732	3735732	G	A	hom	222	LOC389906			0.6	0.6	0.6	rs1054501 [];										0.6	0.0625	0.3375	61		
chrX	3746524	3746524	C	T	hom	158	LOC389906			0.1	0.1	0.1	rs5915844 [];							1486			0.0625	0.025	0.9125	9		
chrX	3746558	3746558	C	T	hom	222	LOC389906			0.99	0.99	0.99	rs4826742 [];										0.9125	0.0125	0.075	85		
chrX	3746950	3746950	T	G	hom	48	LOC389906			0.0036	0.0036	0.0036	rs144738568 [];										0	0	1	0		
chrX	3747085	3747085	A	G	hom	222	LOC389906			0	0	0	rs2258084 [];										0.55	0.0625	0.3875	57		
chrX	3747314	3747314	G	A	hom	206	LOC389906			0.22	0.22	0.22	rs35312615 [];										0.175	0.0625	0.7625	21		
chrX	5808861	5808861	G	A	hom	222	NLGN4X			0.72	0.72	0.72	rs1882260 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.65	0.1125	0.2375	129		
chrX	5808871	5808871	A	C	hom	222	NLGN4X			0.17	0.17	0.17	rs16983882 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.1375	0.0125	0.85	31		
chrX	5810756	5810756	C	T	hom	222	NLGN4X			0.34	0.34	0.34	rs3810688 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.2	0.0375	0.7625	49		
chrX	5811807	5811807	A	G	hom	222	NLGN4X			0.19	0.19	0.19	rs61095217 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.0625	0.0125	0.925	10		
chrX	6145942	6145942	C	T	hom	222	NLGN4X			0.15	0.15	0.15	rs2290487 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.0625	0.0625	0.875	11		
chrX	6146000	6146001	GG	-	hom	57.5	NLGN4X			0	0	0	rs72413786 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.3125	0.0125	0.675	29		
chrX	6451611	6451614	CCCT	-	het	71.5	VCX3A			0.57	0.57	0.57								501			0.075	0.125	0.8	22		
chrX	6452604	6452604	C	A	hom	47	VCX3A			0	0	0	rs201994163 [];										0.4	0.025	0.575	41		
chrX	6452912	6452912	C	G	hom	152	VCX3A			0	0	0	rs142644833 [];										0.3125	0.025	0.6625	37		
chrX	7270996	7270996	A	G	hom	222	STS			0.63	0.63	0.63	rs1131289 [];										0.625	0.0875	0.2875	68		
chrX	7810439	7810444	TTTTTT	-	het	26.5	VCX			0	0	0								2306			0.05	0.0625	0.8875	11		
chrX	7811645	7811645	C	G	hom	10.4	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.C209G:p.A70G,	0	0	0	rs1728761 [];	-0.8300	0.0001	0.4800	0.0000						0.4625	0.0375	0.5	64		
chrX	7811747	7811747	T	C	hom	222	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.T311C:p.L104P,	0.55	0.55	0.55	rs71247277 [];	0.1380	0.0078	0.2500	0.0030						0.375	0.2375	0.3875	86		
chrX	7812017	7812017	C	T	hom	126	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.C581T:p.P194L,	0	0	0	rs78342118 [];	-1.8340	0.0040	0.3300	0.0040	0.4206					0.6625	0.1	0.2375	107		
chrX	7867378	7867378	T	C	hom	222	PNPLA4			0.67	0.67	0.67	rs34709717 [];										0.55	0.0625	0.3875	58		
chrX	7867435	7867435	G	A	hom	222	PNPLA4			0.72	0.72	0.72	rs12009989 [];										0.5625	0.0625	0.375	59		
chrX	7867668	7867668	-	CAGAGAGAGA	hom	214	PNPLA4			0	0	0								486			0.075	0	0.925	6		
chrX	7867732	7867732	A	G	hom	222	PNPLA4			0.62	0.62	0.62	rs6639976 [];										0.55	0.05	0.4	56		
chrX	7890215	7890215	C	T	hom	222	PNPLA4			0.63	0.63	0.63	rs1183732 [];										0.275	0.0375	0.6875	33		
chrX	8138080	8138080	G	C	hom	222	VCX2	nonsynonymous SNV	VCX2:NM_016378:exon3:c.C413G:p.T138S,	0.91	0.91	0.91	rs1058239 [];	-0.7590	0.0001	1.0000	0.0000	0.8064					0.725	0.0125	0.2625	141		
chrX	8138160	8138160	T	C	hom	222	VCX2	synonymous SNV	VCX2:NM_016378:exon3:c.A333G:p.E111E,	0.76	0.76	0.76	rs1058238 [];										0.7	0.0125	0.2875	130		
chrX	8138165	8138165	-	GCTCGG	hom	122	VCX2	nonframeshift insertion	VCX2:NM_016378:exon3:c.327_328insCCGAGC:p.V110delinsPSV,	0	0	0											0.225	0.125	0.65	45		
chrX	8138170	8138170	C	G	het	52	VCX2	nonsynonymous SNV	VCX2:NM_016378:exon3:c.G323C:p.S108T,	0.63	0.63	0.63	rs75657421 [];	-1.4500	0.0000	1.0000	0.0000						0.225	0.3	0.475	91		
chrX	8138284	8138284	G	C	hom	86.8	VCX2	nonsynonymous SNV	VCX2:NM_016378:exon3:c.C209G:p.A70G,	0.68	0.68	0.68	rs41309545 [];	-0.7920	0.0001	1.0000	0.0000						0.4375	0.0125	0.55	59		
chrX	8139196	8139196	C	T	hom	222	VCX2			0	0	0	rs56101217 [];										0.4625	0.1125	0.425	59		
chrX	8432783	8432783	G	C	hom	222	VCX3B			0.63	0.63	0.63	rs6640130 [];										0.175	0.0375	0.7875	20		
chrX	8433049	8433049	C	T	hom	153	VCX3B			0.51	0.51	0.51	rs55658351 [];										0.1375	0	0.8625	12		
chrX	8433285	8433285	G	T	het	116	VCX3B			0	0	0											0.0375	0.25	0.7125	27		
chrX	8433663	8433663	G	C	hom	95.1	VCX3B			0	0	0	rs1728762 [];										0.075	0	0.925	6		
chrX	8434522	8434522	T	A	hom	16.1	VCX3B			0	0	0	rs1071701 [];										0.1875	0.025	0.7875	19		
chrX	9379578	9379578	C	T	het	51	FAM9B;TBL1X		FAM9B:dist=378462;TBL1X:dist=51757	0	0	0	rs28502220 [];										0	0.1375	0.8625	15		
chrX	9651839	9651839	T	A	hom	222	TBL1X			0.92	0.92	0.92	rs2732883 [];										0.85	0.0375	0.1125	82		
chrX	9659768	9659768	-	G	hom	149	TBL1X			0	0	0	rs59911855 [];										0.1125	0.0625	0.825	38		
chrX	9659863	9659863	G	A	hom	222	TBL1X			0.4	0.4	0.4	rs2301674 [];										0.1125	0.0625	0.825	18		
chrX	9661165	9661165	G	T	hom	222	TBL1X			0.43	0.43	0.43	rs3747430 [];					0.4318					0.1125	0.0625	0.825	48		
chrX	9661546	9661546	T	C	hom	207	TBL1X			0.36	0.36	0.36	rs56091227 [];										0.1125	0.0625	0.825	19		
chrX	9677599	9677599	G	A	hom	222	TBL1X			0.5	0.5	0.5	rs1006912 [];										0.1125	0.05	0.8375	15		
chrX	9684711	9684711	T	-	hom	55.5	TBL1X			0	0	0											0.1625	0	0.8375	15		
chrX	9684738	9684738	A	G	hom	222	TBL1X			0.29	0.29	0.29	rs16985675 [];										0.2875	0.0625	0.65	31		
chrX	9684952	9684952	C	T	hom	222	TBL1X			0.28	0.28	0.28	rs1049950 [];										0.4625	0.05	0.4875	49		
chrX	9685901	9685901	T	C	hom	222	TBL1X			0.06	0.06	0.06	rs17321120 [];										0.1125	0.025	0.8625	11		
chrX	9686187	9686187	T	C	hom	222	TBL1X			0.42	0.42	0.42	rs2106705 [];										0.5375	0.05	0.4125	55		
chrX	9859098	9859098	A	G	hom	222	SHROOM2	synonymous SNV	SHROOM2:NM_001649:exon3:c.A399G:p.P133P,	0.89	0.89	0.89	rs6640543 [];					0.9395					0.8875	0.025	0.0875	142		
chrX	9859197	9859197	A	G	hom	222	SHROOM2			0.84	0.84	0.84	rs6640544 [];					0.9386					0.3875	0.025	0.5875	72		
chrX	9866420	9866420	T	C	hom	222	SHROOM2			0.46	0.46	0.46	rs2073944 [];										0.3	0.0375	0.6625	35		
chrX	10085674	10085674	T	C	hom	222	WWC3	synonymous SNV	WWC3:NM_015691:exon11:c.T1575C:p.D525D,	0.94	0.94	0.94	rs6530368 [];					0.8671					0.825	0.0125	0.1625	93		
chrX	11207098	11207098	A	C	hom	222	ARHGAP6	nonsynonymous SNV	ARHGAP6:NM_006125:exon4:c.T827G:p.I276S,ARHGAP6:NM_013427:exon4:c.T827G:p.I276S,ARHGAP6:NM_013423:exon4:c.T218G:p.I73S,	0	0	0	rs146662506 [];	0.7360	0.9547	1.0000	0.0160	0.0009					0	0	1	0		
chrX	12722616	12722616	C	G	hom	222	FRMPD4			0.99	0.99	0.99	rs4469660 [];					0.9921					0.4375	0	0.5625	100		
chrX	12739294	12739294	A	G	hom	222	FRMPD4			0.26	0.26	0.26	rs3827468 [];										0.2625	0.075	0.6625	57		
chrX	12740118	12740118	T	C	hom	222	FRMPD4			0.13	0.13	0.13	rs17321823 [];										0.1625	0.0875	0.75	50		
chrX	12809661	12809661	G	A	hom	200	PRPS2	synonymous SNV	PRPS2:NM_001039091:exon1:c.G45A:p.L15L,PRPS2:NM_002765:exon1:c.G45A:p.L15L,	0.62	0.62	0.62	rs1731469 [];					0.6307					0.525	0.0625	0.4125	89		
chrX	12837558	12837558	C	T	hom	202	PRPS2			0.83	0.83	0.83	rs5935399 [];										0.35	0.0375	0.6125	41		
chrX	12903659	12903659	A	T	hom	222	TLR7	nonsynonymous SNV	TLR7:NM_016562:exon3:c.A32T:p.Q11L,	0.15	0.15	0.15	rs179008 [];	-0.6370	0.0372	0.1900	0.0000	0.2124					0.2	0.0375	0.7625	38		
chrX	12937804	12937804	C	T	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.C645T:p.H215H [1(stomach)]; 	0.63	0.63	0.63	rs5744080 [];					0.3924	150765 [1(stomach)]; 				0.375	0.05	0.575	58		
chrX	12939112	12939112	G	C	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.G1953C:p.L651L,	0.66	0.66	0.66	rs2407992 [];					0.3946					0.3625	0.05	0.5875	58		
chrX	12939412	12939412	C	A	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.C2253A:p.I751I [1(stomach)]; 	0.51	0.51	0.51	rs3747414 [];					0.3448	150766 [1(stomach)]; 				0.3125	0.0625	0.625	52		
chrX	12939928	12939928	T	C	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.T2769C:p.D923D,	1	1	1	rs2109135 [];					0.9967					0.9875	0	0.0125	146		
chrX	12994886	12994886	-	T	het	87.5	TMSB4X			0	0	0											0	0.0375	0.9625	3		
chrX	13056654	13056654	T	C	hom	222	FAM9C			0.5	0.5	0.5	rs4830483 [];					0.4856					0.1375	0.05	0.8125	37		
chrX	13062722	13062722	C	T	hom	222	FAM9C			0.54	0.54	0.54	rs11095602 [];										0.4	0.1	0.5	51		
chrX	13801447	13801447	G	C	hom	222	GPM6B			0	0	0	rs201543004 [];					0.0022					0	0	1	0		
chrX	13803884	13803884	G	A	hom	222	GPM6B	synonymous SNV	GPM6B:NM_001001996:exon3:c.C225T:p.Y75Y,GPM6B:NM_001001995:exon3:c.C225T:p.Y75Y,GPM6B:NM_005278:exon2:c.C105T:p.Y35Y,GPM6B:NM_001001994:exon2:c.C48T:p.Y16Y,	0.01	0.01	0.01	rs36050008 [];					0.0293					0.0125	0	0.9875	4		
chrX	14038773	14038773	-	T	hom	214	GEMIN8			0	0	0	rs63359860 [];										0.15	0.0375	0.8125	18		
chrX	14044242	14044242	G	A	hom	222	GEMIN8			0.18	0.18	0.18	rs7057480 [];										0.3375	0.05	0.6125	35		
chrX	14044458	14044458	G	A	hom	222	GEMIN8			0.21	0.21	0.21	rs6528161 [];										0.15	0.0375	0.8125	18		
chrX	14047834	14047834	G	T	hom	222	GEMIN8			0.15	0.15	0.15	rs11797935 [];										0.15	0.0375	0.8125	18		
chrX	14749014	14749025	ACACACACACAC	-	hom	152	GLRA2			0	0	0								531			0.2625	0.1	0.6375	32		
chrX	15332469	15332469	-	T	het	11.8	ASB11			0	0	0											0	0.0625	0.9375	5		
chrX	15333842	15333842	T	A	hom	205	ASB11			1	1	1	rs4830529 [];										0.4375	0	0.5625	46		
chrX	15511412	15511412	A	C	hom	222	PIR			0.83	0.83	0.83	rs2271550 [];										0.65	0.075	0.275	69		
chrX	15552564	15552564	T	C	hom	222	BMX			0.71	0.71	0.71	rs1877752 [];										0.275	0.075	0.65	36		
chrX	15552574	15552574	-	A	hom	128	BMX			0	0	0	rs5901566 [];										0.2875	0.0625	0.65	36		
chrX	15554602	15554602	T	G	hom	222	BMX			0.71	0.71	0.71	rs28505625 [];					0.6258					0.2875	0.0625	0.65	47		
chrX	15607650	15607650	T	C	hom	222	ACE2			0.79	0.79	0.79	rs971249 [];										0.25	0.075	0.675	34		
chrX	15610348	15610348	C	T	hom	222	ACE2		ACE2:NM_021804:exon5:c.439+4G>A	0.32	0.32	0.32	rs2285666 [];					0.2106					0.2	0.0375	0.7625	29		
chrX	15677316	15677317	CA	-	het	28.5	TMEM27			0	0	0								294			0	0.075	0.925	13		
chrX	15720122	15720122	C	-	hom	83.5	CA5BP1			0	0	0											0.225	0	0.775	21		
chrX	15720325	15720325	A	G	hom	222	CA5BP1			0.71	0.71	0.71	rs1877923 [];										0.5	0.075	0.425	54		
chrX	15720681	15720682	TG	-	hom	214	CA5BP1			0.7	0.7	0.7	rs35373086 [];										0.4875	0.075	0.4375	53		
chrX	15720723	15720723	C	T	hom	222	CA5BP1			0.71	0.71	0.71	rs5934267 [];										0.4875	0.075	0.4375	53		
chrX	15720745	15720745	G	A	hom	222	CA5BP1			0.07	0.07	0.07	rs56002876 [];										0.15	0.0125	0.8375	14		
chrX	15793563	15793563	C	G	hom	202	CA5B			0.06	0.06	0.06	rs17301840 [];										0.075	0.0125	0.9125	8		
chrX	15794764	15794764	G	A	hom	169	CA5B			0.62	0.62	0.62	rs5980183 [];										0.275	0.075	0.65	34		
chrX	15794815	15794815	G	A	hom	222	CA5B			1	1	1	rs5936050 [];					0.9906					0.4375	0	0.5625	74		
chrX	15805571	15805571	G	A	hom	222	INE2			1	1	1	rs5936053 [];										0.9375	0	0.0625	87		
chrX	15808795	15808795	T	C	hom	222	ZRSR2			1	1	1	rs4830994 [];										0.4375	0	0.5625	46		
chrX	15817963	15817963	A	G	hom	222	ZRSR2			0.88	0.88	0.88	rs5980192 [];					0.7116					0.325	0.025	0.65	62		
chrX	15818115	15818115	T	-	hom	214	ZRSR2			0.56	0.56	0.56	rs62985661 [];					0.4751					0.2	0.0875	0.7125	51		
chrX	15822013	15822013	C	T	hom	179	ZRSR2			0.3	0.3	0.3	rs5936060 [];							690			0.1875	0.075	0.7375	29		
chrX	15822022	15822022	C	T	hom	165	ZRSR2			0.56	0.56	0.56	rs5934280 [];							690			0.2	0.0875	0.7125	34		
chrX	15827524	15827524	T	G	hom	222	ZRSR2			0.88	0.88	0.88	rs5980193 [];										0.325	0.025	0.65	39		
chrX	15836648	15836648	T	G	hom	196	ZRSR2			0.56	0.56	0.56	rs5936062 [];					0.4889					0.2	0.0875	0.7125	53		
chrX	15838366	15838366	C	T	hom	222	ZRSR2	synonymous SNV	ZRSR2:NM_005089:exon10:c.C864T:p.N288N,	0.55	0.55	0.55	rs2301724 [];					0.4872					0.4625	0.1	0.4375	91		
chrX	15844915	15844915	-	AA	het	217	AP1S2			0	0	0									300629 [Adaptor-related protein complex 1, sigma-2 subunit - Mental retardation, X-linked 59, 300630 (3)];		0	0.1375	0.8625	24		
chrX	15863953	15863953	A	T	hom	222	AP1S2			1	1	1	rs798169 [];								300629 [Adaptor-related protein complex 1, sigma-2 subunit - Mental retardation, X-linked 59, 300630 (3)];		0.4375	0	0.5625	46		
chrX	16607388	16607388	C	T	hom	190	CTPS2			0.02	0.02	0.02	rs142245573 [];							514			0	0	1	0		
chrX	16709626	16709626	G	A	hom	222	CTPS2			0.56	0.56	0.56	rs5980322 [];					0.4270					0.2	0.075	0.725	37		
chrX	16717353	16717353	G	A	hom	185	CTPS2			0.55	0.55	0.55	rs5980324 [];										0.175	0.0875	0.7375	26		
chrX	16721129	16721129	T	C	hom	222	CTPS2			0.56	0.56	0.56	rs4831053 [];										0.175	0.0875	0.7375	26		
chrX	16762002	16762002	A	G	hom	222	SYAP1			0.86	0.86	0.86	rs4830562 [];					0.8423					0.2875	0.05	0.6625	60		
chrX	16871145	16871145	C	T	hom	222	RBBP7			0.22	0.22	0.22	rs73207149 [];										0.125	0.0625	0.8125	20		
chrX	16887655	16887655	C	T	hom	222	RBBP7	nonsynonymous SNV	RBBP7:NM_001198719:exon1:c.G110A:p.R37H,	0.23	0.23	0.23	rs67984110 [];	2.1730	0.0058	0.0400	0.0740						0.3875	0.05	0.5625	40		
chrX	17070688	17070688	G	A	hom	216	REPS2			0.87	0.87	0.87	rs933946 [];										0.3125	0.0625	0.625	40		
chrX	17092152	17092152	G	T	hom	218	REPS2			0.88	0.88	0.88	rs1346246 [];										0.3125	0.0625	0.625	40		
chrX	17166219	17166219	C	T	hom	222	REPS2			1	1	1	rs1426797 [];										0.925	0	0.075	91		
chrX	17166795	17166795	A	G	hom	222	REPS2			0.89	0.89	0.89	rs5924606 [];										0.6875	0.1	0.2125	77		
chrX	17167482	17167482	G	T	hom	222	REPS2			0.25	0.25	0.25	rs11797250 [];							2498			0.3625	0.1125	0.525	45		
chrX	17171300	17171300	A	G	hom	222	REPS2			0.28	0.28	0.28	rs11864 [];										0.3875	0.1125	0.5	47		
chrX	17705851	17705851	-	T	hom	214	NHS			0	0	0	rs11408157 [];								300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		1	0	0	156		
chrX	17753436	17753436	A	T	hom	222	NHS			1	1	1	rs5909331 [];								300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		0.9625	0	0.0375	155		
chrX	17819377	17819377	T	C	hom	222	RAI2	nonsynonymous SNV	RAI2:NM_021785:exon2:c.A754G:p.M252V,RAI2:NM_001172732:exon3:c.A604G:p.M202V,RAI2:NM_001172743:exon3:c.A754G:p.M252V,RAI2:NM_001172739:exon3:c.A754G:p.M252V,	1	1	1	rs6527818 [];	1.2330	0.0000	1.0000	0.0000	0.9993					0.95	0	0.05	141		
chrX	18265847	18265847	A	G	hom	222	SCML2			0.03	0.03	0.03	rs73191503 [];					0.0657					0.0125	0.0125	0.975	5		
chrX	18372664	18372664	C	G	hom	222	SCML2			1	1	1	rs12689111 [];										0.4375	0	0.5625	45		
chrX	18372668	18372668	C	G	hom	222	SCML2			1	1	1	rs12689113 [];										0.4375	0	0.5625	45		
chrX	18597869	18597869	C	A	hom	203	CDKL5			0.34	0.34	0.34	rs4825261 [];								300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0.1125	0.05	0.8375	15		
chrX	18631235	18631235	G	A	het	18.1	CDKL5			0	0	0								1158	300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0	0.225	0.775	26		
chrX	18638204	18638204	T	A	hom	183	CDKL5			0.56	0.56	0.56	rs3752484 [];								300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0.125	0.05	0.825	16		
chrX	18767881	18767881	A	C	het	4.77	PPEF1			0	0	0	rs199592750 [];							189			0	0.0875	0.9125	7		
chrX	18910879	18910879	-	T	het	13.7	PHKA2			0	0	0											0	0.3125	0.6875	26		
chrX	18954384	18954384	G	A	hom	166	PHKA2			0.12	0.12	0.12	rs12862285 [];										0.1	0.0125	0.8875	10		
chrX	18959796	18959796	G	A	hom	222	PHKA2		PHKA2:NM_000292:exon9:c.718-3C>T	0.01	0.01	0.01	rs140662042 [];					0.0187					0.025	0	0.975	3		
chrX	19478294	19478294	T	A	hom	222	MAP3K15			0.91	0.91	0.91	rs5909118 [];					0.9036					0.4	0.025	0.575	62		
chrX	19478337	19478337	-	A	hom	214	MAP3K15			0	0	0	rs61014139 [];										0.4	0.025	0.575	44		
chrX	19482476	19482476	C	T	hom	222	MAP3K15	nonsynonymous SNV	MAP3K15:NM_001001671:exon4:c.G574A:p.A192T,	0.72	0.72	0.72	rs5909299 [];	0.5730		0.1000		0.8867					0.875	0.0375	0.0875	133		
chrX	19764367	19764367	C	A	hom	222	SH3KBP1			0.01	0.01	0.01	rs113042357 [];										0.0125	0	0.9875	2		
chrX	20159910	20159910	G	A	het	4.13	EIF1AX			0.12	0.12	0.12	rs187747791 [];						COSN414048 [1(urinary_tract)]; 				0.0125	0.1625	0.825	15		
chrX	21613596	21613596	C	T	hom	222	CNKSR2			0	0	0											0	0	1	0		
chrX	21861434	21861434	A	G	hom	222	MBTPS2	synonymous SNV	MBTPS2:NM_015884:exon2:c.A222G:p.Q74Q,	0.47	0.47	0.47	rs3213451 [];					0.3896			300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.2875	0.0875	0.625	98		
chrX	21875822	21875822	A	-	hom	119	YY2			0	0	0	rs11339991 [];								300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.125	0.025	0.85	16		
chrX	21888941	21888966	AAAATCAGCTTCCCAATTCTTTATAC	-	hom	214	MBTPS2			0.21	0.21	0.21	rs201268577 [];								300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.1125	0.075	0.8125	18		
chrX	21889105	21889105	C	T	hom	222	MBTPS2			0.49	0.49	0.49	rs6418748 [];								300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.1125	0.075	0.8125	21		
chrX	21901903	21901903	G	A	hom	222	MBTPS2			0.45	0.45	0.45	rs5951476 [];								300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.3125	0.075	0.6125	74		
chrX	21985464	21985464	C	T	hom	222	SMS			0.49	0.49	0.49	rs3747276 [];					0.3405			300105 [Spermine synthase - Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)];		0.125	0.0375	0.8375	37		
chrX	22051034	22051034	A	G	hom	222	PHEX			0.49	0.49	0.49	rs178710 [];										0.3375	0.0125	0.65	33		
chrX	22115197	22115197	A	G	hom	222	PHEX			0.08	0.08	0.08	rs58524357 [];					0.0300					0.025	0.025	0.95	4		
chrX	23398214	23398214	T	C	hom	222	PTCHD1	synonymous SNV	PTCHD1:NM_173495:exon2:c.T858C:p.C286C,	0.65	0.65	0.65	rs5926304 [];					0.6121					0.575	0.0625	0.3625	155		
chrX	23399245	23399245	-	T	hom	118	PTCHD1			0	0	0	rs67118077 [];										0.4625	0.0625	0.475	49		
chrX	23685964	23685964	T	C	hom	213	PRDX4			0.67	0.67	0.67	rs496067 [];					0.5760					0.1625	0.0375	0.8	33		
chrX	23689636	23689636	A	T	hom	222	PRDX4			0.53	0.53	0.53	rs513572 [];					0.3460					0.1875	0.0375	0.775	54		
chrX	23689637	23689637	T	C	hom	222	PRDX4			0.53	0.53	0.53	rs513573 [];					0.3518					0.45	0.05	0.5	76		
chrX	23697485	23697485	G	A	hom	222	PRDX4			0.66	0.66	0.66	rs795493 [];										0.1625	0.0625	0.775	26		
chrX	23700473	23700473	G	A	hom	222	PRDX4			0.66	0.66	0.66	rs552105 [];					0.5748					0.1625	0.0625	0.775	37		
chrX	23700693	23700693	A	G	hom	222	PRDX4			0.45	0.45	0.45	rs795489 [];					0.4104					0.0875	0.0625	0.85	28		
chrX	23723554	23723554	C	T	hom	222	ACOT9			0.37	0.37	0.37	rs580192 [];										0.075	0.0375	0.8875	13		
chrX	23724984	23724984	C	A	hom	222	ACOT9			0.2	0.2	0.2	rs546321 [];							499			0.2125	0.0375	0.75	22		
chrX	23928489	23928489	C	T	hom	222	CXorf58	nonsynonymous SNV	CXorf58:NM_152761:exon2:c.C70T:p.R24C [1(prostate)]; CXorf58:NM_001169574:exon2:c.C70T:p.R24C [1(prostate)]; 	0.47	0.47	0.47	rs2707164 [];	-0.2740	0.0113	0.1900	0.5500	0.7053	1179846 [1(prostate)]; 				0.55	0.075	0.375	87		
chrX	23934052	23934052	G	A	hom	222	CXorf58			0.51	0.51	0.51	rs2520231 [];										0.2375	0.0875	0.675	33		
chrX	23934202	23934202	A	G	hom	222	CXorf58			0.42	0.42	0.42	rs2520230 [];										0.2625	0.0625	0.675	33		
chrX	24005229	24005229	A	G	hom	222	KLHL15			0.12	0.12	0.12	rs56051542 [];										0.0375	0.05	0.9125	10		
chrX	24073761	24073761	C	T	hom	222	EIF2S3	synonymous SNV	EIF2S3:NM_001415:exon2:c.C99T:p.H33H,	0.48	0.48	0.48	rs36018672 [];	-0.7490				0.6748					0.625	0.0375	0.3375	145		
chrX	24084254	24084254	-	T	hom	214	EIF2S3			0	0	0											0.2625	0.0625	0.675	44		
chrX	24225380	24225380	-	T	het	28.5	ZFX			0	0	0											0	0.0125	0.9875	1		
chrX	24231758	24231758	T	C	hom	222	ZFX			0.39	0.39	0.39	rs5949242 [];										0.275	0.1125	0.6125	36		
chrX	24231817	24231817	-	AA	hom	209	ZFX			0	0	0											0.15	0.1625	0.6875	30		
chrX	24232095	24232095	C	T	hom	222	ZFX			0.56	0.56	0.56	rs1042604 [];										0.4125	0.0625	0.525	45		
chrX	24536986	24536997	ACACACACACAC	-	het	136	PDK3			0	0	0								387			0	0	1	0		
chrX	24545949	24545949	C	G	hom	222	PDK3			0.15	0.15	0.15	rs16983110 [];							206			0.0375	0.0625	0.9	8		
chrX	24577591	24577591	T	A	hom	208	PCYT1B			0.77	0.77	0.77	rs2178608 [];							654			0.6375	0.0375	0.325	63		
chrX	24578306	24578306	G	A	hom	222	PCYT1B			0.66	0.66	0.66	rs3761611 [];										0.7	0.0375	0.2625	73		
chrX	24578551	24578551	T	A	hom	222	PCYT1B			0.71	0.71	0.71	rs3761610 [];										0.75	0.025	0.225	80		
chrX	24578803	24578803	C	T	hom	222	PCYT1B			0.69	0.69	0.69	rs10156959 [];										0.7	0.0375	0.2625	75		
chrX	24593464	24593464	A	-	hom	76.5	PCYT1B			0	0	0											0.3	0.0125	0.6875	41		
chrX	24593513	24593513	T	G	hom	222	PCYT1B			0.6	0.6	0.6	rs3747401 [];										0.3	0.0375	0.6625	38		
chrX	24665388	24665388	-	C	hom	214	PCYT1B			0.02	0.02	0.02											0.25	0.0625	0.6875	36		
chrX	24751958	24751958	T	C	hom	222	POLA1			1	1	1	rs75310488 [];										0.9875	0	0.0125	140		
chrX	24766651	24766651	G	A	hom	222	POLA1			0.54	0.54	0.54	rs3764770 [];										0.2875	0.025	0.6875	35		
chrX	24844699	24844699	C	A	hom	222	POLA1	synonymous SNV	POLA1:NM_016937:exon32:c.C3699A:p.V1233V,	0.03	0.03	0.03	rs11573423 [];					0.0786					0.0375	0.025	0.9375	11		
chrX	26156360	26156360	A	C	hom	183	MAGEB18			0.13	0.13	0.13	rs41305167 [];										0.0125	0	0.9875	2		
chrX	26156448	26156448	A	T	hom	222	MAGEB18			0.69	0.69	0.69	rs6526549 [];										0.1875	0.0375	0.775	22		
chrX	26156610	26156610	A	G	hom	222	MAGEB18			0.13	0.13	0.13	rs41305165 [];										0.0125	0	0.9875	2		
chrX	26157045	26157045	C	A	hom	222	MAGEB18			0.13	0.13	0.13	rs5944316 [];										0.05	0	0.95	6		
chrX	26157058	26157058	T	C	hom	222	MAGEB18			0.11	0.11	0.11	rs5943844 [];					0.0795					0.05	0	0.95	12		
chrX	26157059	26157059	T	C	hom	222	MAGEB18			0.12	0.12	0.12	rs5943845 [];					0.0786					0.05	0	0.95	12		
chrX	26157220	26157220	C	T	hom	222	MAGEB18	nonsynonymous SNV	MAGEB18:NM_173699:exon2:c.C118T:p.P40S,	0.68	0.68	0.68	rs5944317 [];	-2.3050	0.0012	1.0000	0.0000	0.4215					0.4	0.0625	0.5375	67		
chrX	26157792	26157792	C	T	hom	222	MAGEB18	synonymous SNV	MAGEB18:NM_173699:exon2:c.C690T:p.A230A,	0.69	0.69	0.69	rs5944318 [];					0.4217					0.4125	0.05	0.5375	67		
chrX	26158233	26158233	C	A	hom	222	MAGEB18			0.13	0.13	0.13	rs5944319 [];										0.0125	0	0.9875	2		
chrX	26158470	26158470	-	TTT	hom	214	MAGEB18			0	0	0											0.0125	0	0.9875	2		
chrX	26158493	26158493	G	T	hom	222	MAGEB18			0.13	0.13	0.13	rs5944320 [];										0.05	0	0.95	6		
chrX	26210586	26210586	C	T	hom	222	MAGEB6			0.4	0.4	0.4	rs11795624 [];										0.3375	0.05	0.6125	38		
chrX	26212251	26212251	C	T	hom	222	MAGEB6	synonymous SNV	MAGEB6:NM_173523:exon2:c.C288T:p.T96T,	0.07	0.07	0.07	rs4351548 [];										0.0375	0	0.9625	14		
chrX	26212256	26212256	G	A	hom	222	MAGEB6	nonsynonymous SNV	MAGEB6:NM_173523:exon2:c.G293A:p.R98H,	0.07	0.07	0.07	rs4630029 [];	-5.1440	0.0010	0.0100	0.0000						0.0375	0	0.9625	13		
chrX	26212262	26212262	-	TC	het	85.5	MAGEB6	frameshift insertion	MAGEB6:NM_173523:exon2:c.299_300insTC:p.A100fs,	0	0	0											0	0	1	1		
chrX	26212305	26212305	T	G	hom	25.5	MAGEB6	synonymous SNV	MAGEB6:NM_173523:exon2:c.T342G:p.S114S [1(prostate),1(large_intestine)]; 	0.04	0.04	0.04	rs4997767 [];						184061 [1(prostate),1(large_intestine)]; 				0.0125	0	0.9875	3		
chrX	26212334	26212334	A	C	hom	129	MAGEB6	nonsynonymous SNV	MAGEB6:NM_173523:exon2:c.A371C:p.Y124S,	0	0	0	rs143802048 [];	-1.3530	0.0001	1.0000	0.0000	0.0121					0	0.0375	0.9625	3		
chrX	26212335	26212335	T	C	hom	128	MAGEB6	synonymous SNV	MAGEB6:NM_173523:exon2:c.T372C:p.Y124Y,	0	0	0						0.0128					0	0.0375	0.9625	3		
chrX	26213219	26213219	T	C	hom	222	MAGEB6			0.4	0.4	0.4	rs5986312 [];					0.3325	COSN414054 [1(urinary_tract)]; 				0.325	0.0625	0.6125	49		
chrX	26213365	26213365	-	TTGTC	hom	214	MAGEB6			0	0	0	rs67830399 [];										0.3625	0.05	0.5875	40		
chrX	26576391	26576391	C	G	hom	200	VENTXP1			0.24	0.24	0.24	rs4537454 [];										0.0125	0.025	0.9625	3		
chrX	26577838	26577838	C	A	hom	222	VENTXP1			0.22	0.22	0.22	rs72623098 [];										0.0375	0.05	0.9125	8		
chrX	27478720	27478720	C	T	hom	222	SMEK3P			0.55	0.55	0.55	rs5926442 [];										0.4875	0.1125	0.4	59		
chrX	27478736	27478736	G	A	hom	222	SMEK3P			0.67	0.67	0.67	rs5926772 [];										0.575	0.075	0.35	61		
chrX	27479339	27479339	A	G	hom	222	SMEK3P			0.53	0.53	0.53	rs12842916 [];										0.5125	0.1	0.3875	64		
chrX	27839572	27839572	T	C	hom	222	MAGEB10	nonsynonymous SNV	MAGEB10:NM_182506:exon3:c.T149C:p.F50S,	0.36	0.36	0.36	rs1368769 [];	0.0020	0.0000	1.0000	0.0000	0.5321					0.425	0.1125	0.4625	82		
chrX	27839617	27839617	G	A	hom	222	MAGEB10	nonsynonymous SNV	MAGEB10:NM_182506:exon3:c.G194A:p.R65Q [1(prostate)]; 	0.25	0.25	0.25	rs12557898 [];	-1.5850	0.0000	1.0000	0.0040	0.5019	1179847 [1(prostate)]; 				0.4	0.0875	0.5125	77		
chrX	28606324	28606325	TG	-	het	61.5	IL1RAPL1			0	0	0	rs71721019 [];							579	300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.05	0.075	0.875	13		
chrX	28807442	28807442	G	A	hom	222	IL1RAPL1			0.71	0.71	0.71	rs6526806 [];					0.4920	COSN414057 [2(urinary_tract)]; COSN414056 [2(urinary_tract)]; 		300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.5125	0.0625	0.425	135		
chrX	29417510	29417510	C	A	hom	222	IL1RAPL1			1	1	1	rs4829347 [];								300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.4375	0	0.5625	46		
chrX	30236658	30236658	T	C	hom	222	MAGEB2			0.33	0.33	0.33	rs6526962 [];					0.3946					0.1	0.0375	0.8625	22		
chrX	30236878	30236878	G	A	hom	222	MAGEB2	nonsynonymous SNV	MAGEB2:NM_002364:exon2:c.G181A:p.E61K [1(stomach)]; 	0.84	0.84	0.84	rs2529541 [];	-0.8280	0.0000	0.8900	0.0040	0.9485	150775 [1(stomach)]; 				0.8875	0	0.1125	135		
chrX	30236913	30236913	G	A	hom	222	MAGEB2	synonymous SNV	MAGEB2:NM_002364:exon2:c.G216A:p.A72A,	0.18	0.18	0.18	rs5973792 [];					0.2846					0.2	0.025	0.775	39		
chrX	30237003	30237003	C	T	hom	222	MAGEB2	synonymous SNV	MAGEB2:NM_002364:exon2:c.C306T:p.S102S,	0.32	0.32	0.32	rs2074793 [];					0.3945					0.2875	0.05	0.6625	51		
chrX	30237836	30237836	-	TT	het	217	MAGEB2			0	0	0											0	0.0375	0.9625	3		
chrX	30238026	30238026	G	A	hom	222	MAGEB2			0.18	0.18	0.18	rs5972091 [];										0.2	0.0375	0.7625	22		
chrX	30238090	30238090	T	G	hom	222	MAGEB2			0.33	0.33	0.33	rs1053918 [];										0.2875	0.05	0.6625	31		
chrX	30248632	30248632	-	TAC	hom	214	MAGEB3			0	0	0	rs72347081 [];										0.2375	0.0375	0.725	27		
chrX	30254376	30254376	T	C	hom	222	MAGEB3	nonsynonymous SNV	MAGEB3:NM_002365:exon5:c.T335C:p.I112T,	0.81	0.81	0.81	rs2071309 [];	-3.1530	0.0000	1.0000	0.0000	0.8971					0.8125	0	0.1875	125		
chrX	30255520	30255520	C	T	hom	222	MAGEB3			0.81	0.81	0.81	rs2529554 [];										0.825	0	0.175	79		
chrX	30261002	30261002	A	G	hom	222	MAGEB4	synonymous SNV	MAGEB4:NM_002367:exon1:c.A750G:p.V250V [1(prostate)]; 	0.81	0.81	0.81	rs2071311 [];					0.8970	1132336 [1(prostate)]; 				0.8125	0	0.1875	131		
chrX	30261158	30261158	G	C	hom	222	MAGEB4	synonymous SNV	MAGEB4:NM_002367:exon1:c.G906C:p.L302L,	0.81	0.81	0.81	rs2856733 [];					0.8970					0.825	0	0.175	132		
chrX	30265213	30265213	G	C	hom	222	MAGEB1			0.15	0.15	0.15	rs17282844 [];										0.1375	0.025	0.8375	16		
chrX	30265555	30265555	G	C	hom	222	MAGEB1			0.82	0.82	0.82	rs2074794 [];										0.8125	0	0.1875	82		
chrX	30269887	30269887	T	A	hom	222	MAGEB1			1	1	1	rs2529569 [];										0.925	0	0.075	90		
chrX	30709444	30709444	G	A	hom	186	GK			0.31	0.31	0.31	rs55895067 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.1	0.05	0.85	15		
chrX	30712796	30712796	G	C	hom	222	GK			0.81	0.81	0.81	rs5927587 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.3	0.0125	0.6875	34		
chrX	30715827	30715827	C	T	hom	222	GK			0.77	0.77	0.77	rs2035432 [];					0.7519			300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.2875	0.0125	0.7	108		
chrX	30718877	30718877	-	AAAT	hom	214	GK			0	0	0	rs143145925 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.3	0.0125	0.6875	33		
chrX	30748284	30748284	T	C	hom	222	GK			0.7	0.7	0.7	rs5926945 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.6	0.025	0.375	111		
chrX	30849042	30849042	-	CCC	hom	214	TAB3			0	0	0											0.225	0.0375	0.7375	22		
chrX	30849176	30849176	G	A	hom	222	TAB3			0.58	0.58	0.58	rs5972240 [];										0.5375	0.0375	0.425	58		
chrX	30872602	30872602	A	G	hom	222	TAB3	nonsynonymous SNV	TAB3:NM_152787:exon6:c.T1180C:p.W394R,	1	1	1	rs5927629 [];	0.4700	0.0000	1.0000	0.0000	0.9997					0.9875	0	0.0125	147		
chrX	30889857	30889857	A	G	hom	222	TAB3			0.87	0.87	0.87	rs5927633 [];										0.825	0.0125	0.1625	81		
chrX	31144938	31144941	AAAA	-	het	8.3	DMD			0	0	0								219	300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0625	0.05	0.8875	10		
chrX	31165668	31165671	AAAG	-	hom	214	DMD			0.66	0.66	0.66	rs200534475 [];					0.8199		279	300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.3	0.0625	0.6375	67		
chrX	31191589	31191589	C	T	hom	222	DMD			0.87	0.87	0.87	rs2404496 [];					0.8476			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.325	0.0625	0.6125	64		
chrX	31200833	31200833	-	T	hom	9.03	DMD			0	0	0	rs34762573 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.2	0	0.8	23		
chrX	31496350	31496350	C	T	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon59:c.G8798A:p.R2933Q,DMD:NM_004014:exon5:c.G623A:p.R208Q,DMD:NM_004011:exon31:c.G4787A:p.R1596Q,DMD:NM_004010:exon59:c.G8441A:p.R2814Q,DMD:NM_004022:exon16:c.G1430A:p.R477Q,DMD:NM_004006:exon59:c.G8810A:p.R2937Q,DMD:NM_004013:exon16:c.G1430A:p.R477Q,DMD:NM_004007:exon58:c.G8441A:p.R2814Q,DMD:NM_004020:exon16:c.G1430A:p.R477Q,DMD:NM_004023:exon16:c.G1430A:p.R477Q,DMD:NM_004012:exon31:c.G4778A:p.R1593Q,DMD:NM_004021:exon16:c.G1430A:p.R477Q,DMD:NM_000109:exon59:c.G8786A:p.R2929Q,	0.94	0.94	0.94	rs1800280 [];	0.7890	0.0000	0.8200	0.0010	0.9392			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.8875	0	0.1125	199		
chrX	31986430	31986430	C	A	hom	222	DMD			0.33	0.33	0.33	rs3761604 [];					0.3123			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1375	0.05	0.8125	37		
chrX	32363965	32363965	-	AG	hom	214	DMD			0	0	0	rs34160829 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.2875	0.05	0.6625	36		
chrX	32380996	32380996	C	T	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon37:c.G5222A:p.R1741H,DMD:NM_004011:exon9:c.G1211A:p.R404H,DMD:NM_004010:exon37:c.G4865A:p.R1622H,DMD:NM_004006:exon37:c.G5234A:p.R1745H,DMD:NM_004007:exon36:c.G4865A:p.R1622H,DMD:NM_004012:exon9:c.G1202A:p.R401H,DMD:NM_000109:exon37:c.G5210A:p.R1737H,	0.45	0.45	0.45	rs1801187 [];	2.1640	0.0000	0.2900	0.9970	0.4770			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.3625	0.1	0.5375	112		
chrX	32383034	32383034	C	T	hom	222	DMD			0.52	0.52	0.52	rs5927975 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1875	0.075	0.7375	27		
chrX	32459402	32459402	C	G	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon28:c.G3804C:p.L1268F,DMD:NM_004010:exon28:c.G3447C:p.L1149F,DMD:NM_004006:exon28:c.G3816C:p.L1272F,DMD:NM_004007:exon27:c.G3447C:p.L1149F,DMD:NM_000109:exon28:c.G3792C:p.L1264F,	0	0	0		2.0810	0.0000	0.3000	0.9970				300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	32481863	32481863	T	C	hom	207	DMD			0.68	0.68	0.68	rs170608 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.3125	0.025	0.6625	37		
chrX	32486806	32486806	C	G	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon23:c.G2959C:p.E987Q,DMD:NM_004010:exon23:c.G2602C:p.E868Q,DMD:NM_004006:exon23:c.G2971C:p.E991Q,DMD:NM_004007:exon22:c.G2602C:p.E868Q,DMD:NM_000109:exon23:c.G2947C:p.E983Q,	0	0	0	rs72468667 [];	2.2340	0.0000	0.4300	0.8150	0.0022			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	32614103	32614103	C	T	hom	178	DMD			0.57	0.57	0.57	rs808543 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1375	0.025	0.8375	17		
chrX	32841370	32841370	A	G	hom	218	DMD			0.0012	0.0012	0.0012	rs72470529 [];					0.0043			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0125	0	0.9875	1		
chrX	37313299	37313299	A	G	hom	222	PRRG1			0.003	0.003	0.003	rs181842450 [];										0	0	1	0		
chrX	37536392	37536393	TG	-	het	26.5	LANCL3			0	0	0								281			0.0375	0.1375	0.825	14		
chrX	37699365	37699365	-	TAAG	hom	214	DYNLT3			0	0	0											0.25	0.0375	0.7125	28		
chrX	37699977	37699978	AC	-	het	21.5	DYNLT3			0.1	0.1	0.1								585			0	0.05	0.95	5		
chrX	37701048	37701048	G	A	hom	222	DYNLT3	synonymous SNV	DYNLT3:NM_006520:exon3:c.C183T:p.A61A,	0.3	0.3	0.3	rs11771 [];					0.1550					0.2	0.025	0.775	30		
chrX	37701208	37701208	A	G	hom	222	DYNLT3			0.37	0.37	0.37	rs5964203 [];					0.1465					0.1125	0	0.8875	14		
chrX	38008727	38008727	G	C	hom	222	SRPX			0.91	0.91	0.91	rs9934 [];										0.8375	0.0375	0.125	83		
chrX	38186561	38186561	G	C	hom	98.1	RPGR			0	0	0											0	0	1	0		
chrX	38663104	38663104	T	C	hom	222	MID1IP1			0.66	0.66	0.66	rs198783 [];										0.675	0.0375	0.2875	69		
chrX	38663750	38663750	-	TGG	hom	214	MID1IP1			0	0	0											0	0	1	0		
chrX	39911062	39911062	-	TT	hom	214	BCOR			0	0	0	rs35289701 [];								300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.2125	0	0.7875	40		
chrX	39911657	39911657	C	A	hom	222	BCOR		BCOR:NM_001123385:exon16:c.4977-4G>T,NM_017745:exon16:c.4875-4G>T,NM_001123383:exon16:c.4875-4G>T,NM_001123384:exon15:c.4821-4G>T	0.14	0.14	0.14	rs78992023 [];					0.1989			300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.1875	0	0.8125	46		
chrX	39922359	39922359	A	G	hom	147	BCOR			0.6	0.6	0.6	rs3810694 [];					0.3265			300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.1125	0.025	0.8625	33		
chrX	39933339	39933339	A	G	hom	222	BCOR	synonymous SNV	BCOR:NM_001123383:exon4:c.T1260C:p.D420D,BCOR:NM_001123385:exon4:c.T1260C:p.D420D,BCOR:NM_001123384:exon4:c.T1260C:p.D420D,BCOR:NM_017745:exon4:c.T1260C:p.D420D,	0.93	0.93	0.93	rs5917933 [];					0.8792			300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.8375	0.0125	0.15	184		
chrX	40460197	40460197	-	AAA	hom	214	ATP6AP2			0	0	0									300556 [ATPase, H+ transporting, lysosomal, accessory protein 2 - Mental retardation, X-linked, with epilepsy, 300423 (3)];		0.125	0.0375	0.8375	23		
chrX	40506697	40506697	A	G	hom	222	CXorf38	synonymous SNV	CXorf38:NM_144970:exon1:c.T76C:p.L26L [1(prostate)]; 	0.97	0.97	0.97	rs6610447 [];					0.9436	1132306 [1(prostate)]; 				0.8875	0.0125	0.1	135		
chrX	40507542	40507542	A	G	hom	222	CXorf38			0.0042	0.0042	0.0042	rs41310649 [];										0	0	1	0		
chrX	40514322	40514322	G	A	hom	222	MED14			0.59	0.59	0.59	rs11266293 [];					0.8092					0.7125	0.025	0.2625	120		
chrX	40556492	40556492	C	G	hom	222	MED14			0.88	0.88	0.88	rs5918029 [];										0.275	0.05	0.675	34		
chrX	40990665	40990665	T	C	hom	222	USP9X			0	0	0											0	0	1	0		
chrX	41031320	41031320	T	G	het	61	USP9X			0	0	0	rs200304284 [];							1165			0	0.425	0.575	45		
chrX	41078151	41078151	A	T	hom	222	USP9X			0	0	0											0	0	1	0		
chrX	41094888	41094888	G	A	hom	222	USP9X			0.02	0.02	0.02	rs73203659 [];										0.0125	0	0.9875	1		
chrX	41209169	41209169	-	T	het	149	DDX3X			0	0	0											0	0.125	0.875	11		
chrX	41530668	41530668	-	T	hom	214	CASK			0	0	0									300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.0375	0.0375	0.925	10		
chrX	41548943	41548943	T	C	hom	194	CASK;GPR34			0.95	0.95	0.95	rs5918226 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.3875	0.025	0.5875	42		
chrX	43085367	43085367	G	T	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447881;MAOA:dist=428788	0.95	0.95	0.95	rs2410927 [];							2354			0.925	0.0125	0.0625	85		
chrX	43137719	43137719	G	A	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=500233;MAOA:dist=376436	0.4	0.4	0.4	rs7052538 [];										0.1875	0.0375	0.775	21		
chrX	43571197	43571197	A	C	hom	222	MAOA	synonymous SNV	MAOA:NM_000240:exon4:c.A385C:p.R129R,	0.14	0.14	0.14	rs1800464 [];					0.0410					0.025	0.025	0.95	19		
chrX	43591036	43591036	G	T	hom	222	MAOA	synonymous SNV	MAOA:NM_000240:exon8:c.G891T:p.R297R,MAOA:NM_001270458:exon9:c.G492T:p.R164R,	0.67	0.67	0.67	rs6323 [];					0.7045					0.65	0.0625	0.2875	155		
chrX	43595428	43595428	A	G	hom	222	MAOA			0.67	0.67	0.67	rs2235186 [];					0.7048					0.275	0.05	0.675	79		
chrX	43601142	43601142	C	T	hom	205	MAOA			0.67	0.67	0.67	rs979606 [];										0.275	0.05	0.675	33		
chrX	43601363	43601363	A	G	hom	222	MAOA			0.61	0.61	0.61	rs979605 [];										0.275	0.05	0.675	33		
chrX	43603391	43603391	T	C	hom	222	MAOA	synonymous SNV	MAOA:NM_000240:exon14:c.T1410C:p.D470D,MAOA:NM_001270458:exon15:c.T1011C:p.D337D,	0.6	0.6	0.6	rs1137070 [];					0.7035					0.6375	0.0625	0.3	154		
chrX	43604841	43604841	A	G	hom	222	MAOA			0.6	0.6	0.6	rs3027407 [];										0.6125	0.0625	0.325	111		
chrX	43741616	43741616	G	C	hom	149	MAOB			1	1	1	rs1181251 [];							221			0.875	0	0.125	107		
chrX	44382809	44382809	C	-	het	13.7	FUNDC1			0.05	0.05	0.05								2413			0	0.05	0.95	7		
chrX	44935936	44935937	TT	-	hom	43.5	KDM6A			0	0	0											0.35	0.2625	0.3875	84		
chrX	45707382	45707382	-	A	hom	133	MIR222;KRBOX4		MIR222:dist=100852;KRBOX4:dist=599242	0	0	0											0.2125	0.0625	0.725	25		
chrX	45709517	45709517	-	AAA	het	146	MIR222;KRBOX4		MIR222:dist=102987;KRBOX4:dist=597107	0	0	0											0	0.225	0.775	18		
chrX	45710227	45710227	T	A	hom	222	MIR222;KRBOX4		MIR222:dist=103697;KRBOX4:dist=596397	0.64	0.64	0.64	rs5906091 [];										0.325	0.1375	0.5375	42		
chrX	46306930	46306930	G	T	hom	122	KRBOX4			0.33	0.33	0.33	rs4824581 [];										0.1625	0.075	0.7625	23		
chrX	46737139	46737139	-	GTGTGT	hom	211	RP2			0	0	0								270			0.3625	0	0.6375	38		
chrX	46740032	46740032	G	A	hom	222	RP2			0.99	0.99	0.99	rs4239962 [];										0.9625	0	0.0375	93		
chrX	46893249	46893249	G	A	hom	222	PHF16			0.98	0.98	0.98	rs5906311 [];										0.3875	0.0375	0.575	45		
chrX	46918917	46918917	-	A	hom	214	PHF16			0	0	0	rs66617346 [];										0.9625	0	0.0375	93		
chrX	46918975	46918975	-	A	hom	214	PHF16			0	0	0	rs59370972 [];										0.9625	0	0.0375	93		
chrX	46919652	46919652	A	-	hom	140	PHF16			0	0	0	rs60606687 [];										0.925	0	0.075	90		
chrX	47060844	47060844	C	G	hom	222	UBA1			0.33	0.33	0.33	rs4239963 [];					0.3203			314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.0875	0.05	0.8625	39		
chrX	47061018	47061018	C	G	hom	222	UBA1			0.98	0.98	0.98	rs4239964 [];					0.9841			314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.9375	0	0.0625	202		
chrX	47063164	47063164	-	T	het	62.5	UBA1			0	0	0								2386	314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0	0.175	0.825	17		
chrX	47065186	47065186	G	A	hom	222	INE1			0.33	0.33	0.33	rs4339766 [];							2003	314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.2375	0.0625	0.7	27		
chrX	47086682	47086682	-	C	hom	54.5	CDK16			0	0	0	rs33927416 [];										0.0375	0.05	0.9125	15		
chrX	47088740	47088740	C	G	het	50	CDK16			0	0	0											0	0.3875	0.6125	44		
chrX	47088744	47088744	A	C	het	20	CDK16			0	0	0											0	0.3625	0.6375	38		
chrX	47103049	47103049	C	T	hom	181	USP11			0.0024	0.0024	0.0024	rs73201999 [];					0.0089		299			0	0	1	0		
chrX	47327111	47327111	T	C	hom	222	ZNF41			0.78	0.78	0.78	rs5905607 [];										0.45	0.0875	0.4625	49		
chrX	47341780	47341780	T	C	hom	222	ZNF41			0.97	0.97	0.97	rs5905609 [];										0.4375	0	0.5625	45		
chrX	47341785	47341785	C	T	hom	222	ZNF41			0.08	0.08	0.08	rs5905610 [];										0.025	0.05	0.925	6		
chrX	47444879	47444879	G	C	hom	222	SYN1;TIMP1			0.45	0.45	0.45	rs5953060 [];	-0.0050	0.2709	0.0000	0.0000				313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.2125	0.025	0.7625	22		
chrX	47444985	47444985	T	C	hom	222	TIMP1	synonymous SNV	TIMP1:NM_003254:exon5:c.T372C:p.F124F,	0.45	0.45	0.45	rs4898 [];	-0.3520	0.2772			0.4575			313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.4625	0.0375	0.5	67		
chrX	47466361	47466361	A	G	hom	222	SYN1	synonymous SNV	SYN1:NM_133499:exon3:c.T510C:p.N170N,SYN1:NM_006950:exon3:c.T510C:p.N170N,	0.35	0.35	0.35	rs1142636 [];					0.3786			313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.2625	0.0625	0.675	72		
chrX	47484680	47484680	C	A	hom	222	CFP			0.14	0.14	0.14	rs2239455 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.0125	0.05	0.9375	6		
chrX	47484840	47484840	C	T	hom	222	CFP			0.14	0.14	0.14	rs7060246 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.0125	0.05	0.9375	6		
chrX	47485245	47485245	G	A	hom	222	CFP			0.84	0.84	0.84	rs8177079 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.7625	0.0375	0.2	75		
chrX	47487913	47487913	-	G	hom	214	CFP			0	0	0	rs11453568 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.9625	0	0.0375	89		
chrX	47863552	47863552	-	C	hom	214	SPACA5;ZNF182			0	0	0	rs36101191 [];										0.4375	0	0.5625	46		
chrX	47920356	47920356	A	G	hom	222	ZNF630			1	1	1	rs727079 [];					0.9945					0.4375	0	0.5625	74		
chrX	47967040	47967040	G	A	hom	186	SSX6			0.44	0.44	0.44	rs12156664 [];										0.125	0.025	0.85	17		
chrX	47967162	47967162	C	T	hom	222	SSX6			0.36	0.36	0.36	rs12156676 [];										0.225	0.05	0.725	28		
chrX	47967190	47967190	A	G	hom	222	SSX6			0.36	0.36	0.36	rs12156891 [];										0.225	0.0625	0.7125	29		
chrX	47970842	47970842	A	T	hom	222	SSX6			0.47	0.47	0.47	rs543755 [];							534			0.125	0.0375	0.8375	18		
chrX	48045802	48045803	GT	-	hom	214	SSX5			0	0	0								351			0.55	0.075	0.375	61		
chrX	48046032	48046032	T	C	hom	222	SSX5			0.96	0.96	0.96	rs2314191 [];										0.9875	0	0.0125	100		
chrX	48049666	48049666	C	T	hom	222	SSX5	synonymous SNV	SSX5:NM_021015:exon7:c.G492A:p.S164S,SSX5:NM_175723:exon6:c.G369A:p.S123S,	0.93	0.93	0.93	rs5906557 [];					0.9991					0.9875	0	0.0125	145		
chrX	48053521	48053521	T	C	hom	222	SSX5			0.88	0.88	0.88	rs4239967 [];					0.9967					0.4375	0	0.5625	74		
chrX	48054740	48054740	C	G	hom	222	SSX5	nonsynonymous SNV	SSX5:NM_021015:exon2:c.G55C:p.E19Q,SSX5:NM_175723:exon2:c.G55C:p.E19Q,	0.88	0.88	0.88	rs4824675 [];	0.0950	0.0010	0.1400	0.7210	0.9969					0.975	0	0.025	147		
chrX	48056189	48056189	C	G	hom	222	SSX5			0.96	0.96	0.96	rs4824676 [];										0.975	0	0.025	97		
chrX	48126692	48126693	AC	-	het	89.5	SSX1			0	0	0								303			0	0.175	0.825	21		
chrX	48155075	48155078	GTGT	-	het	217	SSX1;SSX9		SSX1:dist=28196;SSX9:dist=5907	0	0	0								312			0	0	1	0		
chrX	48155136	48155136	G	C	hom	222	SSX1;SSX9		SSX1:dist=28257;SSX9:dist=5849	1	1	1	rs4824689 [];										0.9875	0	0.0125	99		
chrX	48161281	48161281	C	G	hom	222	SSX9			0.95	0.95	0.95	rs4571855 [];										0.4375	0	0.5625	46		
chrX	48164138	48164138	A	G	hom	222	SSX9			0.94	0.94	0.94	rs5906631 [];										0.4375	0	0.5625	46		
chrX	48206013	48206022	GGTGTGTGTC	-	het	217	SSX3			0	0	0								340			0	0.0625	0.9375	5		
chrX	48206037	48206037	T	-	het	14.6	SSX3			0	0	0								340			0	0.0125	0.9875	1		
chrX	48206692	48206692	C	T	hom	222	SSX3			0.18	0.18	0.18	rs9887689 [];										0.0125	0.025	0.9625	4		
chrX	48206722	48206722	C	G	hom	222	SSX3			0.17	0.17	0.17	rs9887693 [];										0.0125	0.025	0.9625	4		
chrX	48206746	48206746	C	G	hom	222	SSX3			0.21	0.21	0.21	rs9887695 [];										0.0125	0.025	0.9625	4		
chrX	48206831	48206831	T	C	hom	222	SSX3			0.16	0.16	0.16	rs12688751 [];										0.0125	0.025	0.9625	4		
chrX	48320301	48320301	C	G	hom	222	SLC38A5			0.28	0.28	0.28	rs2293952 [];										0.0625	0.0375	0.9	10		
chrX	48326216	48326216	A	G	hom	222	SLC38A5			0.38	0.38	0.38	rs2293953 [];					0.1762					0.0625	0.0375	0.9	18		
chrX	48339985	48339985	C	T	hom	222	FTSJ1			0.28	0.28	0.28	rs2070991 [];					0.1963			300499 [FTSJ homolog 1 - Mental retardation, X-linked-9, 309549 (3)];		0.0375	0.0375	0.925	25		
chrX	48418632	48418632	G	A	hom	222	TBC1D25	nonsynonymous SNV	TBC1D25:NM_002536:exon6:c.G1336A:p.V446I,	0	0	0		0.1090	0.0056	0.2400	0.0010						0	0	1	0		
chrX	48432791	48432791	T	C	hom	222	RBM3			0.92	0.92	0.92	rs2661105 [];										0.4	0.0125	0.5875	43		
chrX	48433499	48433499	C	G	hom	222	RBM3			0.46	0.46	0.46	rs2249583 [];										0.5125	0.05	0.4375	52		
chrX	48433529	48433529	C	T	hom	222	RBM3			0.46	0.46	0.46	rs2249585 [];					0.5718					0.5125	0.05	0.4375	72		
chrX	48435308	48435308	G	A	hom	222	RBM3			0.46	0.46	0.46	rs235830 [];										0.25	0.05	0.7	31		
chrX	48435928	48435928	C	T	hom	222	RBM3			0.92	0.92	0.92	rs235829 [];	0.8700	0.2820	1.0000							0.85	0.025	0.125	84		
chrX	48436507	48436507	C	G	hom	222	RBM3			0.81	0.81	0.81	rs8931 [];										0.825	0.025	0.15	78		
chrX	48456223	48456223	G	T	hom	222	WDR13			0.81	0.81	0.81	rs235824 [];										0.8375	0.025	0.1375	84		
chrX	48460314	48460314	A	G	hom	222	WDR13	nonsynonymous SNV	WDR13:NM_001166426:exon5:c.A698G:p.H233R,WDR13:NM_017883:exon6:c.A974G:p.H325R,	1	1	1	rs235842 [];	0.5070	0.0000	0.2800	0.0000	1.0000					0.975	0	0.025	147		
chrX	48460625	48460625	G	C	hom	222	WDR13			0.81	0.81	0.81	rs235841 [];					0.9078					0.4	0.0125	0.5875	69		
chrX	48462951	48462951	C	G	hom	91.5	WDR13			0.46	0.46	0.46	rs235840 [];										0.25	0.025	0.725	28		
chrX	48649449	48649449	T	G	hom	201	GATA1			1	1	1	rs62600348 [];										0.4375	0	0.5625	46		
chrX	48649456	48649456	T	G	hom	187	GATA1			1	1	1	rs66717003 [];										0.4375	0	0.5625	46		
chrX	48675171	48675171	G	A	hom	194	HDAC6			0	0	0											0	0	1	0		
chrX	48770852	48770852	G	-	het	14.6	PIM2			0	0	0								186			0.0125	0.0625	0.925	6		
chrX	48847497	48847497	T	C	hom	222	GRIPAP1	synonymous SNV	GRIPAP1:NM_020137:exon7:c.A483G:p.E161E,GRIPAP1:NM_207672:exon6:c.A324G:p.E108E,	0.31	0.31	0.31	rs11545861 [];					0.4446					0.4	0.025	0.575	65		
chrX	48898183	48898183	C	G	hom	222	TFE3			0.99	0.99	0.99	rs7056903 [];										0.4375	0	0.5625	46		
chrX	48925467	48925467	C	G	het	4.77	CCDC120	nonsynonymous SNV	CCDC120:NM_001163323:exon10:c.C1676G:p.A559G,CCDC120:NM_001271835:exon10:c.C1712G:p.A571G,CCDC120:NM_001163321:exon10:c.C1817G:p.A606G,CCDC120:NM_033626:exon10:c.C1712G:p.A571G,CCDC120:NM_001271836:exon10:c.C1712G:p.A571G,CCDC120:NM_001163322:exon10:c.C1676G:p.A559G,	0	0	0		0.2360	0.0022	0.6300	0.0120						0	0.0625	0.9375	7		
chrX	49021256	49021256	A	G	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099680:exon2:c.A134G:p.H45R,MAGIX:NM_024859:exon4:c.A335G:p.H112R,	1	1	1	rs5906744 [];	-0.6460	0.2709	0.6100	0.0000	0.9982					0.9875	0	0.0125	148		
chrX	49021537	49021537	G	C	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099682:exon4:c.G289C:p.V97L,MAGIX:NM_001099681:exon4:c.G289C:p.V97L,MAGIX:NM_001099680:exon3:c.G316C:p.V106L,MAGIX:NM_024859:exon5:c.G517C:p.V173L,	1	1	1	rs5905720 [];	0.8800		0.2400	0.0010	0.9983					0.975	0	0.025	146		
chrX	49022700	49022700	T	C	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099682:exon5:c.T724C:p.F242L,MAGIX:NM_001099681:exon5:c.T739C:p.F247L,MAGIX:NM_001099680:exon4:c.T751C:p.F251L,MAGIX:NM_024859:exon6:c.T967C:p.F323L,	1	1	1	rs4824462 [];	-0.0500	0.0000	1.0000	0.0000						0.95	0	0.05	149		
chrX	49047325	49047325	A	G	hom	222	SYP			0.57	0.57	0.57	rs3817678 [];								313475 [Synaptophysin - Mental retardation, X-linked, with or without epilepsy, 300802 (3)];		0.3	0.05	0.65	32		
chrX	49047619	49047619	T	C	hom	222	SYP			0.57	0.57	0.57	rs2293945 [];								313475 [Synaptophysin - Mental retardation, X-linked, with or without epilepsy, 300802 (3)];		0.3125	0.0625	0.625	34		
chrX	49069366	49069366	C	T	hom	222	CACNA1F			0.47	0.47	0.47	rs2071316 [];					0.2865			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.125	0.0625	0.8125	33		
chrX	49070813	49070813	G	A	hom	222	CACNA1F			0.47	0.47	0.47	rs2071317 [];								300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.125	0.0625	0.8125	18		
chrX	49071964	49071964	A	G	hom	222	CACNA1F	synonymous SNV	CACNA1F:NM_005183:exon28:c.T3309C:p.H1103H,CACNA1F:NM_001256789:exon28:c.T3276C:p.H1092H,CACNA1F:NM_001256790:exon28:c.T3114C:p.H1038H,	0.55	0.55	0.55	rs2075866 [];					0.2930			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.25	0.075	0.675	72		
chrX	49074801	49074801	G	A	hom	185	CACNA1F			0.45	0.45	0.45	rs926175 [];								300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.1125	0.075	0.8125	18		
chrX	49077583	49077583	G	A	hom	196	CACNA1F			0.45	0.45	0.45	rs2869212 [];					0.2765			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.1125	0.0625	0.825	36		
chrX	49081291	49081291	G	A	hom	222	CACNA1F	synonymous SNV	CACNA1F:NM_005183:exon14:c.C1842T:p.G614G,CACNA1F:NM_001256789:exon14:c.C1809T:p.G603G,CACNA1F:NM_001256790:exon14:c.C1647T:p.G549G,	0.45	0.45	0.45	rs2235127 [];					0.2786			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.2375	0.0875	0.675	70		
chrX	49084492	49084492	C	T	hom	222	CACNA1F			0.38	0.38	0.38	rs6609854 [];					0.2748		211	300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.225	0.0875	0.6875	70		
chrX	49087487	49087487	G	A	hom	222	CACNA1F			0.45	0.45	0.45	rs5905724 [];					0.2785			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.125	0.075	0.8	37		
chrX	49093528	49093528	T	C	hom	222	CCDC22			0.67	0.67	0.67	rs2294016 [];					0.3734					0.15	0.075	0.775	40		
chrX	49098631	49098631	A	G	hom	222	CCDC22			0.56	0.56	0.56	rs2294018 [];					0.2745					0.125	0.075	0.8	33		
chrX	49103224	49103224	G	A	hom	222	CCDC22	synonymous SNV	CCDC22:NM_014008:exon7:c.G747A:p.Q249Q,	0.47	0.47	0.47	rs2294020 [];					0.2727					0.2125	0.1	0.6875	48		
chrX	49687435	49687435	-	G	hom	214	CLCN5			0	0	0	rs11440111 [];								300008 [Chloride channel-5 - Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)];		0.4375	0	0.5625	71		
chrX	49969467	49969467	-	CT	het	196	AKAP4;CCNB3		AKAP4:dist=3803;CCNB3:dist=58073	0	0	0	rs71952635 [];							180			0.025	0.5125	0.4625	50		
chrX	50056814	50056814	A	G	hom	222	CCNB3			0.38	0.38	0.38	rs5915179 [];					0.5910					0.2375	0.05	0.7125	49		
chrX	50121147	50121147	-	G	hom	214	DGKK	unknown	UNKNOWN	0	0	0	rs11415594 [];										0.9625	0	0.0375	167		
chrX	50336022	50336022	A	T	hom	222	SHROOM4			0.66	0.66	0.66	rs5915277 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.6625	0.0625	0.275	117		
chrX	50336530	50336530	-	C	hom	139	SHROOM4			0	0	0	rs71728121 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.6375	0.075	0.2875	106		
chrX	50341598	50341598	G	A	hom	222	SHROOM4			0.65	0.65	0.65	rs2295544 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.3125	0.05	0.6375	37		
chrX	50341675	50341675	G	C	hom	222	SHROOM4			0.66	0.66	0.66	rs2295543 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.3125	0.05	0.6375	37		
chrX	50350674	50350674	T	C	hom	222	SHROOM4	synonymous SNV	SHROOM4:NM_020717:exon6:c.A3468G:p.E1156E [1(skin)]; 	0.28	0.28	0.28	rs3747282 [];					0.3393	235350 [1(skin)]; 	525	300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.3	0.075	0.625	71		
chrX	50350759	50350759	-	TGCTGCTGCTGT	hom	214	SHROOM4	nonframeshift insertion	SHROOM4:NM_020717:exon6:c.3382_3383insACAGCAGCAGCA:p.Q1128delinsHSSSK,	0	0	0								243	300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.2	0.075	0.725	57		
chrX	51075660	51075660	C	T	hom	130	NUDT10			0.03	0.03	0.03	rs186166067 [];										0.0125	0.0375	0.95	4		
chrX	51239296	51239309	TCCTCGAGGCAGCC	-	hom	128	NUDT11	frameshift deletion	NUDT11:NM_018159:wholegene [1(breast),1(skin),1(prostate),2(upper_aerodigestive_tract),1(central_nervous_system)]; 	0	0	0						0.9486	127214 [1(breast),1(skin),1(prostate),2(upper_aerodigestive_tract),1(central_nervous_system)]; 				0.8125	0	0.1875	132		
chrX	51637471	51637471	C	T	hom	222	MAGED1			0.12	0.12	0.12	rs12837412 [];					0.1305					0.05	0.025	0.925	19		
chrX	51637551	51637551	G	A	hom	222	MAGED1			0.12	0.12	0.12	rs12835969 [];										0.05	0.025	0.925	8		
chrX	51641607	51641607	C	T	hom	222	MAGED1			0.12	0.12	0.12	rs35559927 [];										0.05	0.025	0.925	8		
chrX	51645065	51645065	G	C	hom	222	MAGED1			0.12	0.12	0.12	rs35860208 [];					0.1335					0.05	0.025	0.925	13		
chrX	52662823	52662824	AC	-	het	101	SSX8			0	0	0								244			0	0.85	0.15	82		
chrX	52726098	52726099	GT	-	het	34.5	SSX2			0	0	0								478			0.1625	0.3375	0.5	46		
chrX	52825471	52825471	A	G	hom	222	SPANXN5			0.98	0.98	0.98	rs2806837 [];										0.975	0	0.025	98		
chrX	52825546	52825546	C	G	hom	222	SPANXN5	synonymous SNV	SPANXN5:NM_001009616:exon2:c.G201C:p.L67L,	0.98	0.98	0.98	rs2806838 [];					0.9704					0.9625	0	0.0375	145		
chrX	52891565	52891565	A	G	het	106	XAGE3			0	0	0	rs79831867 [];										0	0.8375	0.1625	115		
chrX	52891584	52891584	C	A	het	172	XAGE3			0	0	0	rs5943751 [];										0.0125	0.3625	0.625	62		
chrX	52891620	52891620	T	-	het	102	XAGE3			0	0	0	rs66488051 [];										0	0.8	0.2	139		
chrX	52891645	52891645	A	G	het	205	XAGE3			0	0	0	rs75808475 [];						COSN215910 [1(central_nervous_system)]; 				0	0.8875	0.1125	156		
chrX	52891653	52891653	C	T	het	225	XAGE3	synonymous SNV	XAGE3:NM_130776:exon5:c.G330A:p.Q110Q [1(large_intestine)]; XAGE3:NM_133179:exon5:c.G330A:p.Q110Q [1(large_intestine)]; 	0	0	0	rs73206488 [];						287951 [1(large_intestine)]; 				0	0.8875	0.1125	157		
chrX	52895580	52895581	GT	-	hom	214	XAGE3			0	0	0	rs5902508 [];							243			0.425	0.0125	0.5625	71		
chrX	52896377	52896377	G	A	hom	222	XAGE3			0.08	0.08	0.08	rs41306369 [];										0.025	0.05	0.925	9		
chrX	52955522	52955522	A	G	hom	200	FAM156A		FAM156A:dist=17937;FAM156A:dist=20942	0.08	0.08	0.08	rs113211974 [];							2051			0.025	0.05	0.925	9		
chrX	52956501	52956501	C	A	hom	222	FAM156A		FAM156A:dist=18916;FAM156A:dist=19963	0.08	0.08	0.08	rs111986216 [];										0.1375	0.075	0.7875	20		
chrX	53220836	53220836	G	T	hom	222	KDM5C			0.82	0.82	0.82	rs1886889 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.925	0	0.075	152		
chrX	53222050	53222050	-	C	hom	214	KDM5C			0	0	0									314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.9	0	0.1	138		
chrX	53226311	53226311	T	C	hom	186	KDM5C			0.81	0.81	0.81	rs5933555 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.4375	0	0.5625	46		
chrX	53228148	53228148	C	A	hom	222	KDM5C			0.75	0.75	0.75	rs1977364 [];					0.9752			314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.425	0	0.575	104		
chrX	53262303	53262303	G	A	hom	222	IQSEC2			0.06	0.06	0.06	rs12851791 [];								300522 [IQ motif- and Sec7 domain-containing protein 2 - Mental retardation, X-linked 1, 309530 (3)];		0.025	0.0125	0.9625	12		
chrX	53271147	53271147	T	G	hom	222	IQSEC2			0.7	0.7	0.7	rs2274307 [];								300522 [IQ motif- and Sec7 domain-containing protein 2 - Mental retardation, X-linked 1, 309530 (3)];		0.3625	0.025	0.6125	41		
chrX	53436232	53436232	G	T	hom	222	SMC1A			0.98	0.98	0.98	rs1264008 [];					0.9417			300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.3875	0.0125	0.6	95		
chrX	53449337	53449337	-	G	hom	214	SMC1A			0	0	0	rs11462431 [];								300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.4375	0	0.5625	45		
chrX	53449568	53449568	G	A	hom	222	SMC1A			0.45	0.45	0.45	rs1264011 [];					0.5838			300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.45	0.0375	0.5125	113		
chrX	53457622	53457622	T	C	hom	222	RIBC1	synonymous SNV	RIBC1:NM_001267053:exon6:c.T597C:p.T199T,RIBC1:NM_001031745:exon7:c.T942C:p.T314T,	0.48	0.48	0.48	rs1264013 [];					0.5871					0.4625	0.0625	0.475	80		
chrX	53461359	53461359	G	C	hom	75.3	HSD17B10			0.45	0.45	0.45	rs1264014 [];					0.5820					0.1625	0.0375	0.8	59		
chrX	53559668	53559668	C	A	hom	171	HUWE1			0.07	0.07	0.07	rs12836234 [];								300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.0375	0.0375	0.925	17		
chrX	53563589	53563589	A	G	hom	222	HUWE1	synonymous SNV	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G,	0.99	0.99	0.99	rs426298 [];	-0.2100				0.9997			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.95	0	0.05	207		
chrX	53565659	53565660	AC	-	hom	29.4	HUWE1			0	0	0								252	300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.125	0.0125	0.8625	13		
chrX	53629650	53629651	AT	-	het	34.5	HUWE1			0	0	0									300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0	0.1125	0.8875	16		
chrX	53641647	53641647	T	C	hom	222	HUWE1	synonymous SNV	HUWE1:NM_031407:exon23:c.A2109G:p.S703S,	0.42	0.42	0.42	rs6638360 [];					0.5378			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.3875	0.05	0.5625	112		
chrX	53654501	53654502	TA	-	het	47.5	HUWE1			0	0	0						0.2237		24	300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0	0.325	0.675	35		
chrX	54107692	54107692	T	C	hom	222	FAM120C			1	1	1	rs2516098 [];										0.4375	0	0.5625	46		
chrX	54117740	54117740	C	A	hom	222	FAM120C			1	1	1	rs2495797 [];					0.9999					0.9375	0	0.0625	142		
chrX	54161859	54161859	C	T	hom	222	FAM120C			0.99	0.99	0.99	rs4826523 [];										0.4375	0	0.5625	46		
chrX	54209387	54209387	A	G	hom	222	FAM120C	nonsynonymous SNV	FAM120C:NM_198456:exon1:c.T245C:p.I82T,FAM120C:NM_017848:exon1:c.T245C:p.I82T,	1	1	1	rs2495783 [];	0.1380	0.0000	0.5300	0.0000						0.9375	0	0.0625	161		
chrX	54836239	54836239	A	G	hom	222	MAGED2	nonsynonymous SNV	MAGED2:NM_201222:exon3:c.A130G:p.K44E,MAGED2:NM_014599:exon3:c.A130G:p.K44E,MAGED2:NM_177433:exon3:c.A130G:p.K44E,	0.0006	0.0006	0.0006	rs11555928 [];	0.7980	0.0306	0.9900	0.9790	0.0051					0.0125	0	0.9875	7		
chrX	54953647	54953647	G	A	hom	222	TRO			0.46	0.46	0.46	rs2273138 [];										0.2875	0.025	0.6875	34		
chrX	55116466	55116466	C	G	hom	222	PAGE2	nonsynonymous SNV	PAGE2:NM_207339:exon2:c.C13G:p.L5V,	0.95	0.95	0.95	rs1845444 [];	-0.9520	0.0000	1.0000	0.0000	0.9943					0.95	0	0.05	143		
chrX	55116766	55116766	-	CCTATCTA	het	217	PAGE2			0	0	0								523			0	0	1	0		
chrX	55172373	55172373	A	G	het	197	FAM104B			0	0	0	rs1047069 [];										0	0.9375	0.0625	86		
chrX	55246965	55246965	C	T	hom	222	PAGE5			0.86	0.86	0.86	rs5914272 [];					0.9736					0.9	0.025	0.075	119		
chrX	55247030	55247030	C	G	hom	222	PAGE5			0.87	0.87	0.87	rs5914273 [];					0.9680					0.9	0.025	0.075	139		
chrX	55248090	55248090	C	A	hom	222	PAGE5			0.7	0.7	0.7	rs4826274 [];										0.2375	0.05	0.7125	32		
chrX	55248376	55248376	A	G	hom	222	PAGE5			0.52	0.52	0.52	rs5914275 [];										0.2125	0.0625	0.725	29		
chrX	55249049	55249049	T	C	hom	222	PAGE5			0.49	0.49	0.49	rs2148982 [];					0.6510					0.6	0.0875	0.3125	101		
chrX	55289774	55289774	T	C	hom	222	PAGE3			0.86	0.86	0.86	rs4826381 [];	0.0030	0.0000	0.9100	0.0010	0.9682					0.9125	0.025	0.0625	143		
chrX	55291168	55291168	G	C	hom	222	PAGE3			0.49	0.49	0.49	rs2887654 [];										0.5375	0.0875	0.375	59		
chrX	55514818	55514818	C	T	hom	222	USP51	synonymous SNV	USP51:NM_201286:exon2:c.G555A:p.E185E,	0.53	0.53	0.53	rs3126255 [];					0.6888					0.5875	0.075	0.3375	103		
chrX	55651001	55651001	T	C	hom	222	FOXR2	nonsynonymous SNV	FOXR2:NM_198451:exon1:c.T857C:p.V286A,	0.86	0.86	0.86	rs2375465 [];	-0.0900	0.0008	1.0000	0.0010	0.9729					0.925	0.0125	0.0625	141		
chrX	55748820	55748820	A	G	hom	204	RRAGB			0.87	0.87	0.87	rs1473761 [];										0.4125	0	0.5875	44		
chrX	55757744	55757744	T	G	hom	222	RRAGB			0.87	0.87	0.87	rs5960480 [];										0.4125	0	0.5875	44		
chrX	56295959	56295960	TG	-	hom	159	KLF8			0	0	0	rs200952140 [];							240			0.2	0.0875	0.7125	79		
chrX	56296781	56296781	-	ACACAC	hom	200	KLF8			0	0	0								306			0.1125	0	0.8875	23		
chrX	56843771	56843771	G	A	hom	222	LOC550643			0.57	0.57	0.57	rs7044 [];							305			0.6	0.075	0.325	64		
chrX	56844640	56844640	A	G	hom	222	LOC550643			0.59	0.59	0.59	rs5913999 [];										0.5625	0.075	0.3625	61		
chrX	57019891	57019891	T	G	hom	222	SPIN3			0.55	0.55	0.55	rs6612746 [];										0.5875	0.075	0.3375	67		
chrX	57020115	57020115	C	T	hom	222	SPIN3			0.87	0.87	0.87	rs1325856 [];										0.9625	0	0.0375	94		
chrX	57405163	57405163	T	C	hom	222	FAAH2	synonymous SNV	FAAH2:NM_174912:exon6:c.T822C:p.R274R,	0.93	0.93	0.93	rs4826543 [];					0.9994					0.9875	0	0.0125	145		
chrX	57474943	57474943	A	T	hom	222	FAAH2			0.92	0.92	0.92	rs1821118 [];					0.9991					0.4375	0	0.5625	74		
chrX	57475132	57475132	T	C	hom	222	FAAH2	synonymous SNV	FAAH2:NM_174912:exon10:c.T1404C:p.P468P,	0.55	0.55	0.55	rs1367830 [];					0.7308					0.5875	0.075	0.3375	103		
chrX	57515439	57515439	T	C	hom	222	FAAH2			0.55	0.55	0.55	rs1048358 [];										0.6125	0.075	0.3125	68		
chrX	57619648	57619648	G	T	hom	222	ZXDB	synonymous SNV	ZXDB:NM_007157:exon1:c.G1167T:p.P389P,	1	1	1	rs1057328 [];					0.9997					0.9625	0	0.0375	147		
chrX	64734415	64734416	CA	-	hom	116	LAS1L			0	0	0	rs200255138 [];							297			0.45	0.0625	0.4875	48		
chrX	65247884	65247884	A	G	hom	222	VSIG4			0	0	0	rs201039111 [];					0.0012					0	0	1	0		
chrX	65382685	65382685	T	C	hom	222	HEPH	nonsynonymous SNV	HEPH:NM_138737:exon1:c.T116C:p.V39A,	0.88	0.88	0.88	rs5919015 [];	-2.2110	0.2894			0.6888					0.7625	0.0125	0.225	118		
chrX	65393658	65393658	A	G	hom	222	HEPH			1	1	1	rs5918591 [];										0.4375	0	0.5625	72		
chrX	65420609	65420609	A	G	hom	222	HEPH			0.98	0.98	0.98	rs1264215 [];					0.9359					0.4375	0	0.5625	74		
chrX	65478923	65478923	-	A	hom	214	HEPH			0	0	0	rs35431478 [];										0.35	0.0375	0.6125	41		
chrX	65815591	65815591	T	C	hom	222	EDA2R			0.77	0.77	0.77	rs1485682 [];										0.7	0.0625	0.2375	75		
chrX	65815817	65815817	G	A	hom	222	EDA2R			0.71	0.71	0.71	rs11093958 [];										0.7125	0.0625	0.225	74		
chrX	65817522	65817522	A	G	hom	222	EDA2R			0.77	0.77	0.77	rs12855916 [];										0.675	0.0625	0.2625	72		
chrX	65817740	65817740	A	C	hom	222	EDA2R			0.77	0.77	0.77	rs4827380 [];										0.6875	0.075	0.2375	74		
chrX	65819223	65819223	A	G	hom	183	EDA2R			0.68	0.68	0.68	rs4827499 [];										0.35	0.0375	0.6125	40		
chrX	65819287	65819287	-	T	hom	27.5	EDA2R			0	0	0	rs76899814 [];										0.3125	0.0375	0.65	50		
chrX	65822607	65822607	T	C	hom	222	EDA2R	nonsynonymous SNV	EDA2R:NM_001199687:exon5:c.A385G:p.T129A,EDA2R:NM_001242310:exon4:c.A385G:p.T129A,EDA2R:NM_021783:exon5:c.A385G:p.T129A,	0.95	0.95	0.95	rs1385698 [];	0.1700		0.1400	0.0000	0.9996					0.925	0	0.075	137		
chrX	65824986	65824986	C	T	hom	222	EDA2R	nonsynonymous SNV	EDA2R:NM_001199687:exon3:c.G170A:p.R57K,EDA2R:NM_001242310:exon2:c.G170A:p.R57K,EDA2R:NM_021783:exon3:c.G170A:p.R57K,	0.69	0.69	0.69	rs1385699 [];	1.8410	0.1249	1.0000	0.1260	0.7977					0.65	0.0625	0.2875	111		
chrX	66941597	66941597	T	G	hom	222	AR			0.91	0.91	0.91	rs1337076 [];								313700 [Androgen receptor (dihydrotestosterone receptor) - Androgen insensitivity, 300068 (3); Spinal and bulbar muscularatrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},176807 (3); Hypospadias 1, X-linked, 300633 (3)];		0.4375	0	0.5625	46		
chrX	67263222	67263222	G	A	hom	166	OPHN1			0.3	0.3	0.3	rs7883184 [];							7133	300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.15	0.0625	0.7875	32		
chrX	67263229	67263229	A	G	het	44.1	OPHN1			0.15	0.15	0.15	rs184510922 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.0125	0.2	0.7875	30		
chrX	67263293	67263293	A	G	hom	222	OPHN1			0.47	0.47	0.47	rs7888212 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.2875	0.05	0.6625	60		
chrX	67263844	67263844	C	T	hom	222	OPHN1			0.46	0.46	0.46	rs492933 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.3	0.05	0.65	65		
chrX	67265417	67265417	G	T	hom	222	OPHN1			0.4	0.4	0.4	rs2254886 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.2875	0.05	0.6625	62		
chrX	67265922	67265922	-	T	hom	214	OPHN1			0	0	0								517	300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.225	0.0625	0.7125	48		
chrX	67273791	67273791	-	TTT	hom	19.5	OPHN1			0	0	0									300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.025	0.0125	0.9625	4		
chrX	67412906	67412906	G	A	hom	222	OPHN1			1	1	1	rs1191948 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.425	0.0125	0.5625	46		
chrX	67719085	67719085	G	T	hom	199	YIPF6			0.64	0.64	0.64	rs12843249 [];										0.3125	0.0375	0.65	37		
chrX	67936140	67936140	T	G	het	46	STARD8			0	0	0											0	0.4375	0.5625	46		
chrX	67937976	67937976	G	A	hom	222	STARD8	nonsynonymous SNV	STARD8:NM_014725:exon5:c.G980A:p.R327Q,STARD8:NM_001142503:exon6:c.G1220A:p.R407Q,STARD8:NM_001142504:exon5:c.G980A:p.R327Q,	0.04	0.04	0.04	rs55962426 [];	0.5710	0.0018	0.2900	0.0010	0.1156					0.0625	0.0125	0.925	17		
chrX	67945398	67945399	AT	-	het	25.5	STARD8			0	0	0								420			0.0125	0.35	0.6375	33		
chrX	68061232	68061232	-	AC	hom	145	EFNB1			0	0	0									300035 [eph-related receptor tyrosine kinase ligand 2 (ephrin B1) - Craniofrontonasal dysplasia, 304110 (3)];		0.1125	0.1125	0.775	32		
chrX	68385148	68385148	G	A	hom	198	PJA1			0.17	0.17	0.17	rs5937161 [];										0.0625	0.0125	0.925	9		
chrX	68749379	68749379	G	A	hom	222	FAM155B			0.43	0.43	0.43	rs35383499 [];					0.5625					0.1875	0.0625	0.75	42		
chrX	69243118	69243118	T	A	hom	222	EDA			0.09	0.09	0.09	rs2274469 [];					0.1297			300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.0625	0.0125	0.925	11		
chrX	69247897	69247898	CT	-	hom	214	EDA			0.41	0.41	0.41	rs145138166 [];					0.4203			300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.3625	0.05	0.5875	83		
chrX	69249513	69249513	G	T	hom	222	EDA			0.19	0.19	0.19	rs62604271 [];								300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.05	0.0125	0.9375	6		
chrX	69262855	69262857	TCT	-	hom	214	AWAT2			0	0	0	rs72284868 [];										0.4	0.0125	0.5875	43		
chrX	69459945	69459945	C	T	hom	222	AWAT1			0.95	0.95	0.95	rs74490344 [];					0.9099					0.3625	0.025	0.6125	65		
chrX	69496228	69496228	T	C	hom	222	ARR3			0.6	0.6	0.6	rs1572732 [];					0.7608					0.3125	0.0375	0.65	57		
chrX	69502054	69502054	A	G	hom	222	RAB41			0.81	0.81	0.81	rs5936549 [];					0.8653					0.35	0.025	0.625	65		
chrX	69502479	69502479	A	G	hom	209	RAB41			0.95	0.95	0.95	rs1626469 [];					0.9145					0.375	0.0125	0.6125	68		
chrX	69504073	69504073	T	C	hom	222	RAB41			0.73	0.73	0.73	rs2275412 [];										0.2875	0.0875	0.625	50		
chrX	69504078	69504078	T	G	hom	222	RAB41			0.63	0.63	0.63	rs12556489 [];										0.2375	0.1375	0.625	52		
chrX	69510335	69510335	C	T	hom	222	KIF4A	synonymous SNV	KIF4A:NM_012310:exon2:c.C27T:p.P9P,	0.92	0.92	0.92	rs1199470 [];					0.9905					0.9625	0	0.0375	203		
chrX	69595909	69595909	C	G	hom	194	KIF4A			0.96	0.96	0.96	rs1199407 [];					0.9147					0.375	0.0125	0.6125	90		
chrX	69639698	69639698	G	T	hom	222	KIF4A			0.99	0.99	0.99	rs1886892 [];										0.4375	0	0.5625	46		
chrX	69652762	69652762	A	G	hom	222	GDPD2	synonymous SNV	GDPD2:NM_001171192:exon16:c.A1692G:p.R564R,GDPD2:NM_001171191:exon13:c.A1302G:p.R434R,GDPD2:NM_017711:exon15:c.A1539G:p.R513R,GDPD2:NM_001171193:exon14:c.A1302G:p.R434R,	0.88	0.88	0.88	rs2296542 [];					0.9510					0.9	0.025	0.075	138		
chrX	69673464	69673464	C	T	hom	222	DLG3			0.1	0.1	0.1	rs28391150 [];					0.1935			300189 [Discs large, Drosophila, homolog of, 3 - Mental retardation, X-linked-90 (3)];		0.05	0.0375	0.9125	30		
chrX	69673811	69673811	T	C	hom	222	DLG3			0.53	0.53	0.53	rs2274309 [];								300189 [Discs large, Drosophila, homolog of, 3 - Mental retardation, X-linked-90 (3)];		0.1375	0.0625	0.8	23		
chrX	69718314	69718314	C	T	hom	222	DLG3			0.51	0.51	0.51	rs1886890 [];					0.4450			300189 [Discs large, Drosophila, homolog of, 3 - Mental retardation, X-linked-90 (3)];		0.1125	0.0625	0.825	33		
chrX	69718534	69718537	TCAT	-	hom	214	DLG3			0	0	0	rs3215810 [];								300189 [Discs large, Drosophila, homolog of, 3 - Mental retardation, X-linked-90 (3)];		0.1125	0.0625	0.825	21		
chrX	69720172	69720172	C	G	hom	222	DLG3			0.09	0.09	0.09	rs41306139 [];								300189 [Discs large, Drosophila, homolog of, 3 - Mental retardation, X-linked-90 (3)];		0.05	0.0375	0.9125	8		
chrX	69724731	69724731	G	T	hom	222	DLG3			0.51	0.51	0.51	rs3828017 [];								300189 [Discs large, Drosophila, homolog of, 3 - Mental retardation, X-linked-90 (3)];		0.3375	0.0875	0.575	88		
chrX	69725361	69725361	C	T	hom	222	DLG3			0.15	0.15	0.15	rs3752323 [];										0.075	0.0375	0.8875	29		
chrX	69749852	69749852	A	G	hom	222	TEX11		TEX11:NM_001003811:exon31:c.2566-3T>C,NM_031276:exon30:c.2521-3T>C	0.8	0.8	0.8	rs1536250 [];					0.9034					0.875	0.0125	0.1125	131		
chrX	69749853	69749853	T	A	hom	222	TEX11		TEX11:NM_001003811:exon31:c.2566-4A>T,NM_031276:exon30:c.2521-4A>T	0.82	0.82	0.82	rs1536251 [];					0.9077					0.875	0.0125	0.1125	131		
chrX	69774517	69774517	A	T	hom	222	TEX11	synonymous SNV	TEX11:NM_001003811:exon27:c.T2319A:p.T773T,TEX11:NM_031276:exon26:c.T2274A:p.T758T,	0.98	0.98	0.98	rs4844240 [];					0.9996					0.9625	0	0.0375	139		
chrX	69844799	69844799	T	C	hom	222	TEX11			0.12	0.12	0.12	rs5980983 [];					0.2024					0.0625	0.0375	0.9	16		
chrX	69890179	69890179	T	A	hom	222	TEX11			0.1	0.1	0.1	rs5980996 [];					0.2018					0.0625	0.0375	0.9	15		
chrX	69898755	69898755	A	-	hom	6.54	TEX11			0	0	0											0.375	0	0.625	73		
chrX	70080895	70080895	T	A	het	10.4	TEX11			0	0	0											0	0.0875	0.9125	8		
chrX	70148927	70148927	T	A	hom	222	SLC7A3			0.9	0.9	0.9	rs5936605 [];										0.4125	0	0.5875	44		
chrX	70279172	70279172	A	T	hom	222	SNX12			0.05	0.05	0.05	rs11549130 [];										0.05	0.025	0.925	6		
chrX	70279177	70279177	C	G	hom	222	SNX12			0.05	0.05	0.05	rs11549129 [];										0.05	0.025	0.925	6		
chrX	70279492	70279492	A	C	hom	222	SNX12			0.61	0.61	0.61	rs6780 [];										0.6375	0.0875	0.275	66		
chrX	70282696	70282696	A	G	hom	222	SNX12			0.61	0.61	0.61	rs34211894 [];					0.5544					0.6	0.0875	0.3125	101		
chrX	70321631	70321631	T	G	hom	222	FOXO4			0.56	0.56	0.56	rs5980742 [];					0.4597					0.175	0.0625	0.7625	29		
chrX	70324157	70324157	C	T	hom	222	CXorf65	synonymous SNV	CXorf65:NM_001025265:exon5:c.G417A:p.A139A,	0.15	0.15	0.15	rs1130009 [];					0.3200					0.2375	0.0875	0.675	58		
chrX	70324397	70324397	G	A	hom	222	CXorf65			0.18	0.18	0.18	rs12857595 [];										0.1125	0.0625	0.825	17		
chrX	70331101	70331101	-	AAGA	hom	214	IL2RG			0	0	0	rs67165954 [];								308380 [Interleukin-2 receptor, gamma - Severe combined immunodeficiency, X-linked, 300400 (3); Combinedimmunodeficiency, X-linked, moderate, 312863 (3)];		0.1	0.0625	0.8375	16		
chrX	70338399	70338399	A	G	hom	222	MED12			0.53	0.53	0.53	rs11796153 [];										0.45	0.1	0.45	92		
chrX	70339498	70339498	C	T	hom	222	MED12			0.15	0.15	0.15	rs12850852 [];					0.3188			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	43		
chrX	70341123	70341123	-	ACTTTATCTGCTTC	hom	214	MED12			0	0	0	rs71951253 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.05	0.0625	0.8875	14		
chrX	70341169	70341169	A	C	hom	222	MED12			0.16	0.16	0.16	rs62609586 [];					0.3206			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.275	0.0875	0.6375	125		
chrX	70342820	70342820	A	G	hom	222	MED12			0.15	0.15	0.15	rs7053139 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70343621	70343621	A	G	hom	222	MED12			0.16	0.16	0.16	rs12841977 [];					0.2594			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70344331	70344331	G	C	hom	222	MED12			0.36	0.36	0.36	rs59024650 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.125	0.0625	0.8125	18		
chrX	70344763	70344763	G	T	hom	222	MED12			0.16	0.16	0.16	rs5030616 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70345683	70345683	T	G	hom	222	MED12			0.16	0.16	0.16	rs73214869 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70348344	70348344	G	A	hom	222	MED12			0.16	0.16	0.16	rs5030618 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70349947	70349947	A	C	hom	222	MED12	synonymous SNV	MED12:NM_005120:exon28:c.A3930C:p.P1310P,	0.15	0.15	0.15	rs5030619 [];					0.3176			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.25	0.0875	0.6625	123		
chrX	70352417	70352417	T	C	hom	222	MED12			0.16	0.16	0.16	rs10521349 [];					0.3148			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	43		
chrX	70352516	70352516	A	G	hom	222	MED12			0.16	0.16	0.16	rs12843026 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70352647	70352647	T	C	het	114	MED12			0.09	0.09	0.09	rs12849277 [];							713	300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0	0.0625	0.9375	14		
chrX	70356642	70356642	T	C	hom	222	MED12			0.55	0.55	0.55	rs12852829 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1875	0.075	0.7375	27		
chrX	70361967	70361967	G	A	hom	222	MED12			0.19	0.19	0.19	rs36072155 [];					0.3317			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	33		
chrX	70367328	70367328	A	G	hom	155	NLGN3			0.55	0.55	0.55	rs11795613 [];								300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0.1875	0.075	0.7375	27		
chrX	70390008	70390009	CA	-	het	83.5	NLGN3			0	0	0								387	300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0	0.2625	0.7375	42		
chrX	70469182	70469182	G	A	hom	222	ZMYM3			1	1	1	rs2341539 [];							373			0.9875	0	0.0125	153		
chrX	70514343	70514343	G	A	hom	222	NONO	synonymous SNV	NONO:NM_001145408:exon6:c.G615A:p.L205L,NONO:NM_001145409:exon4:c.G615A:p.L205L,NONO:NM_001145410:exon3:c.G348A:p.L116L,NONO:NM_007363:exon5:c.G615A:p.L205L,	0	0	0		0.4650	0.3592								0	0	1	0		
chrX	70794622	70794622	-	T	het	25.5	OGT			0	0	0											0	0.4625	0.5375	43		
chrX	71347955	71347955	T	C	hom	222	NHSL2;RGAG4			0.44	0.44	0.44	rs7472250 [];										0.325	0.0125	0.6625	39		
chrX	71348837	71348837	G	A	hom	222	RGAG4			0.39	0.39	0.39	rs9887642 [];										0.75	0.0125	0.2375	74		
chrX	71349143	71349143	A	C	hom	222	RGAG4			0.44	0.44	0.44	rs9887370 [];										0.775	0.0125	0.2125	75		
chrX	71349753	71349753	G	A	hom	222	RGAG4	synonymous SNV	RGAG4:NM_001024455:exon1:c.C1638T:p.R546R,	0.38	0.38	0.38	rs12397326 [];					0.7855					0.775	0.0125	0.2125	114		
chrX	71349774	71349774	T	C	hom	222	RGAG4	synonymous SNV	RGAG4:NM_001024455:exon1:c.A1617G:p.G539G,	0.44	0.44	0.44	rs12393722 [];					0.7925					0.775	0.0125	0.2125	115		
chrX	71351443	71351443	A	G	hom	222	RGAG4			0.44	0.44	0.44	rs62614085 [];										0.7625	0.0125	0.225	77		
chrX	71351519	71351519	C	A	hom	111	RGAG4			0.99	0.99	0.99	rs12390168 [];										0.9	0	0.1	85		
chrX	71353658	71353658	C	T	hom	222	NHSL2			0.38	0.38	0.38	rs7392268 [];										0.7875	0.0125	0.2	73		
chrX	71360865	71360865	C	T	hom	222	NHSL2			0.37	0.37	0.37	rs7392389 [];										0.7625	0.0125	0.225	71		
chrX	71364479	71364479	A	C	hom	222	FLJ44635			0.96	0.96	0.96	rs11094247 [];					1.0000					0.4375	0	0.5625	74		
chrX	71379702	71379702	T	C	hom	222	FLJ44635	nonsynonymous SNV	FLJ44635:NM_207422:exon2:c.T23C:p.I8T,	0.42	0.42	0.42	rs7884806 [];					0.7378					0.775	0.0125	0.2125	121		
chrX	71379853	71379853	C	T	hom	222	FLJ44635	synonymous SNV	FLJ44635:NM_207422:exon2:c.C174T:p.S58S,	0.42	0.42	0.42	rs7880917 [];					0.7390					0.775	0.0125	0.2125	120		
chrX	71380152	71380152	C	T	hom	222	FLJ44635			0.42	0.42	0.42	rs7881332 [];					0.7383	COSN414096 [1(urinary_tract)]; 				0.75	0.025	0.225	92		
chrX	71401607	71401607	G	A	hom	222	PIN4	nonsynonymous SNV	PIN4:NM_006223:exon1:c.G47A:p.R16Q,PIN4:NM_001170747:exon1:c.G47A:p.R16Q,	0.76	0.76	0.76	rs6525589 [];	-0.9750	0.0000	1.0000	0.0000	0.9631					0.9375	0	0.0625	140		
chrX	71401614	71401614	C	A	hom	222	PIN4	nonsynonymous SNV	PIN4:NM_006223:exon1:c.C54A:p.S18R,PIN4:NM_001170747:exon1:c.C54A:p.S18R,	0.76	0.76	0.76	rs7058353 [];	-1.6670	0.0000	0.9800	0.0000	0.9633					0.925	0	0.075	140		
chrX	71493691	71493691	C	T	hom	222	RPS4X	synonymous SNV	RPS4X:NM_001007:exon5:c.G492A:p.L164L,	0.37	0.37	0.37	rs16897731 [];					0.7657					0.7125	0.0625	0.225	117		
chrX	71495344	71495344	C	T	hom	222	RPS4X			0.62	0.62	0.62	rs3827426 [];					0.7843					0.325	0.0375	0.6375	60		
chrX	71495389	71495389	-	CTA	hom	214	RPS4X			0	0	0	rs146599276 [];										0.8125	0.0125	0.175	130		
chrX	71495869	71495869	A	G	hom	222	RPS4X			0.64	0.64	0.64	rs3747303 [];										0.325	0.0375	0.6375	40		
chrX	71521867	71521867	G	C	hom	222	CITED1	nonsynonymous SNV	CITED1:NM_001144885:exon4:c.C366G:p.H122Q,CITED1:NM_004143:exon3:c.C288G:p.H96Q,CITED1:NM_001144887:exon3:c.C288G:p.H96Q,CITED1:NM_001144886:exon3:c.C288G:p.H96Q,	0.75	0.75	0.75	rs3012627 [];	0.1910	0.0000	1.0000	0.0000	0.8793					0.825	0.0125	0.1625	132		
chrX	71526684	71526684	C	T	hom	222	CITED1			0	0	0											0.0125	0	0.9875	1		
chrX	71549512	71549512	G	C	hom	222	HDAC8			0.68	0.68	0.68	rs660392 [];					0.8216					0.75	0.0625	0.1875	84		
chrX	71788885	71788885	C	T	hom	222	HDAC8			0.01	0.01	0.01	rs12156784 [];										0.025	0.05	0.925	7		
chrX	71877511	71877511	A	G	hom	222	PHKA1			0	0	0											0	0	1	0		
chrX	71896111	71896112	AT	-	het	31.5	PHKA1			0	0	0											0	0.2125	0.7875	20		
chrX	72225593	72225593	C	G	hom	222	PABPC1L2B			0.37	0.37	0.37	rs4892374 [];										0.3	0.025	0.675	35		
chrX	72297417	72297417	T	C	hom	222	PABPC1L2A			0.35	0.35	0.35	rs11093406 [];										0.675	0.05	0.275	71		
chrX	72297541	72297541	T	C	hom	202	PABPC1L2A			0.35	0.35	0.35	rs11093407 [];										0.6625	0.05	0.2875	71		
chrX	72297562	72297563	AC	-	hom	177	PABPC1L2A			0	0	0								354			0.575	0.225	0.2	80		
chrX	72434394	72434394	A	C	hom	222	NAP1L2			0	0	0											0	0	1	0		
chrX	73068573	73068573	T	C	hom	222	XIST			0.01	0.01	0.01	rs6528 [];					0.0390					0.0125	0	0.9875	1		
chrX	73290216	73290216	A	-	hom	73.5	JPX			0	0	0	rs59904201 [];							396			0.475	0.075	0.45	50		
chrX	73499888	73499888	T	A	hom	222	FTX			0.9	0.9	0.9	rs174154 [];							747			0.8	0.025	0.175	77		
chrX	73499963	73499963	T	C	hom	222	FTX			0.89	0.89	0.89	rs174153 [];							747			0.8125	0.025	0.1625	78		
chrX	73501562	73501562	T	C	hom	222	FTX			0.89	0.89	0.89	rs174151 [];										0.85	0.025	0.125	86		
chrX	73641569	73641569	T	C	hom	65	SLC16A2	nonsynonymous SNV	SLC16A2:NM_006517:exon1:c.T97C:p.S33P,	0.63	0.63	0.63	rs6647476 [];	-0.4200	0.0000	0.4700	0.4030	0.3704			300095 [Solute carrier family 16 (monocarboxylic acid transporters), - Allan-Herndon-Dudley syndrome, 300523 (3)];	RCV000020650.1 [non-pathogenic]; 	0.1125	0	0.8875	127		
chrX	73749319	73749319	T	G	hom	222	SLC16A2			0.4	0.4	0.4	rs5937843 [];					0.7941			300095 [Solute carrier family 16 (monocarboxylic acid transporters), - Allan-Herndon-Dudley syndrome, 300523 (3)];		0.275	0.0625	0.6625	76		
chrX	73802892	73802892	A	C	het	36	RLIM			0	0	0	rs200442865 [];										0	0.0625	0.9375	43		
chrX	73958670	73958671	TA	-	het	5.08	KIAA2022			0.02	0.02	0.02								245			0	0.0375	0.9625	6		
chrX	74289344	74289344	C	T	hom	222	ABCB7			0.55	0.55	0.55	rs5981317 [];										0.075	0.0125	0.9125	8		
chrX	74293618	74293618	G	A	hom	222	ABCB7			0.01	0.01	0.01	rs5937938 [];					0.0141					0	0	1	6		
chrX	74375871	74375871	G	C	hom	208	ABCB7			0.93	0.93	0.93	rs1039123 [];										0.4375	0	0.5625	46		
chrX	74494470	74494470	T	G	hom	222	UPRT	synonymous SNV	UPRT:NM_145052:exon1:c.T381G:p.R127R,	0.93	0.93	0.93	rs4892396 [];					0.9990					0.95	0	0.05	140		
chrX	74514456	74514456	G	A	hom	222	UPRT			0.02	0.02	0.02	rs5938014 [];					0.0237					0.0125	0	0.9875	1		
chrX	74519839	74519839	T	C	hom	222	UPRT			0.05	0.05	0.05	rs5938015 [];										0.0125	0	0.9875	1		
chrX	74523830	74523830	T	A	hom	222	UPRT			0.05	0.05	0.05	rs12156864 [];										0.025	0	0.975	2		
chrX	74523871	74523871	G	A	hom	222	UPRT			0.93	0.93	0.93	rs5937351 [];										0.9875	0	0.0125	96		
chrX	74743007	74743007	G	A	hom	143	ZDHHC15			0.07	0.07	0.07	rs5938090 [];								300576 [Zinc finger DHHC domain-containing protein 15 - Mental retardation, X-linked-91, 300577 (3)];		0.0125	0	0.9875	4		
chrX	75395172	75395172	T	C	hom	222	PBDC1			0.73	0.73	0.73	rs2301863 [];										0.3875	0	0.6125	42		
chrX	76814423	76814423	T	G	het	3.54	ATRX			0	0	0	rs201586778 [];								300032 [ATR-X gene (helicase 2; X-linked nuclear protein) - Alpha-thalassemia/mental retardation syndrome, 301040 (3);Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)];		0	0.0125	0.9875	1		
chrX	76937963	76937963	G	C	hom	222	ATRX	nonsynonymous SNV	ATRX:NM_138270:exon8:c.C2671G:p.Q891E,ATRX:NM_000489:exon9:c.C2785G:p.Q929E,	0.51	0.51	0.51	rs3088074 [];	0.6070	0.0000	1.0000	0.0000	0.3060			300032 [ATR-X gene (helicase 2; X-linked nuclear protein) - Alpha-thalassemia/mental retardation syndrome, 301040 (3);Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)];		0.3375	0.0875	0.575	98		
chrX	77254266	77254266	-	T	hom	214	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1125	0.05	0.8375	16		
chrX	77264534	77264534	T	G	het	30	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0	0.4	0.6	39		
chrX	77265580	77265580	A	C	hom	222	ATP7A			0.29	0.29	0.29	rs2157389 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2625	0.075	0.6625	30		
chrX	77267996	77267996	A	G	hom	194	ATP7A			0.47	0.47	0.47	rs112626820 [];							886	300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2625	0.075	0.6625	29		
chrX	77268502	77268502	G	C	hom	222	ATP7A	nonsynonymous SNV	ATP7A:NM_000052:exon10:c.G2299C:p.V767L,	0.28	0.28	0.28	rs2227291 [];	2.3770	0.7328	0.0900	0.9610	0.2139			300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2125	0.075	0.7125	70		
chrX	77276036	77276036	G	A	hom	222	ATP7A			0.28	0.28	0.28	rs7053543 [];							1932	300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1125	0.05	0.8375	14		
chrX	77276413	77276413	C	A	hom	222	ATP7A			0.29	0.29	0.29	rs113968994 [];					0.2249			300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1	0.05	0.85	37		
chrX	77286831	77286831	T	-	hom	27.5	ATP7A			1	1	1	rs5902762 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.4375	0	0.5625	46		
chrX	77296047	77296047	G	C	hom	222	ATP7A			1	1	1	rs5913631 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.4375	0	0.5625	98		
chrX	77298857	77298857	G	A	hom	222	ATP7A	nonsynonymous SNV	ATP7A:NM_000052:exon21:c.G4048A:p.E1350K,	1	1	1	rs4826245 [];	0.6310	0.0000	1.0000	0.0000				300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.9625	0	0.0375	208		
chrX	77302397	77302397	-	AA	hom	175	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1875	0.0875	0.725	43		
chrX	77304027	77304027	T	C	hom	222	ATP7A			0.47	0.47	0.47	rs1062472 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2625	0.075	0.6625	65		
chrX	77373524	77373524	C	T	hom	222	PGK1			0.33	0.33	0.33	rs2007039 [];					0.2130			311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.1	0.05	0.85	36		
chrX	77380307	77380307	G	C	hom	194	PGK1			0.1	0.1	0.1	rs17303413 [];								311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.0625	0.025	0.9125	8		
chrX	77381002	77381002	A	G	hom	222	PGK1			0.33	0.33	0.33	rs2073177 [];								311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.1	0.05	0.85	13		
chrX	77381014	77381014	G	A	hom	222	PGK1			0.33	0.33	0.33	rs2073178 [];								311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.1	0.05	0.85	13		
chrX	77385748	77385748	C	T	hom	222	TAF9B			0.33	0.33	0.33	rs10991 [];										0.2125	0.075	0.7125	27		
chrX	77386696	77386696	-	AAA	het	157	TAF9B			0	0	0											0	0.1125	0.8875	9		
chrX	78217400	78217400	A	-	hom	52.5	P2RY10			0	0	0											0.1125	0	0.8875	11		
chrX	78616214	78616214	C	G	hom	222	ITM2A			0.45	0.45	0.45	rs13789 [];										0.6375	0.025	0.3375	64		
chrX	78616371	78616371	T	G	hom	222	ITM2A			0.25	0.25	0.25	rs1045345 [];										0.25	0.05	0.7	27		
chrX	78616455	78616455	-	T	hom	214	ITM2A			0	0	0											0.5625	0.05	0.3875	55		
chrX	78618050	78618050	A	G	hom	222	ITM2A			0.91	0.91	0.91	rs1751134 [];					0.8711					0.425	0.0125	0.5625	65		
chrX	79698593	79698593	C	G	hom	222	FAM46D	nonsynonymous SNV	FAM46D:NM_152630:exon3:c.C555G:p.D185E,FAM46D:NM_001170574:exon5:c.C555G:p.D185E,	0.43	0.43	0.43	rs1113265 [];	-2.2910	0.0272	1.0000	0.0030	0.7099					0.575	0.075	0.35	98		
chrX	79931832	79931835	GTGT	-	hom	214	BRWD3			0.59	0.59	0.59	rs35220611 [];							376	300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.55	0.0625	0.3875	101		
chrX	79937084	79937084	G	A	hom	222	BRWD3			0.68	0.68	0.68	rs3122406 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.25	0.05	0.7	33		
chrX	79942600	79942603	TATA	-	hom	214	BRWD3			0	0	0	rs3029738 [];							225	300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.2	0.0375	0.7625	28		
chrX	79943569	79943569	T	C	hom	222	BRWD3	nonsynonymous SNV	BRWD3:NM_153252:exon34:c.A3863G:p.K1288R,	0.99	0.99	0.99	rs3122407 [];	1.1020	0.0000		0.0010	1.0000			300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.95	0	0.05	209		
chrX	79999797	79999797	-	CAC	hom	214	BRWD3			0	0	0	rs67376083 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.4375	0	0.5625	91		
chrX	80064911	80064911	-	C	hom	52.5	BRWD3			0	0	0	rs68020026 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.2125	0.0375	0.75	58		
chrX	80553229	80553229	C	T	hom	222	SH3BGRL			0.56	0.56	0.56	rs1044828 [];										0.6375	0.0125	0.35	63		
chrX	82764040	82764040	A	G	hom	222	POU3F4	synonymous SNV	POU3F4:NM_000307:exon1:c.A708G:p.E236E,	0.92	0.92	0.92	rs5921978 [];										0.9625	0	0.0375	145		
chrX	82764042	82764042	G	C	hom	222	POU3F4	nonsynonymous SNV	POU3F4:NM_000307:exon1:c.G710C:p.G237A [1(upper_aerodigestive_tract)]; 	0.89	0.89	0.89	rs5921979 [];	1.0570	0.0001	1.0000	0.0000		1180653 [1(upper_aerodigestive_tract)]; 				0.9625	0	0.0375	145		
chrX	83124802	83124802	A	T	hom	176	CYLC1			0.99	0.99	0.99	rs5968237 [];										0.3125	0	0.6875	34		
chrX	83352970	83352970	T	C	hom	185	RPS6KA6			0.74	0.74	0.74	rs10521366 [];										0.3625	0	0.6375	38		
chrX	83403178	83403178	G	C	hom	222	RPS6KA6			0.44	0.44	0.44	rs1539517 [];					0.7088					0.2875	0.0125	0.7	32		
chrX	84501033	84501033	C	T	hom	222	ZNF711			0.22	0.22	0.22	rs41311563 [];										0.1375	0.0375	0.825	30		
chrX	84520059	84520059	T	C	hom	197	ZNF711			0.22	0.22	0.22	rs12560186 [];										0.0375	0.0375	0.925	6		
chrX	84520105	84520105	G	A	hom	222	ZNF711			0.22	0.22	0.22	rs12557399 [];					0.1360					0.0375	0.0375	0.925	19		
chrX	84523298	84523298	-	T	hom	24.4	ZNF711		ZNF711:NM_021998:exon7:c.917-2->T	0	0	0											0.025	0	0.975	6		FP
chrX	84525287	84525288	TT	-	hom	30.5	ZNF711			0	0	0	rs200962174 [];										0.025	0	0.975	2		
chrX	84526987	84526987	A	G	hom	222	ZNF711			0.22	0.22	0.22	rs2343388 [];										0.1375	0.0375	0.825	30		
chrX	84527466	84527466	A	G	hom	222	ZNF711			0.22	0.22	0.22	rs6653049 [];										0.1375	0.0375	0.825	30		
chrX	84532801	84532801	C	T	hom	222	POF1B			0.22	0.22	0.22	rs16980188 [];										0.1375	0.0375	0.825	15		
chrX	84532996	84532996	T	G	hom	222	POF1B			0.22	0.22	0.22	rs16980189 [];										0.1375	0.0375	0.825	15		
chrX	84533408	84533408	G	T	hom	222	POF1B			0.22	0.22	0.22	rs12557804 [];										0.1375	0.0375	0.825	15		
chrX	84533758	84533758	A	G	hom	222	POF1B			0.13	0.13	0.13	rs41300878 [];										0.125	0.0375	0.8375	14		
chrX	84534115	84534115	T	G	hom	222	POF1B			0.22	0.22	0.22	rs12008480 [];										0.1375	0.0375	0.825	16		
chrX	84534383	84534383	A	C	hom	222	POF1B			1	1	1	rs2227090 [];					0.9976					0.95	0	0.05	136		
chrX	84537071	84537071	G	A	hom	169	POF1B			0.22	0.22	0.22	rs3810760 [];										0.0375	0.0375	0.925	6		
chrX	84561465	84561465	G	C	hom	222	POF1B			0.22	0.22	0.22	rs363780 [];										0.0375	0.0375	0.925	6		
chrX	84562118	84562118	C	T	hom	181	POF1B			0.1	0.1	0.1	rs363776 [];					0.1341					0.025	0.0375	0.9375	5		
chrX	84563135	84563135	T	A	hom	222	POF1B	nonsynonymous SNV	POF1B:NM_024921:exon10:c.A1045T:p.M349L,	0.9	0.9	0.9	rs363774 [];	0.3300	0.0000	1.0000	0.0000	0.7723					0.8	0.0125	0.1875	122		
chrX	85906213	85906213	C	T	hom	222	DACH2			0.45	0.45	0.45	rs6623751 [];					0.2561					0.0875	0.0125	0.9	15		
chrX	86083040	86083043	AGTT	-	hom	214	DACH2			0.71	0.71	0.71	rs34412966 [];							214			0.7625	0.0375	0.2	75		
chrX	86084856	86084856	T	C	hom	222	DACH2			0.71	0.71	0.71	rs5969011 [];										0.7875	0.0375	0.175	77		
chrX	86086810	86086810	-	G	hom	81.5	DACH2			0	0	0	rs67991204 [];										0.7375	0.025	0.2375	72		
chrX	86087385	86087385	A	T	hom	222	DACH2			0.71	0.71	0.71	rs3087525 [];										0.775	0.0375	0.1875	78		
chrX	86877348	86877348	G	T	hom	222	KLHL4	synonymous SNV	KLHL4:NM_057162:exon5:c.G1062T:p.G354G,KLHL4:NM_019117:exon5:c.G1062T:p.G354G,	0.19	0.19	0.19	rs2273050 [];					0.1960					0.0625	0.025	0.9125	17		
chrX	86887244	86887244	C	T	hom	222	KLHL4	synonymous SNV	KLHL4:NM_057162:exon7:c.C1359T:p.T453T,KLHL4:NM_019117:exon7:c.C1359T:p.T453T,	0.59	0.59	0.59	rs222084 [];					0.7432					0.7125	0.025	0.2625	110		
chrX	86922097	86922097	-	A	hom	214	KLHL4			0	0	0											0.7375	0.025	0.2375	72		
chrX	88008423	88008423	A	C	hom	222	CPXCR1	nonsynonymous SNV	CPXCR1:NM_001184771:exon3:c.A8C:p.Y3S,CPXCR1:NM_033048:exon3:c.A8C:p.Y3S,	0.9	0.9	0.9	rs5940915 [];	0.7890	0.0000		0.0000	0.8713					0.825	0.0125	0.1625	121		
chrX	88008807	88008807	G	A	hom	222	CPXCR1	nonsynonymous SNV	CPXCR1:NM_001184771:exon3:c.G392A:p.R131H,CPXCR1:NM_033048:exon3:c.G392A:p.R131H,	0.23	0.23	0.23	rs5984611 [];	-0.0910	0.0085		0.4960	0.4135					0.3	0.05	0.65	60		
chrX	88009322	88009322	A	G	hom	222	CPXCR1			0.9	0.9	0.9	rs5984613 [];					0.8728					0.8125	0.0125	0.175	107		
chrX	89177024	89177024	A	G	hom	222	TGIF2LX			0.52	0.52	0.52	rs200945458 [];										0.2625	0.0625	0.675	31		
chrX	89177673	89177673	G	A	hom	222	TGIF2LX	nonsynonymous SNV	TGIF2LX:NM_138960:exon2:c.G589A:p.V197I,	0.74	0.74	0.74	rs2290380 [];	-0.3200	0.0000		0.0000	0.6819					0.6875	0.0625	0.25	105		
chrX	91518024	91518025	AA	-	hom	8.4	PCDH11X			0	0	0											0.025	0	0.975	3		
chrX	92927634	92927634	G	C	hom	222	NAP1L3	nonsynonymous SNV	NAP1L3:NM_004538:exon1:c.C670G:p.P224A,	0.57	0.57	0.57	rs1045686 [];	1.9280	0.0405	0.3000	0.0670	0.6452					0.55	0.0875	0.3625	96		
chrX	96139406	96139406	G	A	hom	222	RPA4	nonsynonymous SNV	RPA4:NM_013347:exon1:c.G97A:p.A33T,	0.44	0.44	0.44	rs2642219 [];	0.2130	0.0213	0.0300	0.0350	0.2976					0.275	0.025	0.7	48		
chrX	96139459	96139459	T	C	hom	222	RPA4	synonymous SNV	RPA4:NM_013347:exon1:c.T150C:p.N50N,	0.44	0.44	0.44	rs2642218 [];					0.2980					0.275	0.025	0.7	48		
chrX	96197175	96197175	G	A	hom	222	DIAPH2			1	1	1	rs5920973 [];					0.9999					0.425	0	0.575	71		
chrX	96502650	96502650	C	T	hom	222	DIAPH2			0.42	0.42	0.42	rs1409192 [];										0.15	0.05	0.8	24		
chrX	96856457	96856457	-	A	hom	214	DIAPH2			0	0	0											0.5	0.05	0.45	49		
chrX	96860054	96860054	G	C	hom	222	DIAPH2;XRCC6P5		DIAPH2:dist=4457;XRCC6P5:dist=1856546	0.85	0.85	0.85	rs5967330 [];										0.4125	0	0.5875	42		
chrX	99890204	99890204	C	T	hom	222	TSPAN6	nonsynonymous SNV	TSPAN6:NM_003270:exon3:c.G322A:p.A108T,	0.08	0.08	0.08	rs1802288 [];	2.2980	0.9750		0.9000	0.1707					0.175	0.0375	0.7875	27		
chrX	99919733	99919733	G	A	hom	222	SRPX2			0.8	0.8	0.8	rs2022475 [];					0.9778			300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.425	0.0125	0.5625	101		
chrX	99926044	99926044	G	A	hom	222	SRPX2			0.01	0.01	0.01	rs148234042 [];								300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.0125	0	0.9875	4		
chrX	99926122	99926122	G	A	hom	222	SRPX2			0.97	0.97	0.97	rs5967163 [];								300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.9875	0	0.0125	158		
chrX	99929532	99929532	G	C	hom	222	SYTL4			0.34	0.34	0.34	rs8780 [];										0.3375	0.0875	0.575	42		
chrX	99930892	99930892	-	CACACA	hom	177	SYTL4			0	0	0								393			0.0125	0	0.9875	1		
chrX	99930915	99930915	-	TCACACAC	het	217	SYTL4			0	0	0								393			0	0	1	0		
chrX	99941369	99941369	T	C	hom	222	SYTL4			0.35	0.35	0.35	rs5921626 [];										0.3625	0.0625	0.575	39		
chrX	99941705	99941705	T	C	hom	222	SYTL4	nonsynonymous SNV	SYTL4:NM_001174068:exon12:c.A1258G:p.I420V,SYTL4:NM_080737:exon14:c.A1258G:p.I420V,SYTL4:NM_001129896:exon13:c.A1258G:p.I420V,	0.95	0.95	0.95	rs2022039 [];	-1.3330	0.7677		0.0030	0.9988					0.975	0	0.025	146		
chrX	99941980	99941980	T	C	hom	222	SYTL4			0.95	0.95	0.95	rs2022040 [];										0.9875	0	0.0125	91		
chrX	99943103	99943103	A	C	hom	222	SYTL4			0.35	0.35	0.35	rs5920842 [];										0.3625	0.0625	0.575	39		
chrX	99943244	99943244	G	C	hom	222	SYTL4			0.34	0.34	0.34	rs5921627 [];										0.35	0.05	0.6	37		
chrX	99956157	99956157	T	C	hom	222	SYTL4			0.41	0.41	0.41	rs5967170 [];										0.2	0.05	0.75	25		
chrX	99957136	99957136	T	C	hom	222	SYTL4			0.33	0.33	0.33	rs5967171 [];										0.2	0.05	0.75	25		
chrX	99957238	99957238	G	C	hom	221	SYTL4			0.4	0.4	0.4	rs1343214 [];										0.2	0.05	0.75	25		
chrX	100077193	100077193	C	T	hom	222	CSTF2			0.42	0.42	0.42	rs2859168 [];					0.5450					0.1875	0.0625	0.75	58		
chrX	100081914	100081914	G	A	hom	205	CSTF2			0.59	0.59	0.59	rs3830149 [];							614			0.2	0.0625	0.7375	27		
chrX	100098356	100098358	AAG	-	hom	214	NOX1			0.55	0.55	0.55	rs148448908 [];										0.4875	0.075	0.4375	54		
chrX	100105008	100105008	T	C	hom	222	NOX1			1	1	1	rs1476011 [];										0.425	0	0.575	45		
chrX	100105418	100105418	A	G	hom	192	NOX1			0.61	0.61	0.61	rs5921669 [];					0.6337		1124			0.2125	0.0625	0.725	42		
chrX	100168373	100168373	-	AC	het	169	XKRX			0	0	0								399			0.025	0.1375	0.8375	19		
chrX	100169144	100169144	C	G	hom	222	XKRX			0.0042	0.0042	0.0042	rs41309502 [];										0.0125	0.0125	0.975	2		
chrX	100242305	100242305	G	A	hom	222	ARL13A			0.81	0.81	0.81	rs5921702 [];										0.375	0.0375	0.5875	43		
chrX	100243459	100243459	G	T	hom	222	ARL13A	nonsynonymous SNV	ARL13A:NM_001012990:exon8:c.G837T:p.M279I,ARL13A:NM_001162490:exon8:c.G837T:p.M279I,	0.91	0.91	0.91	rs3934462 [];					0.9146					0.9125	0	0.0875	126		
chrX	100245606	100245606	A	G	hom	222	ARL13A			0.86	0.86	0.86	rs6523438 [];					0.8595					0.85	0.0375	0.1125	120		
chrX	100265552	100265552	T	A	hom	222	TRMT2B			0.37	0.37	0.37	rs5921705 [];					0.4150					0.375	0.0625	0.5625	56		
chrX	100350301	100350301	C	T	hom	222	TMEM35			0	0	0	rs62602432 [];							202			0.2375	0.1125	0.65	34		
chrX	100350684	100350684	A	-	hom	214	TMEM35			0.41	0.41	0.41	rs34994578 [];										0.525	0.0625	0.4125	54		
chrX	100357194	100357194	C	G	hom	192	CENPI			0.41	0.41	0.41	rs12156858 [];										0.1875	0.0625	0.75	29		
chrX	100357201	100357201	T	C	hom	171	CENPI			0.41	0.41	0.41	rs12156663 [];										0.1875	0.0625	0.75	29		
chrX	100375371	100375371	A	-	hom	214	CENPI			0.26	0.26	0.26	rs56066672 [];					0.2671					0.075	0.0625	0.8625	27		
chrX	100387337	100387337	C	T	hom	222	CENPI			0.21	0.21	0.21	rs7883144 [];					0.2614	COSN168777 [1(large_intestine)]; 				0.075	0.0625	0.8625	31		
chrX	100395663	100395663	G	T	hom	222	CENPI	synonymous SNV	CENPI:NM_006733:exon15:c.G1479T:p.V493V,	0.29	0.29	0.29	rs2273380 [];					0.2466					0.1875	0.075	0.7375	38		
chrX	100400023	100400023	A	G	hom	222	CENPI			0.67	0.67	0.67	rs2295376 [];					0.7491					0.3	0.025	0.675	60		
chrX	100416623	100416623	A	T	hom	222	CENPI			0.23	0.23	0.23	rs72615569 [];					0.2528					0.0625	0.0375	0.9	20		
chrX	100511062	100511062	G	A	hom	176	DRP2			0.003	0.003	0.003	rs139691084 [];					0.0025					0	0	1	0		
chrX	100515969	100515971	CTC	-	hom	214	DRP2			0	0	0											0	0	1	0		
chrX	100547933	100547933	A	G	hom	222	TAF7L	nonsynonymous SNV	TAF7L:NM_024885:exon1:c.T101C:p.L34P,	0.99	0.99	0.99	rs5951328 [];	-1.4180	0.0000	0.3600	0.0000	0.9886					0.95	0	0.05	205		
chrX	100911707	100911707	G	A	hom	222	ARMCX2	nonsynonymous SNV	ARMCX2:NM_177949:exon6:c.C868T:p.R290W,ARMCX2:NM_014782:exon5:c.C868T:p.R290W,	0	0	0	rs143836164 [];	0.3010	0.4529	0.0100	0.4540	0.0004					0	0	1	0		
chrX	100914185	100914185	T	C	hom	222	ARMCX2			1	1	1	rs7877615 [];										0.4375	0	0.5625	46		
chrX	100914701	100914701	-	C	hom	214	ARMCX2			0	0	0	rs61487673 [];										0.4375	0	0.5625	46		
chrX	101093049	101093049	A	-	hom	106	NXF5			1	1	1	rs66689050 [];										0.4375	0	0.5625	46		
chrX	101093122	101093122	-	G	hom	67.5	NXF5			0	0	0	rs145072756 [];										0.4125	0	0.5875	43		
chrX	101138792	101138792	T	C	hom	222	ZMAT1	nonsynonymous SNV	ZMAT1:NM_001011657:exon7:c.A1607G:p.Q536R,	1	1	1	rs5944882 [];	-0.2600	0.0000	1.0000	0.0000						0.9625	0	0.0375	144		
chrX	101395784	101395784	-	G	hom	214	TCEAL6	frameshift insertion	TCEAL6:NM_001006938:exon3:c.519_520insC:p.A174fs,	0	0	0											0.975	0	0.025	167		
chrX	101396812	101396812	G	T	hom	222	TCEAL6			0.53	0.53	0.53	rs57096787 [];										0.1375	0.075	0.7875	23		
chrX	101396813	101396813	G	A	hom	222	TCEAL6			0.53	0.53	0.53	rs60206377 [];										0.1375	0.075	0.7875	23		
chrX	101409271	101409271	-	T	het	80.5	BEX5			0	0	0											0	0.5875	0.4125	56		
chrX	101409586	101409586	-	G	hom	214	BEX5			0	0	0	rs11424734 [];										0.4375	0	0.5625	46		
chrX	101410777	101410777	G	C	hom	176	BEX5			0.73	0.73	0.73	rs929009 [];										0.2625	0.0875	0.65	38		
chrX	101410823	101410823	-	C	hom	214	BEX5			0	0	0	rs11451071 [];										0.9375	0	0.0625	92		
chrX	101410995	101410995	T	C	hom	222	BEX5			0.73	0.73	0.73	rs6621362 [];										0.625	0.1	0.275	73		
chrX	101623587	101623589	TGG	-	hom	214	NXF2;NXF2B			0	0	0	rs111593567 [];					0.5362		597			0.1125	0.0625	0.825	17		
chrX	101856718	101856718	A	T	hom	222	ARMCX5;ARMCX5-GPRASP2			1	1	1	rs2379211 [];										0.4375	0	0.5625	46		
chrX	102082173	102082173	C	T	hom	222	LINC00630			0.71	0.71	0.71	rs4907856 [];										0.4125	0	0.5875	41		
chrX	102318393	102318394	CG	-	hom	9.01	BEX1			0.98	0.98	0.98	rs200197441 [];										0.0125	0	0.9875	2		
chrX	102319228	102319228	T	C	hom	222	BEX1			0.81	0.81	0.81	rs11797226 [];										0.225	0.025	0.75	25		
chrX	102339606	102339606	T	C	hom	222	NXF3			0.81	0.81	0.81	rs1029305 [];					0.6975					0.3	0.05	0.65	59		
chrX	102470539	102470539	G	A	hom	54.5	BEX4			0.59	0.59	0.59	rs80101197 [];							279			0.15	0.025	0.825	17		
chrX	102470814	102470814	G	C	hom	222	BEX4			0.59	0.59	0.59	rs2273065 [];										0.15	0.0625	0.7875	21		
chrX	102471531	102471531	G	T	hom	222	BEX4			0.59	0.59	0.59	rs1064784 [];										0.375	0.0625	0.5625	40		
chrX	102564583	102564583	A	G	hom	222	BEX2	synonymous SNV	BEX2:NM_001168400:exon3:c.T415C:p.L139L,BEX2:NM_001168401:exon3:c.T322C:p.L108L,BEX2:NM_001168399:exon3:c.T418C:p.L140L,BEX2:NM_032621:exon3:c.T322C:p.L108L,	0.79	0.79	0.79	rs7557 [];					0.6162					0.5625	0.05	0.3875	99		
chrX	102565203	102565203	G	C	hom	222	BEX2			0.34	0.34	0.34	rs2246252 [];										0.15	0.0625	0.7875	21		
chrX	102565906	102565906	C	A	hom	222	BEX2			0.05	0.05	0.05	rs12559214 [];										0.05	0.05	0.9	9		
chrX	102863108	102863108	T	G	hom	77.5	TCEAL3			0.99	0.99	0.99	rs221939 [];										0.3875	0	0.6125	38		
chrX	102883666	102883666	C	A	hom	222	TCEAL1			0.0006	0.0006	0.0006	rs17331890 [];										0	0	1	0		
chrX	102930684	102930684	A	-	hom	49.5	MORF4L2			0	0	0											0.5375	0	0.4625	47		
chrX	102930960	102930960	A	G	hom	222	MORF4L2			0.4	0.4	0.4	rs874 [];										0.4375	0.025	0.5375	42		
chrX	102941053	102941054	CC	-	hom	4.39	MORF4L2			0	0	0											0.075	0.025	0.9	8		
chrX	102941747	102941747	A	G	hom	218	MORF4L2			0.82	0.82	0.82	rs5987565 [];										0.25	0.025	0.725	28		
chrX	102942666	102942666	A	G	hom	120	MORF4L2-AS1			0.84	0.84	0.84	rs2057101 [];										0.2375	0.0125	0.75	23		
chrX	102946721	102946721	C	T	hom	222	MORF4L2-AS1			0.84	0.84	0.84	rs1543384 [];										0.2375	0.0375	0.725	26		
chrX	103031701	103031701	-	G	hom	214	PLP1			0	0	0	rs55692651 [];							200	300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.4375	0	0.5625	46		
chrX	103046527	103046527	G	-	hom	214	PLP1			1	1	1	rs11317331 [];								300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.9875	0	0.0125	156		
chrX	103173633	103173633	A	C	hom	222	MIR1256			0.29	0.29	0.29	rs151143781 [];										0.3125	0.0625	0.625	35		
chrX	103219004	103219004	C	T	hom	212	MIR1256			0.58	0.58	0.58	rs1180753 [];							2324			0.3125	0.0125	0.675	34		
chrX	103267865	103267865	C	T	hom	222	H2BFWT	nonsynonymous SNV	H2BFWT:NM_001002916:exon1:c.G368A:p.R123H,	0.58	0.58	0.58	rs553509 [];	-0.9440	0.8365	0.0300	0.0170	0.6654					0.625	0.025	0.35	105		
chrX	103268241	103268241	G	A	hom	222	H2BFWT			0.33	0.33	0.33	rs7885967 [];					0.4303					0.4125	0.0625	0.525	73		
chrX	103294760	103294760	C	T	hom	222	H2BFM	stopgain SNV	H2BFM:NM_001164416:exon1:c.C217T:p.Q73X,	0.33	0.33	0.33	rs2301384 [];	-2.5870	1.0000	0.0400		0.4408					0.4125	0.0625	0.525	74		
chrX	103348230	103348230	C	T	hom	222	SLC25A53			0.33	0.33	0.33	rs5916825 [];										0.425	0.0625	0.5125	46		
chrX	103348398	103348398	-	C	hom	214	SLC25A53			0	0	0	rs67397909 [];										0.9875	0	0.0125	96		
chrX	103401770	103401770	A	C	hom	222	SLC25A53			0.62	0.62	0.62	rs7882194 [];										0.2875	0.0125	0.7	31		
chrX	104464283	104464283	-	CACAT	hom	214	TEX13A	frameshift insertion	TEX13A:NM_031274:exon3:c.594_595insATGTG:p.D199fs,	0	0	0											0.65	0	0.35	82		
chrX	105153001	105153001	A	G	hom	222	NRK	synonymous SNV	NRK:NM_198465:exon13:c.A1368G:p.K456K,	1	1	1	rs209372 [];										0.9625	0	0.0375	145		
chrX	105179132	105179132	C	T	hom	222	NRK			0.53	0.53	0.53	rs209095 [];					0.6170					0.2375	0.025	0.7375	46		
chrX	105202600	105202600	A	T	hom	222	NRK			0.53	0.53	0.53	rs209111 [];										0.5375	0.025	0.4375	55		
chrX	105415129	105415129	A	G	hom	222	MUM1L1			0.99	0.99	0.99	rs5916976 [];										0.9375	0	0.0625	87		
chrX	106184638	106184641	GAGA	-	het	155	MORC4			0	0	0								391			0.025	0.0875	0.8875	11		
chrX	106186159	106186159	C	T	hom	222	MORC4	synonymous SNV	MORC4:NM_001085354:exon15:c.G1962A:p.Q654Q,MORC4:NM_024657:exon15:c.G1962A:p.Q654Q,	0.01	0.01	0.01	rs150263726 [];					0.0064					0.025	0	0.975	2		
chrX	106411120	106411120	T	C	hom	222	NUP62CL			0.01	0.01	0.01	rs183114728 [];										0.025	0	0.975	2		
chrX	106888333	106888333	C	T	hom	178	PRPS1			0.13	0.13	0.13	rs151295141 [];							2604	311850 [Phosphoribosyl pyrophosphate synthetase-1 - Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphatesynthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1,304500 (3)];		0.1125	0.05	0.8375	19		
chrX	107019298	107019298	-	G	hom	140	TSC22D3			0	0	0	rs66853123 [];										0.4375	0	0.5625	46		
chrX	107084075	107084075	A	C	hom	222	MID2	synonymous SNV	MID2:NM_012216:exon2:c.A180C:p.S60S,MID2:NM_052817:exon2:c.A180C:p.S60S,	0.11	0.11	0.11	rs2236083 [];					0.0645					0.0625	0.025	0.9125	8		
chrX	107174169	107174169	T	A	hom	222	MID2			0.16	0.16	0.16	rs742584 [];										0.1625	0.0375	0.8	17		
chrX	107415825	107415825	T	C	hom	222	COL4A6			0.99	0.99	0.99	rs2881142 [];					1.0000					0.4375	0	0.5625	74		
chrX	107418281	107418281	C	T	hom	222	COL4A6			0.51	0.51	0.51	rs2295914 [];					0.7718					0.35	0	0.65	60		
chrX	107418906	107418906	A	G	hom	222	COL4A6	synonymous SNV	COL4A6:NM_033641:exon29:c.T2808C:p.R936R,COL4A6:NM_001847:exon29:c.T2811C:p.R937R,	0.99	0.99	0.99	rs4623610 [];					0.9999					0.95	0	0.05	143		
chrX	107423702	107423705	TACA	-	het	102	COL4A6			0	0	0								294			0	0	1	0		
chrX	107430579	107430579	G	A	hom	222	COL4A6			0.59	0.59	0.59	rs1266715 [];										0.35	0	0.65	37		
chrX	107433688	107433688	A	G	hom	222	COL4A6	nonsynonymous SNV	COL4A6:NM_033641:exon20:c.T1360C:p.S454P [1(stomach)]; COL4A6:NM_001847:exon20:c.T1363C:p.S455P [1(stomach)]; 	0.59	0.59	0.59	rs1042065 [];	-0.3780	0.0000	1.0000	0.0000	0.7949	150805 [1(stomach)]; 				0.725	0	0.275	108		
chrX	107437848	107437848	G	C	hom	222	COL4A6			0.48	0.48	0.48	rs1266719 [];	-1.6180				0.7742					0.35	0	0.65	73		
chrX	107438119	107438119	G	T	hom	222	COL4A6			0.59	0.59	0.59	rs1266720 [];										0.35	0	0.65	37		
chrX	107448639	107448639	G	T	hom	222	COL4A6			0.6	0.6	0.6	rs1266730 [];					0.7947	COSN168790 [1(large_intestine)]; 				0.35	0	0.65	74		
chrX	107455014	107455014	C	T	hom	222	COL4A6			0.99	0.99	0.99	rs1266736 [];					0.9999					0.4375	0	0.5625	61		
chrX	107463091	107463102	CCATATTGTATT	-	hom	214	COL4A6			0.49	0.49	0.49	rs201304389 [];										0.35	0	0.65	37		
chrX	107510915	107510915	G	-	hom	214	COL4A6			0.89	0.89	0.89	rs11351626 [];							725			0.9375	0	0.0625	87		
chrX	107511012	107511012	G	A	hom	222	COL4A6			0.89	0.89	0.89	rs1266765 [];							725			0.9625	0	0.0375	89		
chrX	107511430	107511430	C	T	hom	222	COL4A6			0.49	0.49	0.49	rs1266766 [];							1067			0.7125	0	0.2875	66		
chrX	107940920	107940920	-	AT	hom	214	COL4A5			0	0	0	rs66932703 [];										0.4375	0	0.5625	46		
chrX	108708516	108708516	C	T	hom	222	GUCY2F	nonsynonymous SNV	GUCY2F:NM_001522:exon3:c.G887A:p.R296Q,	0.92	0.92	0.92	rs502209 [];	0.6690	0.0000	0.6500	0.0000	0.8320					0.8375	0.025	0.1375	124		
chrX	108708552	108708552	A	G	hom	222	GUCY2F	nonsynonymous SNV	GUCY2F:NM_001522:exon3:c.T851C:p.L284P,	0.19	0.19	0.19	rs12008095 [];	1.7640	0.9843	0.2100	0.8410	0.3671					0.3	0.05	0.65	55		
chrX	108867177	108867177	G	A	hom	222	KCNE1L			0.79	0.79	0.79	rs697829 [];										0.575	0.0625	0.3625	63		
chrX	108904729	108904729	C	T	hom	222	ACSL4			1	1	1	rs839408 [];					0.9923			300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.4375	0	0.5625	96		
chrX	108917757	108917757	T	C	hom	222	ACSL4			0.31	0.31	0.31	rs5942830 [];					0.5668			300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.2	0.0625	0.7375	37		
chrX	108917773	108917773	A	G	hom	222	ACSL4			0.31	0.31	0.31	rs5943413 [];								300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.2	0.0625	0.7375	26		
chrX	109246605	109246605	C	T	hom	205	TMEM164			0.48	0.48	0.48	rs4893444 [];										0.1625	0.05	0.7875	20		
chrX	109918851	109918851	C	T	hom	222	CHRDL1			0.34	0.34	0.34	rs2223782 [];										0.3375	0.075	0.5875	39		
chrX	109918881	109918881	C	A	hom	222	CHRDL1			0.34	0.34	0.34	rs2404177 [];										0.3375	0.075	0.5875	39		
chrX	109918954	109918957	GGAG	-	hom	214	CHRDL1			0	0	0								290			0.125	0.025	0.85	14		
chrX	109931799	109931799	A	G	hom	222	CHRDL1			0.37	0.37	0.37	rs5943052 [];					0.3919					0.1375	0.0625	0.8	32		
chrX	109931856	109931856	T	C	hom	222	CHRDL1	synonymous SNV	CHRDL1:NM_001143983:exon7:c.A714G:p.K238K,CHRDL1:NM_001143981:exon9:c.A954G:p.K318K,CHRDL1:NM_001143982:exon9:c.A951G:p.K317K,CHRDL1:NM_145234:exon9:c.A951G:p.K317K,	0.37	0.37	0.37	rs5943053 [];					0.3968					0.35	0.075	0.575	65		
chrX	110248758	110248758	G	T	hom	222	PAK3			0.91	0.91	0.91	rs4893477 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9625	0	0.0375	89		
chrX	110248776	110248776	C	T	hom	222	PAK3			0.92	0.92	0.92	rs4893478 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9625	0	0.0375	89		
chrX	110368657	110368657	T	A	hom	222	PAK3			0.93	0.93	0.93	rs1361321 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9875	0	0.0125	91		
chrX	110368829	110368829	A	G	hom	222	PAK3			1	1	1	rs77566096 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.95	0	0.05	88		
chrX	110369974	110369974	C	T	hom	222	PAK3			0.02	0.02	0.02	rs144835276 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0	0.0125	0.9875	1		
chrX	110372020	110372020	C	A	hom	222	PAK3			0.02	0.02	0.02	rs143399551 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0	0.0125	0.9875	1		
chrX	110489520	110489520	A	G	hom	222	CAPN6			0.98	0.98	0.98	rs6642884 [];										0.95	0.0125	0.0375	93		
chrX	110497423	110497423	C	T	hom	222	CAPN6			0.0036	0.0036	0.0036	rs17879807 [];										0.05	0	0.95	4		
chrX	110761959	110761959	G	A	hom	222	DKFZp686D0853			0.03	0.03	0.03	rs144268644 [];										0.025	0.0125	0.9625	6		
chrX	111873936	111873936	A	G	hom	222	LHFPL1			0	0	0	rs41310723 [];										0	0	1	0		
chrX	111923376	111923376	C	T	hom	94.1	LHFPL1			0.74	0.74	0.74	rs75345634 [];							297			0.1	0.5375	0.3625	59		
chrX	112019808	112019808	C	T	hom	222	AMOT			0	0	0											0	0	1	0		
chrX	114082535	114082535	G	A	hom	222	HTR2C			0.92	0.92	0.92	rs5946005 [];					0.8389					0.325	0.0375	0.6375	61		
chrX	114346361	114346361	T	-	hom	184	LRCH2			0	0	0											0.3	0.025	0.675	34		
chrX	114391291	114391291	A	T	hom	222	LRCH2			0.11	0.11	0.11	rs6644191 [];										0.0375	0.0375	0.925	8		
chrX	114400318	114400318	T	G	hom	222	LRCH2			0.94	0.94	0.94	rs4361922 [];										0.4375	0	0.5625	46		
chrX	114404806	114404806	T	G	hom	222	LRCH2			0.08	0.08	0.08	rs6643945 [];										0.0375	0.0375	0.925	7		
chrX	114541631	114541631	G	A	hom	222	LUZP4			0.11	0.11	0.11	rs17326520 [];										0.3	0.0125	0.6875	31		
chrX	114541763	114541763	T	C	hom	222	LUZP4			0.11	0.11	0.11	rs41304490 [];										0.3	0.0125	0.6875	31		
chrX	114753754	114753762	AATTGGTGA	-	hom	214	LUZP4;PLS3		LUZP4:dist=211633;PLS3:dist=41415	0.19	0.19	0.19	rs141856697 [];										0.3375	0.0375	0.625	34		
chrX	114869488	114869488	G	A	hom	222	PLS3			0.02	0.02	0.02	rs148608302 [];										0	0	1	0		
chrX	114952661	114952661	-	TT	hom	157	PLS3;AGTR2		PLS3:dist=67482;AGTR2:dist=349297	0	0	0											0.05	0.025	0.925	7		
chrX	114953061	114953061	A	T	hom	222	PLS3;AGTR2		PLS3:dist=67882;AGTR2:dist=348897	0.09	0.09	0.09	rs5988005 [];										0.125	0.025	0.85	14		
chrX	115586325	115586325	G	A	hom	222	SLC6A14			0.45	0.45	0.45	rs5905287 [];										0.1875	0.05	0.7625	22		
chrX	115590299	115590299	C	G	hom	222	SLC6A14			0.49	0.49	0.49	rs2011162 [];										0.5625	0.075	0.3625	60		
chrX	117584008	117584008	C	A	hom	187	WDR44			1	1	1	rs5910351 [];										0.4375	0	0.5625	46		
chrX	117700141	117700141	A	G	hom	222	DOCK11	synonymous SNV	DOCK11:NM_144658:exon8:c.A867G:p.A289A [1(prostate)]; 	0.37	0.37	0.37	rs2286977 [];					0.3699	1179702 [1(prostate)]; 				0.375	0.0625	0.5625	68		
chrX	117727327	117727327	T	C	hom	222	DOCK11			0.25	0.25	0.25	rs5909551 [];					0.3676					0.15	0.0375	0.8125	29		
chrX	117742356	117742356	C	T	hom	222	DOCK11			0.57	0.57	0.57	rs5910394 [];					0.5792					0.225	0.0375	0.7375	39		
chrX	117788888	117788888	G	A	hom	222	DOCK11	nonsynonymous SNV	DOCK11:NM_144658:exon44:c.G4933A:p.V1645I,	0.0018	0.0018	0.0018	rs138152540 [];	2.0830	0.9446	0.9400	0.9930	0.0036					0.0125	0	0.9875	3		
chrX	117810831	117810831	C	T	hom	210	DOCK11			0.59	0.59	0.59	rs5957040 [];							989			0.3125	0.0375	0.65	35		
chrX	117817266	117817266	C	T	hom	222	DOCK11			0.92	0.92	0.92	rs4372173 [];										0.3875	0.0375	0.575	44		
chrX	117874898	117874898	T	C	hom	197	IL13RA1			0.96	0.96	0.96	rs2246663 [];										0.3875	0.0375	0.575	45		
chrX	117979393	117979404	TTCCTTCCTTCC	-	hom	214	ZCCHC12;LONRF3		ZCCHC12:dist=18462;LONRF3:dist=129309	0	0	0	rs200495130 [];							528			0.0125	0	0.9875	3		
chrX	118117063	118117063	T	C	hom	222	LONRF3			0.25	0.25	0.25	rs12391696 [];										0.1125	0.05	0.8375	15		
chrX	118143043	118143043	A	G	hom	222	LONRF3			0.4	0.4	0.4	rs2168379 [];					0.3790					0.125	0.05	0.825	33		
chrX	118147233	118147233	G	T	hom	222	LONRF3			0.37	0.37	0.37	rs2290514 [];										0.125	0.05	0.825	17		
chrX	118148229	118148229	A	G	hom	222	LONRF3	synonymous SNV	LONRF3:NM_001031855:exon10:c.A2034G:p.A678A,LONRF3:NM_024778:exon9:c.A1911G:p.A637A,	0.41	0.41	0.41	rs2278954 [];	-2.5850	0.2772			0.3790					0.325	0.075	0.6	64		
chrX	118533299	118533299	A	G	hom	119	SLC25A43			0.86	0.86	0.86	rs217975 [];										0.75	0.0125	0.2375	71		
chrX	118544448	118544448	T	C	hom	222	SLC25A43			0.98	0.98	0.98	rs16274 [];										0.4	0	0.6	42		
chrX	118587003	118587003	C	T	hom	222	SLC25A43	nonsynonymous SNV	SLC25A43:NM_145305:exon5:c.C1001T:p.P334L,	0.55	0.55	0.55	rs3810755 [];	0.6530	0.0000	0.8700	0.0000	0.5796					0.6125	0.0375	0.35	90		
chrX	118587321	118587321	A	G	hom	222	SLC25A43			0.46	0.46	0.46	rs3747455 [];										0.5	0.0125	0.4875	46		
chrX	118587669	118587669	T	G	hom	222	SLC25A43			0.55	0.55	0.55	rs3747454 [];							1810			0.5625	0.0375	0.4	53		
chrX	118588371	118588371	C	T	hom	222	SLC25A43			0.55	0.55	0.55	rs10907045 [];										0.575	0.0375	0.3875	53		
chrX	118601473	118601473	T	C	hom	222	SLC25A5-AS1			0.78	0.78	0.78	rs392020 [];										0.7	0.0625	0.2375	71		
chrX	118601707	118601707	A	G	hom	222	SLC25A5-AS1			0.64	0.64	0.64	rs6603508 [];										0.575	0.025	0.4	54		
chrX	118603844	118603844	T	G	hom	222	SLC25A5	nonsynonymous SNV	SLC25A5:NM_001152:exon2:c.T332G:p.L111R,	0.77	0.77	0.77	rs371749 [];	0.9400	0.0022	1.0000	0.0000						0.15	0.6375	0.2125	115		
chrX	118604436	118604436	T	C	hom	222	SLC25A5	synonymous SNV	SLC25A5:NM_001152:exon3:c.T699C:p.T233T,	0.78	0.78	0.78	rs12390 [];					0.7570					0.7	0.0625	0.2375	115		
chrX	118604554	118604554	-	A	hom	214	SLC25A5			0	0	0	rs3216181 [];										0.3	0.05	0.65	34		
chrX	118605196	118605196	-	TGATGGTGG	het	117	SLC25A5			0	0	0											0	0.7625	0.2375	72		
chrX	118605217	118605217	G	A	het	64	SLC25A5			0	0	0											0	0.4125	0.5875	40		
chrX	118672126	118672126	C	T	hom	222	CXorf56			0.61	0.61	0.61	rs5910608 [];										0.5875	0.0625	0.35	60		
chrX	118678364	118678364	G	A	hom	222	CXorf56	synonymous SNV	CXorf56:NM_001170570:exon3:c.C333T:p.G111G,CXorf56:NM_001170569:exon4:c.C228T:p.G76G,CXorf56:NM_022101:exon4:c.C375T:p.G125G,	0.6	0.6	0.6	rs5910611 [];					0.6295					0.6	0.0625	0.3375	107		
chrX	118699320	118699320	A	G	hom	222	CXorf56			0.94	0.94	0.94	rs5910616 [];					0.8579					0.7875	0.05	0.1625	125		
chrX	118718417	118718417	-	TTT	het	146	UBE2A			0	0	0											0.0125	0.0375	0.95	5		
chrX	118750256	118750256	G	A	hom	222	SEPT6			0.02	0.02	0.02	rs41300319 [];										0.0125	0	0.9875	4		
chrX	118751105	118751112	GTGTGTGT	-	het	147	SEPT6			0	0	0								489			0.2125	0.0875	0.7	30		
chrX	118751732	118751732	T	C	hom	222	SEPT6			0.73	0.73	0.73	rs305154 [];							389			0.7375	0.05	0.2125	77		
chrX	118751950	118751950	G	A	hom	222	SEPT6			0.75	0.75	0.75	rs305153 [];										0.775	0.05	0.175	80		
chrX	118752148	118752148	-	TT	het	167	SEPT6			0	0	0											0.0125	0.3375	0.65	32		
chrX	118752312	118752312	T	C	hom	222	SEPT6			0.75	0.75	0.75	rs7060 [];										0.7625	0.0625	0.175	80		
chrX	118754077	118754078	AA	-	hom	5.3	SEPT6			0	0	0											0.025	0.0125	0.9625	4		
chrX	118827317	118827317	A	C	hom	222	SEPT6			0.59	0.59	0.59	rs17261138 [];										0.525	0.075	0.4	57		
chrX	118920809	118920809	C	T	hom	193	RPL39			0.36	0.36	0.36	rs7885997 [];										0.1625	0.0625	0.775	22		
chrX	118921530	118921530	A	C	hom	222	RPL39			0.28	0.28	0.28	rs73214964 [];										0.15	0.0625	0.7875	20		
chrX	118921593	118921593	T	C	hom	200	RPL39			0.28	0.28	0.28	rs34447789 [];										0.15	0.0625	0.7875	20		
chrX	118925705	118925705	C	T	hom	222	RPL39			0.3	0.3	0.3	rs2240448 [];										0.15	0.05	0.8	20		
chrX	119054001	119054001	C	T	hom	222	AKAP14			0.26	0.26	0.26	rs3829719 [];					0.2710					0.125	0.0625	0.8125	17		
chrX	119065893	119065893	G	A	hom	222	NKAP			0.65	0.65	0.65	rs194302 [];					0.5431					0.5125	0.0625	0.425	87		
chrX	119070411	119070411	T	A	hom	222	NKAP			0.58	0.58	0.58	rs194307 [];					0.5317					0.2375	0.05	0.7125	41		
chrX	119070567	119070567	A	T	hom	222	NKAP			0.58	0.58	0.58	rs194308 [];					0.5042					0.525	0.0625	0.4125	80		
chrX	119071803	119071803	C	T	hom	185	NKAP			0.24	0.24	0.24	rs11797947 [];										0.275	0.0875	0.6375	31		
chrX	119387834	119387834	-	TGA	hom	214	ZBTB33	stopgain SNV	ZBTB33:NM_006777:exon2:c.564_565insTGA:p.S188delinsSX,ZBTB33:NM_001184742:exon3:c.564_565insTGA:p.S188delinsSX,	0	0	0	rs72413232 [];							180			0.6125	0.0625	0.325	99		
chrX	119389966	119389966	C	T	hom	222	ZBTB33			0.65	0.65	0.65	rs7882480 [];										0.6375	0.075	0.2875	66		
chrX	119390465	119390465	A	G	hom	222	ZBTB33			0.53	0.53	0.53	rs11537755 [];										0.5625	0.0875	0.35	60		
chrX	119391880	119391880	G	A	hom	222	ZBTB33			0.54	0.54	0.54	rs1044413 [];										0.5375	0.0875	0.375	57		
chrX	119392796	119392796	G	A	hom	222	TMEM255A			0.99	0.99	0.99	rs5910811 [];										0.9375	0	0.0625	91		
chrX	119394904	119394904	G	T	hom	222	TMEM255A			0.5	0.5	0.5	rs3752341 [];					0.6174					0.2125	0.075	0.7125	42		
chrX	119402264	119402264	A	C	hom	222	TMEM255A			0.4	0.4	0.4	rs41300936 [];					0.4407		834			0.15	0.05	0.8	37		
chrX	119421164	119421164	-	ACACACACACACAC	hom	169	TMEM255A			0	0	0								261			0.075	0.025	0.9	8		
chrX	119438372	119438372	T	G	hom	222	TMEM255A			0.08	0.08	0.08	rs41310458 [];					0.0884	COSN168800 [1(large_intestine)]; 				0	0.025	0.975	4		
chrX	119514692	119514692	T	G	hom	222	ATP1B4			0.39	0.39	0.39	rs3810745 [];										0.3125	0.025	0.6625	31		
chrX	119560140	119560140	T	C	hom	222	LAMP2			0.32	0.32	0.32	rs2748 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.3125	0.025	0.6625	72		
chrX	119560599	119560599	T	C	hom	222	LAMP2			0.7	0.7	0.7	rs42885 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.4625	0.0375	0.5	85		
chrX	119571073	119571073	G	A	hom	222	LAMP2			0.29	0.29	0.29	rs14410 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.3	0.025	0.675	70		
chrX	119571268	119571269	AA	-	hom	51.5	LAMP2			0	0	0	rs201938539 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.2	0.0125	0.7875	52		
chrX	119571541	119571541	T	C	hom	222	LAMP2			0.78	0.78	0.78	rs42889 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.5	0.0375	0.4625	90		
chrX	119572587	119572587	-	ACAAAA	hom	214	LAMP2			0	0	0								360	309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.1625	0.0125	0.825	36		
chrX	119590533	119590533	T	A	hom	222	LAMP2	synonymous SNV	LAMP2:NM_013995:exon2:c.A156T:p.V52V,LAMP2:NM_002294:exon2:c.A156T:p.V52V,LAMP2:NM_001122606:exon2:c.A156T:p.V52V,	0.39	0.39	0.39	rs12097 [];					0.4261			309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.3625	0.0375	0.6	113		
chrX	119660452	119660452	T	C	hom	222	CUL4B			0.0012	0.0012	0.0012	rs185867059 [];								300304 [Cullin-4B - Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)];		0	0.025	0.975	2		
chrX	119746008	119746008	T	C	hom	222	MCTS1			0.13	0.13	0.13	rs2233113 [];					0.2179					0.0875	0.0375	0.875	21		
chrX	119760629	119760629	A	T	hom	222	C1GALT1C1	nonsynonymous SNV	C1GALT1C1:NM_152692:exon3:c.T393A:p.D131E,C1GALT1C1:NM_001011551:exon2:c.T393A:p.D131E,	0.13	0.13	0.13	rs17261572 [];	0.2430	0.2923		0.0010	0.2278				RCV000011539.1 [other]; 	0.1875	0.05	0.7625	42		
chrX	122318387	122318387	-	G	hom	214	GRIA3			0	0	0	rs66632982 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.975	0	0.025	210		
chrX	122336601	122336601	-	G	hom	214	GRIA3	frameshift insertion	GRIA3:NM_001256743:exon3:c.382_383insG:p.G128fs,	0	0	0	rs11452643 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.975	0	0.025	157		
chrX	122338531	122338531	C	G	hom	222	GRIA3			0	0	0								233	305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0	0	1	0		
chrX	122528803	122528803	T	C	hom	222	GRIA3			0.59	0.59	0.59	rs550640 [];					0.6112			305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.2625	0.05	0.6875	65		
chrX	122537277	122537277	T	C	hom	222	GRIA3	synonymous SNV	GRIA3:NM_000828:exon9:c.T1200C:p.N400N,GRIA3:NM_007325:exon9:c.T1200C:p.N400N,	0.6	0.6	0.6	rs502434 [];					0.6116			305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.6	0.0625	0.3375	141		
chrX	122537418	122537418	C	T	hom	222	GRIA3			0.62	0.62	0.62	rs504096 [];					0.6090			305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.2625	0.05	0.6875	65		
chrX	122735221	122735221	G	C	hom	222	THOC2			0.44	0.44	0.44	rs2473181 [];										0.125	0.0625	0.8125	31		
chrX	122757353	122757353	-	T	hom	24.5	THOC2			0	0	0	rs61439088 [];										0.1	0	0.9	8		
chrX	122758529	122758529	G	A	hom	222	THOC2			0.46	0.46	0.46	rs2072914 [];					0.3129					0.3125	0.05	0.6375	89		
chrX	122761967	122761967	T	C	hom	213	THOC2			0.47	0.47	0.47	rs2498051 [];										0.1375	0.0375	0.825	15		
chrX	122765750	122765750	T	C	hom	222	THOC2			0.39	0.39	0.39	rs3764750 [];					0.2993					0.125	0.0375	0.8375	29		
chrX	123034511	123034511	A	C	hom	222	XIAP	nonsynonymous SNV	XIAP:NM_001167:exon6:c.A1268C:p.Q423P,XIAP:NM_001204401:exon6:c.A1268C:p.Q423P,	0.33	0.33	0.33	rs5956583 [];	1.7090	0.0307	0.0200	0.0020	0.3536			300079 [Inhibitor of apoptosis, X-linked - Lymphoproliferative syndrome, X-linked, 2, 300635 (3)];		0.3625	0.0875	0.55	87		
chrX	123506104	123506104	T	A	hom	222	SH2D1A			0.79	0.79	0.79	rs7876065 [];								300490 [SH2 domain protein 1A - Lymphoproliferative syndrome, X-linked, 308240 (3)];		0.875	0	0.125	137		
chrX	123513104	123513104	T	G	hom	222	TENM1			0.98	0.98	0.98	rs5958476 [];										0.925	0.025	0.05	91		
chrX	123516789	123516789	-	TATTTATT	hom	214	TENM1			0	0	0	rs72396072 [];							2028			0.1875	0	0.8125	21		
chrX	123526031	123526031	T	C	hom	222	TENM1	synonymous SNV	TENM1:NM_001163279:exon28:c.A5556G:p.S1852S,TENM1:NM_014253:exon27:c.A5538G:p.S1846S,TENM1:NM_001163278:exon28:c.A5559G:p.S1853S,	0.19	0.19	0.19	rs2076165 [];					0.1128					0.0375	0	0.9625	9		
chrX	123526333	123526333	T	C	hom	219	TENM1			0.19	0.19	0.19	rs2076163 [];										0.025	0	0.975	2		
chrX	123540315	123540315	G	T	hom	222	TENM1	synonymous SNV	TENM1:NM_001163279:exon26:c.C5004A:p.T1668T,TENM1:NM_014253:exon25:c.C4986A:p.T1662T,TENM1:NM_001163278:exon26:c.C5007A:p.T1669T,	0.4	0.4	0.4	rs960869 [];					0.4217					0.3375	0.0375	0.625	57		
chrX	123587110	123587110	C	A	hom	222	TENM1			0.63	0.63	0.63	rs2223416 [];										0.2125	0.075	0.7125	30		
chrX	128674642	128674642	T	G	het	13.2	OCRL			0	0	0									300535 [Phosphatidylinositol polyphosphate 5-phosphatase - Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)];		0	0.025	0.975	2		
chrX	128691930	128691930	A	G	hom	222	OCRL		OCRL:NM_001587:exon6:c.439+3A>G,NM_000276:exon6:c.439+3A>G	0.0012	0.0012	0.0012	rs61752971 [];					0.0027			300535 [Phosphatidylinositol polyphosphate 5-phosphatase - Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)];		0	0.0125	0.9875	1		
chrX	128938958	128938958	T	C	hom	222	ZDHHC9			0.67	0.67	0.67	rs1053486 [];								300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.95	0	0.05	154		
chrX	128948893	128948893	T	C	hom	222	ZDHHC9			0.94	0.94	0.94	rs5932686 [];								300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.4375	0	0.5625	46		
chrX	128957640	128957640	T	C	hom	222	ZDHHC9			0.81	0.81	0.81	rs2275605 [];					0.9894			300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.425	0	0.575	104		
chrX	129147079	129147079	T	C	hom	222	BCORL1	nonsynonymous SNV	BCORL1:NM_021946:exon3:c.T331C:p.F111L,	1	1	1	rs4830173 [];	1.0250	0.0000	0.3700	0.0000						0.9375	0	0.0625	139		
chrX	129244261	129244261	C	G	hom	53	ELF4			1	1	1	rs210015 [];										0.225	0	0.775	23		
chrX	129244268	129244268	C	G	hom	66	ELF4			1	1	1	rs210016 [];										0.2375	0	0.7625	24		
chrX	129498836	129498836	T	A	hom	222	SLC25A14			0.38	0.38	0.38	rs2235800 [];										0.1875	0.0625	0.75	22		
chrX	130223137	130223137	G	A	hom	222	ARHGAP36			0.82	0.82	0.82	rs3810727 [];										0.8375	0.0625	0.1	84		
chrX	130408431	130408431	T	C	hom	222	IGSF1			0.73	0.73	0.73	rs6418944 [];										0.225	0.025	0.75	26		
chrX	130409884	130409884	A	T	hom	222	IGSF1			0.28	0.28	0.28	rs55936630 [];					0.3470					0.1375	0.0375	0.825	16		
chrX	130410965	130410965	A	G	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon14:c.T2556C:p.Y852Y,IGSF1:NM_001170961:exon14:c.T2571C:p.Y857Y,IGSF1:NM_001170962:exon13:c.T2529C:p.Y843Y,	0.27	0.27	0.27	rs4830219 [];					0.3472					0.2875	0.05	0.6625	58		
chrX	130412178	130412178	C	G	hom	222	IGSF1			0.72	0.72	0.72	rs4524963 [];										0.225	0.025	0.75	26		
chrX	130416958	130416958	C	T	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon6:c.G948A:p.V316V,IGSF1:NM_001170961:exon6:c.G948A:p.V316V,IGSF1:NM_001170962:exon5:c.G921A:p.V307V,	0.92	0.92	0.92	rs5932877 [];					0.9991					0.975	0	0.025	143		
chrX	130418926	130418926	A	T	hom	222	IGSF1			0.03	0.03	0.03	rs45584439 [];							733			0.0375	0.0125	0.95	5		
chrX	130419646	130419646	A	G	hom	222	IGSF1			0.96	0.96	0.96	rs4830221 [];										0.4375	0	0.5625	46		
chrX	130420006	130420006	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon4:c.A114G:p.P38P,IGSF1:NM_001170961:exon4:c.A114G:p.P38P,IGSF1:NM_001170963:exon4:c.A114G:p.P38P,IGSF1:NM_205833:exon4:c.A114G:p.P38P,IGSF1:NM_001170962:exon3:c.A87G:p.P29P,	0.96	0.96	0.96	rs5930458 [];					0.9999					0.9875	0	0.0125	144		
chrX	130420415	130420415	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon3:c.A93G:p.S31S,IGSF1:NM_001170961:exon3:c.A93G:p.S31S,IGSF1:NM_001170963:exon3:c.A93G:p.S31S,IGSF1:NM_205833:exon3:c.A93G:p.S31S,	0.98	0.98	0.98	rs4495600 [];					0.9999					0.95	0	0.05	142		
chrX	130533791	130533791	T	C	hom	222	IGSF1;OR13H1		IGSF1:dist=110388;OR13H1:dist=144257	0.65	0.65	0.65	rs2281669 [];										0.2875	0.0375	0.675	31		
chrX	130889788	130889788	A	-	hom	84.5	LOC286467			0	0	0	rs57315866 [];										0.0875	0.0125	0.9	11		
chrX	130918008	130918008	T	C	hom	222	LOC286467			0.37	0.37	0.37	rs5930506 [];										0.2125	0.075	0.7125	28		
chrX	131208596	131208596	T	A	hom	222	MST4			0.77	0.77	0.77	rs995246 [];										0.7125	0.05	0.2375	71		
chrX	131220073	131220073	G	A	hom	222	FRMD7			0.02	0.02	0.02	rs56029310 [];					0.0434					0.0125	0	0.9875	2		
chrX	131231431	131231432	AC	-	het	37.5	FRMD7			0	0	0								309			0.0125	0.1	0.8875	12		
chrX	131337535	131337542	GAGAGAGA	-	hom	46.6	RAP2C			0	0	0								504			0.0625	0.025	0.9125	8		
chrX	131352071	131352071	T	G	hom	48	RAP2C			0.99	0.99	0.99	rs112628697 [];										0.15	0.0125	0.8375	13		
chrX	131760779	131760779	C	T	hom	222	HS6ST2			0.45	0.45	0.45	rs243462 [];										0.3125	0.1	0.5875	38		
chrX	131760865	131760865	G	A	hom	222	HS6ST2			0.44	0.44	0.44	rs243463 [];										0.325	0.1	0.575	39		
chrX	132095372	132095372	G	T	hom	222	HS6ST2			0	0	0											0	0	1	0		
chrX	132161673	132161673	C	T	hom	222	USP26	synonymous SNV	USP26:NM_031907:exon1:c.G576A:p.E192E,	0.32	0.32	0.32	rs41304540 [];					0.4965					0.45	0.0875	0.4625	84		
chrX	132888208	132888208	A	-	hom	8.17	GPC3			0	0	0									300037 [Glypican 3 - Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor,somatic, 194070 (3)];		0	0	1	0		
chrX	133511988	133511988	G	A	hom	222	PHF6			0.82	0.82	0.82	rs5978001 [];					0.7439			300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.325	0.0625	0.6125	62		
chrX	133678852	133678852	G	A	hom	222	MGC16121			0.81	0.81	0.81	rs2503985 [];										0.35	0	0.65	37		
chrX	133699960	133699960	T	G	hom	222	PLAC1			0.49	0.49	0.49	rs1982 [];										0.425	0.0375	0.5375	42		
chrX	133955298	133955298	C	-	het	8.18	FAM122C			0	0	0											0.0125	0.0625	0.925	7		
chrX	134156121	134156121	G	C	hom	222	FAM127C			0.7	0.7	0.7	rs2475853 [];	-0.0010		0.0000		0.7387					0.775	0.025	0.2	100		
chrX	134185997	134185997	T	A	hom	222	FAM127B	nonsynonymous SNV	FAM127B:NM_001078172:exon1:c.A142T:p.S48C [1(stomach)]; FAM127B:NM_001134321:exon1:c.A142T:p.S48C [1(stomach)]; 	0.74	0.74	0.74	rs2498776 [];	0.4460	0.0007	0.0600	0.0460	0.7429	150824 [1(stomach)]; 				0.7875	0.025	0.1875	118		
chrX	134186309	134186309	A	G	hom	176	FAM127B			0.38	0.38	0.38	rs2247343 [];										0.05	0.025	0.925	8		
chrX	134252958	134252958	T	C	hom	10.5	LINC00633			0	0	0	rs2498759 [];										0.0125	0.025	0.9625	5		
chrX	134420007	134420007	G	C	hom	222	ZNF75D			0.18	0.18	0.18	rs7042 [];										0.15	0.075	0.775	24		
chrX	134420028	134420028	T	G	hom	222	ZNF75D			0.17	0.17	0.17	rs4589 [];										0.15	0.075	0.775	24		
chrX	134420223	134420223	C	T	hom	222	ZNF75D			0.18	0.18	0.18	rs14241 [];										0.1625	0.0625	0.775	24		
chrX	134420602	134420602	C	T	hom	222	ZNF75D			0.17	0.17	0.17	rs1129095 [];										0.1625	0.0625	0.775	24		
chrX	134427640	134427640	C	G	hom	222	ZNF75D			0.18	0.18	0.18	rs5978119 [];					0.2661					0.05	0.0375	0.9125	22		
chrX	134477613	134477613	A	C	hom	222	ZNF75D;ZNF449		ZNF75D:dist=47648;ZNF449:dist=1083	0.64	0.64	0.64	rs1419828 [];										0.675	0.025	0.3	70		
chrX	134493284	134493284	C	T	hom	222	ZNF449			0.63	0.63	0.63	rs4829777 [];										0.675	0.0375	0.2875	67		
chrX	134558119	134558119	C	T	hom	222	LINC00086			0.32	0.32	0.32	rs45601034 [];										0.3	0.05	0.65	33		
chrX	134654818	134654818	T	C	hom	222	DDX26B			0.95	0.95	0.95	rs1890584 [];										0.9375	0.025	0.0375	93		
chrX	134683864	134683864	A	G	hom	195	DDX26B			0.86	0.86	0.86	rs6635060 [];										0.425	0.0125	0.5625	46		
chrX	134715274	134715274	G	A	hom	222	DDX26B			0.37	0.37	0.37	rs3737330 [];										0.175	0.05	0.775	23		
chrX	134947727	134947727	A	G	hom	204	CT45A5			0	0	0	rs6635166 [];										0.35	0	0.65	37		
chrX	134948034	134948034	A	G	hom	222	CT45A5	synonymous SNV	CT45A5:NM_001172288:exon3:c.T291C:p.N97N [1(prostate)]; CT45A5:NM_001007551:exon3:c.T291C:p.N97N [1(prostate)]; 	0.8	0.8	0.8	rs2034920 [];					0.7359	1178534 [1(prostate)]; 				0.8375	0.0125	0.15	129		
chrX	134993589	134993589	A	G	hom	222	SAGE1			0.99	0.99	0.99	rs4829798 [];										0.4375	0	0.5625	46		
chrX	135055694	135055694	T	C	hom	173	MMGT1			0.82	0.82	0.82	rs6635201 [];										0.4	0.0125	0.5875	41		
chrX	135426693	135426693	A	G	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.A828G:p.I276M,	0.43	0.43	0.43	rs4829829 [];	-2.1900	0.0003	0.1900	0.0040	0.4761					0.425	0.1	0.475	80		
chrX	135426968	135426968	C	A	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.C1103A:p.P368H,	0.43	0.43	0.43	rs5930931 [];	0.2380	0.0029	0.0200	0.5990	0.4756					0.4375	0.1	0.4625	79		
chrX	135429503	135429503	C	A	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.C3638A:p.T1213N,	0.45	0.45	0.45	rs4829830 [];	-0.3470	0.0012	0.1900	0.0110	0.4786					0.45	0.0875	0.4625	80		
chrX	135430044	135430044	T	C	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon6:c.T4179C:p.T1393T,	0.51	0.51	0.51	rs877761 [];					0.4802					0.45	0.0875	0.4625	80		
chrX	135430483	135430483	T	C	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.T4618C:p.S1540P,	0.45	0.45	0.45	rs912002 [];	1.1950	0.0311	0.0000	0.9940	0.4790					0.45	0.1	0.45	81		
chrX	135431236	135431236	T	C	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.T5371C:p.F1791L [1(prostate)]; 	0.47	0.47	0.47	rs5930932 [];	-1.0130	0.0012	0.4200	0.0000	0.4799	1132400 [1(prostate)]; 				0.45	0.1	0.45	80		
chrX	135431358	135431358	C	T	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon6:c.C5493T:p.P1831P,	0.46	0.46	0.46	rs5930933 [];					0.4798					0.45	0.0875	0.4625	80		
chrX	135435476	135435476	T	-	hom	15.6	GPR112			0	0	0	rs5903915 [];										0.075	0	0.925	37		
chrX	135438388	135438388	A	G	hom	222	GPR112			0.46	0.46	0.46	rs6635268 [];					0.4797					0.1875	0.075	0.7375	44		
chrX	135474420	135474420	C	A	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon17:c.C7941A:p.T2647T,	0.72	0.72	0.72	rs1329546 [];					0.6057					0.575	0.0375	0.3875	109		
chrX	135474445	135474447	GAT	-	hom	214	GPR112	nonframeshift deletion	GPR112:NM_153834:exon17:c.7966_7968del:p.2656_2656del,	0	0	0	rs34255702 [];					0.6067					0.575	0.05	0.375	112		
chrX	135480126	135480126	T	C	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon20:c.T8271C:p.F2757F,	0.75	0.75	0.75	rs5974595 [];					0.6069					0.5875	0.0375	0.375	98		
chrX	135496398	135496398	G	A	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon25:c.G9117A:p.T3039T,	0.75	0.75	0.75	rs5930942 [];					0.6064					0.5875	0.0375	0.375	98		
chrX	135574099	135574099	-	TTTTTTTTTT	hom	103	BRS3			0	0	0											0.0375	0	0.9625	3		
chrX	135723584	135723584	C	T	hom	222	LOC100128420			0.28	0.28	0.28	rs975379 [];										0.0875	0.0375	0.875	11		
chrX	135724017	135724017	T	C	hom	222	LOC100128420			0.01	0.01	0.01	rs147383031 [];										0	0	1	0		
chrX	135741185	135741185	T	C	hom	222	CD40LG			0.26	0.26	0.26	rs3092923 [];					0.0914			300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0.025	0.025	0.95	7		
chrX	135742093	135742095	CCC	-	hom	18.1	CD40LG			0	0	0									300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0.0875	0.0375	0.875	17		
chrX	135742107	135742107	G	A	hom	205	CD40LG			0.07	0.07	0.07	rs11575984 [];								300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0	0	1	0		
chrX	135742237	135742237	C	T	hom	222	CD40LG			0.07	0.07	0.07	rs73560786 [];								300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0	0	1	0		
chrX	135742264	135742264	-	AACACACACACATA	hom	214	CD40LG			0	0	0									300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0	0	1	0		
chrX	135748167	135748167	T	C	hom	222	ARHGEF6			0.01	0.01	0.01	rs151143657 [];								300267 [Rho guanine nucleotide exchange factor-6 - Mental retardation, X-linked nonspecific, type 46, 300436 (3)];		0	0	1	0		
chrX	135829842	135829842	G	A	hom	184	ARHGEF6			0.27	0.27	0.27	rs585356 [];								300267 [Rho guanine nucleotide exchange factor-6 - Mental retardation, X-linked nonspecific, type 46, 300436 (3)];		0.0625	0.05	0.8875	11		
chrX	135951894	135951894	-	A	hom	214	RBMX			0	0	0											0.0125	0.025	0.9625	3		
chrX	135956107	135956107	G	A	het	225	RBMX			0	0	0	rs4020659 [];										0	0.7375	0.2625	73		
chrX	135956218	135956218	G	A	het	225	RBMX			0	0	0	rs75376102 [];										0	0.775	0.225	78		
chrX	135956342	135956342	C	G	het	222	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.G1135C:p.G379R,	0	0	0	rs72615484 [];	2.3130	0.9999	0.2900	0.9960						0	0.75	0.25	112		
chrX	135956370	135956370	G	A	het	162	RBMX	synonymous SNV	RBMX:NM_002139:exon9:c.C1107T:p.R369R,	0	0	0	rs74509382 [];										0	0.725	0.275	100		
chrX	135956408	135956408	A	G	het	225	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.T1069C:p.Y357H,	0	0	0	rs76876438 [];	1.9000	0.9932	0.0800	0.9690						0	0.7	0.3	113		
chrX	135956462	135956462	G	C	het	204	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.C1015G:p.R339G,	0	0	0	rs74463481 [];	1.1680	0.9874	0.0100	0.3190						0	0.55	0.45	109		
chrX	135956467	135956467	C	T	het	181	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.G1010A:p.S337N [1(large_intestine)]; 	0	0	0	rs35899675 [];	2.3800	0.7468	0.1300	0.9540		292203 [1(large_intestine)]; 				0	0.425	0.575	77		
chrX	135956506	135956506	C	G	het	156	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.G971C:p.R324P,	0	0	0	rs77794331 [];	2.3800	0.9999	0.0600	0.9690						0	0.3	0.7	76		
chrX	135957600	135957600	T	A	hom	222	RBMX			0.04	0.04	0.04	rs2306222 [];					0.0327					0.0125	0.025	0.9625	3		
chrX	135960119	135960119	C	T	het	39	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon4:c.G343A:p.G115R [1(prostate)]; 	0	0	0	rs76812369 [];	2.3880	0.9991	0.1200	0.9960		1179950 [1(prostate)]; 				0	0.325	0.675	79		
chrX	135960147	135960147	-	AA	het	206	RBMX	frameshift insertion	RBMX:NM_002139:exon4:c.314_315insTT:p.P105fs,	0	0	0											0	0.575	0.425	107		
chrX	135961586	135961587	TG	-	het	24.5	RBMX	frameshift deletion	RBMX:NM_002139:wholegene,RBMX:NM_001164803:wholegene,	0	0	0											0	0.025	0.975	4		
chrX	137793449	137793449	C	G	hom	43.5	FGF13			0.99	0.99	0.99	rs5012047 [];										0.775	0	0.225	72		
chrX	137793455	137793455	T	G	hom	21	FGF13			1	1	1	rs5012046 [];										0.6875	0	0.3125	65		
chrX	137793458	137793458	T	A	hom	15.1	FGF13			1	1	1	rs5012045 [];										0.675	0	0.325	64		
chrX	137793642	137793642	C	G	hom	149	FGF13			1	1	1	rs12849923 [];							228			0.9375	0	0.0625	88		
chrX	137793653	137793653	C	G	hom	170	FGF13			1	1	1	rs12849929 [];							228			0.9375	0	0.0625	88		
chrX	137793835	137793835	G	A	hom	222	FGF13			0.09	0.09	0.09	rs187191248 [];										0.1	0.025	0.875	11		
chrX	138679712	138679712	T	A	hom	222	MCF2	synonymous SNV	MCF2:NM_001099855:exon21:c.A2142T:p.G714G,MCF2:NM_005369:exon18:c.A1962T:p.G654G,MCF2:NM_001171877:exon17:c.A1845T:p.G615G,MCF2:NM_001171876:exon22:c.A2190T:p.G730G,MCF2:NM_001171878:exon18:c.A1962T:p.G654G,MCF2:NM_001171879:exon19:c.A2010T:p.G670G,	0.24	0.24	0.24	rs1051619 [];	0.2790				0.5143					0.475	0.0625	0.4625	73		
chrX	138697246	138697246	A	C	hom	222	MCF2			0.43	0.43	0.43	rs2076501 [];					0.5304					0.2	0.0375	0.7625	35		
chrX	138698653	138698653	A	-	hom	25.5	MCF2			0	0	0	rs68033160 [];										0.1	0	0.9	9		
chrX	138724725	138724725	G	A	hom	222	MCF2			1	1	1	rs926563 [];										0.9375	0	0.0625	119		
chrX	138809002	138809002	T	C	hom	222	ATP11C			0.76	0.76	0.76	rs2805901 [];										0.925	0	0.075	89		
chrX	138811003	138811003	G	A	hom	222	ATP11C			0.95	0.95	0.95	rs2094702 [];					0.9992					0.975	0	0.025	121		
chrX	138825675	138825675	T	C	hom	222	ATP11C			0.99	0.99	0.99	rs1268015 [];					0.9998					0.4375	0	0.5625	67		
chrX	138897130	138897130	A	C	hom	222	ATP11C	nonsynonymous SNV	ATP11C:NM_001010986:exon5:c.T342G:p.C114W,ATP11C:NM_173694:exon5:c.T342G:p.C114W,	0.99	0.99	0.99	rs2491014 [];	0.9710	0.0000	1.0000	0.0000	0.9778					0.9125	0	0.0875	131		
chrX	139037825	139037828	TAAG	-	hom	214	CXorf66			0.26	0.26	0.26	rs10587653 [];										0.0375	0	0.9625	4		
chrX	139038443	139038443	G	A	hom	222	CXorf66	nonsynonymous SNV	CXorf66:NM_001013403:exon3:c.C698T:p.P233L [1(stomach)]; 	0.32	0.32	0.32	rs5955139 [];	-0.7790	0.0004		0.0000	0.0832	150826 [1(stomach)]; 				0.1125	0.0125	0.875	19		
chrX	139038968	139038968	G	A	hom	222	CXorf66			0.32	0.32	0.32	rs5953892 [];										0.05	0	0.95	5		
chrX	139040477	139040477	G	C	hom	222	CXorf66			0.32	0.32	0.32	rs7053442 [];										0.05	0	0.95	5		
chrX	139099429	139099429	T	G	hom	222	CXorf66;LOC389895		CXorf66:dist=51752;LOC389895:dist=74397	0.94	0.94	0.94	rs5907565 [];										0.9625	0	0.0375	89		
chrX	139099580	139099582	GAA	-	hom	214	CXorf66;LOC389895		CXorf66:dist=51903;LOC389895:dist=74244	0	0	0											0	0	1	0		
chrX	139099828	139099828	T	A	hom	222	CXorf66;LOC389895		CXorf66:dist=52151;LOC389895:dist=73998	0.95	0.95	0.95	rs5909002 [];										0.9	0	0.1	84		
chrX	139100293	139100293	G	A	het	114	CXorf66;LOC389895		CXorf66:dist=52616;LOC389895:dist=73533	0	0	0	rs17400 [];										0.0125	0.0625	0.925	7		
chrX	139863318	139863318	C	T	hom	222	RP1-177G6.2;CDR1		2:dist=66322;CDR1:dist=2107	0.88	0.88	0.88	rs5907055 [];										0.9625	0	0.0375	89		
chrX	139865162	139865162	G	A	hom	222	CDR1			0.12	0.12	0.12	rs6636116 [];										0.1	0.0125	0.8875	10		
chrX	140270418	140270418	T	C	hom	222	LDOC1			0.64	0.64	0.64	rs710106 [];										0.4625	0.1125	0.425	55		
chrX	140271268	140271268	G	C	hom	171	LDOC1			0.66	0.66	0.66	rs2038375 [];										0.4625	0.1	0.4375	52		
chrX	140983031	140983031	A	G	hom	177	MAGEC3			0.81	0.81	0.81	rs176023 [];					0.9845					0.4125	0	0.5875	72		
chrX	140983064	140983064	G	A	hom	222	MAGEC3	nonsynonymous SNV	MAGEC3:NM_138702:exon5:c.G919A:p.A307T,	0.76	0.76	0.76	rs176024 [];	-0.5680	0.0002	0.1300	0.0000	0.9518					0.8375	0.0125	0.15	131		
chrX	140983127	140983127	G	A	hom	222	MAGEC3	nonsynonymous SNV	MAGEC3:NM_138702:exon5:c.G982A:p.A328T,	0.68	0.68	0.68	rs176026 [];	0.6230	0.0000	0.4600	0.8110	0.9291					0.825	0.025	0.15	133		
chrX	140984250	140984250	C	T	hom	222	MAGEC3			0.45	0.45	0.45	rs2205912 [];						COSN414011 [1(urinary_tract)]; 				0.5375	0.05	0.4125	57		
chrX	140991742	140991743	TA	-	hom	214	MAGEC1			0.11	0.11	0.11	rs201533284 [];										0.075	0.0375	0.8875	11		
chrX	140993150	140993150	T	C	hom	222	MAGEC1			0.24	0.24	0.24	rs5953637 [];					0.1881		307			0.0375	0.0375	0.925	18		
chrX	140993980	140993980	G	C	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.G790C:p.A264P,	0.11	0.11	0.11	rs176042 [];	-2.4520	0.0001	1.0000	0.0000	0.0811					0.0375	0.0125	0.95	7		
chrX	140994037	140994037	C	A	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C847A:p.L283I,	0.36	0.36	0.36	rs176045 [];	-1.6190	0.0000	0.4200	0.0100						0.2625	0.2125	0.525	71		
chrX	140994171	140994171	C	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C981G:p.H327Q,	0.68	0.68	0.68	rs176047 [];	-2.3540	0.0001	1.0000	0.0000	0.7289					0.675	0.05	0.275	110		
chrX	140994280	140994280	A	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.A1090G:p.T364A,	0.21	0.21	0.21	rs4824884 [];	0.1270	0.0000	0.0400	0.0390	0.2204					0.1625	0	0.8375	31		
chrX	140996292	140996297	CTTTGC	-	hom	214	MAGEC1	nonframeshift deletion	MAGEC1:NM_005462:exon4:c.3102_3107del:p.1034_1036del,	0	0	0											0	0	1	0		
chrX	142716114	142716114	G	A	hom	222	SLITRK4			0.49	0.49	0.49	rs5907446 [];										0.475	0.0375	0.4875	50		
chrX	142795225	142795225	G	A	hom	222	SPANXN2	synonymous SNV	SPANXN2:NM_001009615:exon2:c.C453T:p.D151D,	0.65	0.65	0.65	rs3859898 [];					0.5525					0.625	0.0625	0.3125	95		
chrX	142795697	142795697	T	G	hom	222	SPANXN2			0.59	0.59	0.59	rs67375287 [];										0.275	0.05	0.675	33		
chrX	142795709	142795709	G	T	hom	222	SPANXN2			0.7	0.7	0.7	rs12389451 [];										0.275	0.05	0.675	33		
chrX	142804302	142804302	T	C	hom	222	SPANXN2			0	0	0	rs60838062 [];										0.025	0.0375	0.9375	5		
chrX	142804308	142804308	-	C	hom	214	SPANXN2			0	0	0	rs60039850 [];										0.025	0.0375	0.9375	5		
chrX	142804326	142804326	C	T	hom	222	SPANXN2			0.59	0.59	0.59	rs851091 [];										0.6375	0.0625	0.3	68		
chrX	142804493	142804493	T	C	hom	222	SPANXN2			0.62	0.62	0.62	rs851090 [];										0.6375	0.0625	0.3	67		
chrX	142967468	142967468	T	G	hom	222	UBE2NL	stopgain SNV	UBE2NL:NM_001012989:exon1:c.T266G:p.L89X,	0.62	0.62	0.62	rs237520 [];	0.6950	1.0000	1.0000		0.6738					0.625	0.025	0.35	97		
chrX	142968008	142968012	TTTAT	-	hom	214	UBE2NL			0.58	0.58	0.58	rs201920118 [];										0.5875	0.025	0.3875	58		
chrX	142968082	142968082	A	C	hom	222	UBE2NL			0.59	0.59	0.59	rs237521 [];										0.5875	0.025	0.3875	59		
chrX	144328540	144328540	G	A	hom	222	SPANXN1			0.44	0.44	0.44	rs41301303 [];										0.3125	0.0625	0.625	33		
chrX	144328634	144328634	T	G	hom	222	SPANXN1			0.42	0.42	0.42	rs41311670 [];										0.3	0.075	0.625	32		
chrX	144328775	144328775	C	T	hom	222	SPANXN1			0.5	0.5	0.5	rs6525938 [];										0.2625	0.1	0.6375	32		
chrX	144328782	144328782	T	G	hom	176	SPANXN1			0.5	0.5	0.5	rs6525939 [];										0.2625	0.0875	0.65	31		
chrX	144328784	144328784	G	A	hom	169	SPANXN1			0.5	0.5	0.5	rs6525940 [];										0.2625	0.0625	0.675	29		
chrX	144328894	144328894	C	T	hom	222	SPANXN1			0.55	0.55	0.55	rs7057127 [];										0.3375	0.0625	0.6	35		
chrX	144337667	144337667	C	A	hom	222	SPANXN1			0.87	0.87	0.87	rs485945 [];										0.375	0.0375	0.5875	45		
chrX	144902644	144902644	-	CACACA	hom	214	SLITRK2			0	0	0								389			0.05	0.0125	0.9375	5		
chrX	144904882	144904882	T	C	hom	222	SLITRK2	synonymous SNV	SLITRK2:NM_001144006:exon3:c.T939C:p.P313P,SLITRK2:NM_001144003:exon5:c.T939C:p.P313P,SLITRK2:NM_001144008:exon3:c.T939C:p.P313P,SLITRK2:NM_032539:exon5:c.T939C:p.P313P,SLITRK2:NM_001144009:exon2:c.T939C:p.P313P,SLITRK2:NM_001144004:exon5:c.T939C:p.P313P,SLITRK2:NM_001144010:exon3:c.T939C:p.P313P,SLITRK2:NM_001144005:exon5:c.T939C:p.P313P,	0.94	0.94	0.94	rs2748588 [];					0.8644					0.7625	0.0375	0.2	127		
chrX	144906705	144906709	TTTTT	-	het	72.5	SLITRK2			0	0	0								231			0.075	0.2	0.725	27		
chrX	144910142	144910142	G	A	hom	222	TMEM257			0.53	0.53	0.53	rs5919909 [];										0.5125	0.0625	0.425	58		
chrX	144910936	144910936	C	T	hom	222	TMEM257			0.93	0.93	0.93	rs2474402 [];										0.775	0.0375	0.1875	80		
chrX	144911518	144911518	-	AATG	hom	214	TMEM257			0	0	0	rs33973705 [];										0.2875	0.0375	0.675	36		
chrX	147003564	147003564	T	C	hom	222	FMR1-AS1			1	1	1	rs1270092 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.4375	0	0.5625	87		
chrX	147007220	147007220	T	A	hom	222	FMR1			0.21	0.21	0.21	rs25731 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.025	0.05	0.925	6		
chrX	147018146	147018146	C	T	hom	222	FMR1			0.27	0.27	0.27	rs25714 [];					0.0690			309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.025	0.05	0.925	14		
chrX	147019192	147019192	G	A	hom	222	FMR1			0.36	0.36	0.36	rs25700 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.05	0.05	0.9	8		
chrX	147026333	147026333	C	-	hom	117	FMR1			0	0	0									309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.425	0	0.575	45		
chrX	147031538	147031538	C	T	hom	222	FMR1			0.46	0.46	0.46	rs25704 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.2	0.0375	0.7625	37		
chrX	147088249	147088249	C	T	hom	222	FMR1NB	nonsynonymous SNV	FMR1NB:NM_152578:exon3:c.C425T:p.A142V,	0.45	0.45	0.45	rs764631 [];	-0.4520	0.0002	1.0000	0.0010	0.3676					0.3875	0.0625	0.55	71		
chrX	147106677	147106677	C	A	hom	222	FMR1NB			1	1	1	rs215110 [];										0.4375	0	0.5625	46		
chrX	147108312	147108312	A	G	hom	199	FMR1NB			0.98	0.98	0.98	rs215112 [];										0.3875	0.025	0.5875	43		
chrX	147134441	147134441	-	C	hom	71.5	FMR1NB;AFF2		FMR1NB:dist=26254;AFF2:dist=447698	0	0	0	rs56076756 [];										0.7125	0.025	0.2625	68		
chrX	147891558	147891558	T	C	hom	222	AFF2			0.95	0.95	0.95	rs11117555 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.425	0	0.575	44		
chrX	148037055	148037055	G	C	hom	198	AFF2			0.75	0.75	0.75	rs16994868 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.4125	0.0125	0.575	44		
chrX	148055144	148055144	A	G	hom	222	AFF2			0.96	0.96	0.96	rs5980615 [];					0.9993			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9625	0	0.0375	210		
chrX	148062377	148062377	G	A	hom	222	AFF2			0.63	0.63	0.63	rs12688573 [];					0.7206			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.2875	0.0375	0.675	56		
chrX	148079639	148079639	A	C	hom	222	AFF2			0.87	0.87	0.87	rs16994920 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.925	0.0125	0.0625	150		
chrX	148079740	148079740	A	C	hom	222	AFF2			0.86	0.86	0.86	rs58901446 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	149		
chrX	148079877	148079877	T	C	hom	222	AFF2			0.83	0.83	0.83	rs16994922 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	150		
chrX	148081110	148081111	GT	-	het	137	AFF2			0	0	0								222	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0	0.7375	0.2625	110		
chrX	148081140	148081140	A	G	hom	222	AFF2			0.91	0.91	0.91	rs184050542 [];							222	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	153		
chrX	148081451	148081451	A	G	hom	222	AFF2			1	1	1	rs141776682 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9875	0	0.0125	156		
chrX	148614478	148614478	C	T	hom	212	LOC100131434			0.8	0.8	0.8	rs2272561 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.8375	0.0125	0.15	81		
chrX	148614505	148614505	A	G	hom	86	LOC100131434			0.78	0.78	0.78	rs5980483 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.525	0.0125	0.4625	49		
chrX	148614589	148614589	G	A	hom	179	LOC100131434			0.79	0.79	0.79	rs145413300 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.85	0	0.15	82		
chrX	148621334	148621334	G	C	hom	222	LOC100131434			0.84	0.84	0.84	rs12116320 [];										0.3625	0.05	0.5875	43		
chrX	148622385	148622385	G	C	hom	222	CXorf40A			1	1	1	rs113049484 [];										0.4375	0	0.5625	46		
chrX	148622398	148622398	C	G	hom	222	CXorf40A			0.96	0.96	0.96	rs112658167 [];										0.4375	0	0.5625	46		
chrX	148622508	148622508	A	C	hom	222	CXorf40A			0.99	0.99	0.99	rs111314546 [];										0.4375	0	0.5625	46		
chrX	148622539	148622539	C	T	hom	222	CXorf40A			0.11	0.11	0.11	rs41302150 [];										0.2	0.0125	0.7875	21		
chrX	148622730	148622730	G	A	hom	222	CXorf40A			0.84	0.84	0.84	rs3747443 [];										0.85	0.05	0.1	90		
chrX	148622745	148622745	T	A	hom	222	CXorf40A			0.84	0.84	0.84	rs3747442 [];										0.85	0.05	0.1	90		
chrX	148627384	148627384	A	G	hom	197	CXorf40A	nonsynonymous SNV	CXorf40A:NM_001171909:exon3:c.A208G:p.T70A,CXorf40A:NM_001171908:exon4:c.A208G:p.T70A,CXorf40A:NM_178124:exon4:c.A208G:p.T70A,CXorf40A:NM_001171907:exon4:c.A208G:p.T70A,	0.91	0.91	0.91	rs145921071 [];	-0.0490	0.0000	0.6800	0.0000						0.9375	0	0.0625	139		
chrX	148627504	148627504	C	G	hom	143	CXorf40A			0	0	0	rs200394392 [];										0.0875	0	0.9125	10		
chrX	148628490	148628490	A	T	hom	220	CXorf40A	synonymous SNV	CXorf40A:NM_001171908:exon5:c.A459T:p.P153P,CXorf40A:NM_178124:exon5:c.A459T:p.P153P,CXorf40A:NM_001171907:exon5:c.A459T:p.P153P,	0	0	0	rs12116111 [];										0.9875	0	0.0125	167		
chrX	148681163	148681163	T	C	hom	29.5	TMEM185A			0	0	0	rs610285 [];										0.0375	0	0.9625	3		
chrX	148851538	148851538	A	G	het	104	MAGEA11;HSFX1		MAGEA11:dist=52610;HSFX1:dist=4188	0.81	0.81	0.81	rs148144905 [];										0.075	0.0375	0.8875	10		
chrX	148853831	148853831	C	T	hom	97.1	MAGEA11;HSFX1		MAGEA11:dist=54903;HSFX1:dist=1895	0	0	0											0.0125	0.0375	0.95	5		
chrX	149013727	149013727	A	G	hom	222	MAGEA8	synonymous SNV	MAGEA8:NM_001166401:exon3:c.A681G:p.A227A,MAGEA8:NM_001166400:exon4:c.A681G:p.A227A,MAGEA8:NM_005364:exon3:c.A681G:p.A227A,	0.87	0.87	0.87	rs5983916 [];					0.7948					0.775	0.025	0.2	127		
chrX	149109123	149109123	C	A	hom	222	LOC100272228			0.99	0.99	0.99	rs28454191 [];										0.4375	0	0.5625	46		
chrX	149638920	149638920	C	T	hom	222	MAMLD1	nonsynonymous SNV	MAMLD1:NM_001177466:exon2:c.C1000T:p.P334S,MAMLD1:NM_005491:exon3:c.C1075T:p.P359S,MAMLD1:NM_001177465:exon3:c.C1000T:p.P334S,	0.07	0.07	0.07	rs41313406 [];	0.0190	0.7930		0.9980	0.1257		207			0.0625	0.05	0.8875	14		
chrX	149642019	149642019	A	G	hom	222	MAMLD1	nonsynonymous SNV	MAMLD1:NM_001177466:exon3:c.A1910G:p.N637S,MAMLD1:NM_005491:exon4:c.A1985G:p.N662S,	0.09	0.09	0.09	rs2073043 [];	0.5800	0.0027	0.3500	0.0580	0.1451					0.1	0.0625	0.8375	17		
chrX	149681925	149681925	T	C	hom	222	MAMLD1			0.62	0.62	0.62	rs567517 [];										0.6	0.0875	0.3125	67		
chrX	149826503	149826503	G	A	hom	222	MTM1		MTM1:NM_000252:exon11:c.1260+3G>A	0.58	0.58	0.58	rs222410 [];					0.4987			300415 [Myotubularin - Myotubular myopathy, X-linked, 310400 (3)];		0.45	0.075	0.475	129		
chrX	149931106	149931106	C	T	hom	222	MTMR1	synonymous SNV	MTMR1:NM_003828:exon15:c.C1902T:p.G634G,	0.85	0.85	0.85	rs16995747 [];					0.8796					0.825	0.05	0.125	131		
chrX	149932703	149932703	G	A	hom	222	MTMR1			0.87	0.87	0.87	rs5925424 [];										0.775	0.05	0.175	74		
chrX	149935100	149935100	T	C	hom	222	CD99L2			0.49	0.49	0.49	rs6877 [];										0.575	0.0625	0.3625	62		
chrX	149936103	149936103	C	A	hom	222	CD99L2			0.23	0.23	0.23	rs9866 [];										0.25	0.075	0.675	27		
chrX	149936748	149936748	C	G	hom	222	CD99L2			0.27	0.27	0.27	rs5925425 [];										0.3375	0.075	0.5875	36		
chrX	149937404	149937404	T	C	hom	222	CD99L2			0.12	0.12	0.12	rs41311690 [];										0.15	0.0625	0.7875	24		
chrX	150348228	150348228	C	T	hom	222	GPR50			0.79	0.79	0.79	rs1202874 [];					0.8839					0.3625	0	0.6375	67		
chrX	150573744	150573744	-	TTAAA	hom	214	VMA21			0	0	0											0.525	0.05	0.425	57		
chrX	150574399	150574399	G	A	hom	222	VMA21			0.13	0.13	0.13	rs3207598 [];										0.0875	0.0125	0.9	8		
chrX	150575598	150575598	C	A	hom	222	VMA21			0.13	0.13	0.13	rs35860657 [];										0.0875	0.0125	0.9	8		
chrX	150577039	150577039	C	A	hom	222	VMA21			0.01	0.01	0.01	rs41314149 [];										0.025	0	0.975	2		
chrX	150732081	150732081	T	C	hom	160	PASD1			0.43	0.43	0.43	rs5970069 [];										0.15	0.0125	0.8375	21		
chrX	150789690	150789690	C	T	hom	222	PASD1			0.8	0.8	0.8	rs5924976 [];										0.3875	0	0.6125	41		
chrX	150789767	150789767	C	T	hom	222	PASD1			0.91	0.91	0.91	rs5924653 [];										0.4375	0	0.5625	46		
chrX	150789950	150789950	C	T	hom	222	PASD1		PASD1:NM_173493:exon6:c.308-4C>T	0.8	0.8	0.8	rs945815 [];					0.9237					0.85	0.0125	0.1375	126		
chrX	150791503	150791503	A	G	hom	222	PASD1	synonymous SNV	PASD1:NM_173493:exon7:c.A513G:p.G171G,	0.11	0.11	0.11	rs5924977 [];					0.1678					0.1625	0.0625	0.775	30		
chrX	150791512	150791512	C	T	hom	222	PASD1	synonymous SNV	PASD1:NM_173493:exon7:c.C522T:p.C174C,	0.1	0.1	0.1	rs5924978 [];					0.1526					0.15	0.0625	0.7875	28		
chrX	150794130	150794130	-	C	hom	137	PASD1			0	0	0	rs67081803 [];										0.1125	0.0375	0.85	16		
chrX	150867321	150867321	C	T	hom	222	PRRG3			0.23	0.23	0.23	rs5925008 [];					0.3971					0.1125	0.0375	0.85	33		
chrX	150869267	150869267	A	G	hom	222	PRRG3	nonsynonymous SNV	PRRG3:NM_024082:exon4:c.A458G:p.N153S,	0.93	0.93	0.93	rs4323608 [];	0.4060	0.0000		0.0000	0.9340					0.8625	0	0.1375	127		
chrX	150889857	150889857	C	T	hom	222	FATE1			0.15	0.15	0.15	rs72612761 [];					0.1168					0.0375	0.0125	0.95	12		
chrX	150907240	150907240	T	C	hom	222	CNGA2			0.23	0.23	0.23	rs7066992 [];					0.1638					0.05	0.05	0.9	19		
chrX	150911278	150911278	C	G	hom	166	CNGA2			0.34	0.34	0.34	rs34058725 [];							196			0.0625	0.05	0.8875	13		
chrX	150911501	150911501	-	TATACACACACA	hom	198	CNGA2			0	0	0								831			0.0125	0	0.9875	1		
chrX	150911512	150911512	G	A	hom	115	CNGA2			0.91	0.91	0.91	rs5924686 [];							831			0.1375	0.275	0.5875	44		
chrX	150911513	150911513	T	C	hom	118	CNGA2			0	0	0	rs5924687 [];							831			0.125	0.2875	0.5875	44		
chrX	150913273	150913273	C	T	hom	222	CNGA2			0.35	0.35	0.35	rs879372 [];										0.125	0.0625	0.8125	19		
chrX	150913599	150913599	G	A	hom	222	CNGA2			0.05	0.05	0.05	rs5925021 [];										0.0625	0.05	0.8875	12		
chrX	151122248	151122248	T	C	hom	222	GABRE			0.1	0.1	0.1	rs5970170 [];										0.0875	0.0375	0.875	12		
chrX	151122596	151122596	T	A	hom	222	GABRE			0.17	0.17	0.17	rs1061421 [];										0.0875	0.0375	0.875	11		
chrX	151122772	151122772	A	G	hom	222	GABRE			0.16	0.16	0.16	rs1061420 [];										0.0875	0.0375	0.875	11		
chrX	151282592	151282592	T	A	hom	222	MAGEA10-MAGEA5;MAGEA5			0.77	0.77	0.77	rs2471978 [];										0.775	0.025	0.2	78		
chrX	151282610	151282610	G	A	hom	222	MAGEA10-MAGEA5;MAGEA5			0.99	0.99	0.99	rs210571 [];										0.95	0	0.05	91		
chrX	151282657	151282657	G	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.81	0.81	0.81	rs2452124 [];										0.7625	0.025	0.2125	77		
chrX	151283004	151283004	G	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.99	0.99	0.99	rs210573 [];										0.9875	0	0.0125	98		
chrX	151283336	151283336	T	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.78	0.78	0.78	rs3565 [];						COSN414020 [1(urinary_tract)]; 				0.7875	0.025	0.1875	82		
chrX	151283437	151283441	TTATC	-	hom	214	MAGEA10-MAGEA5;MAGEA5			0	0	0	rs67540048 [];										0.8125	0.025	0.1625	84		
chrX	151283567	151283567	A	T	hom	222	MAGEA10-MAGEA5;MAGEA5			0.98	0.98	0.98	rs210575 [];										1	0	0	100		
chrX	151283599	151283599	T	G	hom	222	MAGEA10-MAGEA5;MAGEA5			1	1	1	rs210576 [];					0.9999					1	0	0	126		
chrX	151286320	151286320	A	G	hom	222	MAGEA10-MAGEA5;MAGEA5			0.8	0.8	0.8	rs6627537 [];										0.3375	0.025	0.6375	38		
chrX	151303393	151303393	C	T	hom	222	MAGEA10	nonsynonymous SNV	MAGEA10:NM_001251828:exon5:c.G700A:p.V234I,MAGEA10:NM_021048:exon4:c.G700A:p.V234I,MAGEA10:NM_001011543:exon5:c.G700A:p.V234I,	0.99	0.99	0.99	rs210586 [];	0.2920	0.0000	1.0000	0.0020	0.9997					0.975	0	0.025	144		
chrX	151303596	151303596	C	T	hom	222	MAGEA10	nonsynonymous SNV	MAGEA10:NM_001251828:exon5:c.G497A:p.R166K,MAGEA10:NM_021048:exon4:c.G497A:p.R166K,MAGEA10:NM_001011543:exon5:c.G497A:p.R166K,	0.96	0.96	0.96	rs210585 [];	-1.5200	0.0000	1.0000	0.0060	0.9994					0.9875	0	0.0125	143		
chrX	151560868	151560868	G	A	hom	222	GABRA3			0.41	0.41	0.41	rs5970292 [];										0.1875	0.075	0.7375	28		
chrX	151619708	151619708	T	G	hom	222	GABRA3			0.65	0.65	0.65	rs7391474 [];										0.7625	0.075	0.1625	81		
chrX	151619799	151619800	CT	-	het	123	GABRA3			0	0	0	rs67603066 [];							417			0.425	0.1875	0.3875	57		
chrX	151817820	151817820	C	T	hom	222	GABRQ			0.35	0.35	0.35	rs6627251 [];					0.3676					0.175	0.025	0.8	36		
chrX	151818008	151818008	C	T	hom	222	GABRQ			0.44	0.44	0.44	rs5924753 [];							322			0.275	0.025	0.7	31		
chrX	151821277	151821277	T	A	hom	222	GABRQ	nonsynonymous SNV	GABRQ:NM_018558:exon9:c.T1432A:p.F478I,	0.46	0.46	0.46	rs3810651 [];	-4.3390	0.0000	1.0000	0.0000						0.5625	0.05	0.3875	97		
chrX	151870629	151870629	A	T	hom	222	MAGEA6			0.38	0.38	0.38	rs3175206 [];										0.3875	0.05	0.5625	45		
chrX	151896273	151896273	C	T	hom	222	CSAG4			0.35	0.35	0.35	rs2471768 [];										0.4125	0.075	0.5125	43		
chrX	151896334	151896334	G	A	hom	222	CSAG4			0.45	0.45	0.45	rs2515828 [];						488108 [1(kidney),1(endometrium)]; 				0.4125	0.075	0.5125	43		
chrX	151899760	151899760	A	G	hom	222	MAGEA12			0.99	0.99	0.99	rs2515830 [];										0.9875	0	0.0125	96		
chrX	151909156	151909156	A	G	hom	222	CSAG1	nonsynonymous SNV	CSAG1:NM_001102576:exon4:c.A185G:p.K62R,CSAG1:NM_153478:exon5:c.A185G:p.K62R,	0.58	0.58	0.58	rs2515848 [];	-0.0980	0.0000	0.2500	0.0000	0.5847					0.5375	0.075	0.3875	97		
chrX	151909281	151909281	C	G	hom	222	CSAG1			0.41	0.41	0.41	rs2515849 [];										0.4125	0.075	0.5125	46		
chrX	151909305	151909305	C	T	hom	222	CSAG1			0.44	0.44	0.44	rs2471787 [];										0.4	0.075	0.525	45		
chrX	151909490	151909490	A	G	hom	222	CSAG1			0.57	0.57	0.57	rs2515850 [];										0.5625	0.0875	0.35	62		
chrX	151909576	151909576	A	G	hom	222	CSAG1			0.44	0.44	0.44	rs7882673 [];										0.2	0.0625	0.7375	25		
chrX	152018832	152018832	T	G	hom	222	NSDHL	synonymous SNV	NSDHL:NM_015922:exon3:c.T132G:p.G44G,NSDHL:NM_001129765:exon4:c.T132G:p.G44G,	0.87	0.87	0.87	rs5969919 [];					0.8639			300275 [NAD(P)H steroid dehydrogenase-like protein - CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)];		0.825	0.025	0.15	186		
chrX	152090809	152090809	T	C	hom	222	ZNF185			0.13	0.13	0.13	rs12558188 [];					0.2215					0.125	0.0375	0.8375	31		
chrX	152158979	152158979	T	C	hom	222	PNMA5	synonymous SNV	PNMA5:NM_001184924:exon4:c.A1164G:p.P388P,PNMA5:NM_001103150:exon2:c.A1164G:p.P388P,PNMA5:NM_052926:exon2:c.A1164G:p.P388P,PNMA5:NM_001103151:exon3:c.A1164G:p.P388P,	0.06	0.06	0.06	rs56350208 [];					0.1064					0.1	0.05	0.85	23		
chrX	152225379	152225379	C	A	hom	222	PNMA3			0.21	0.21	0.21	rs73244173 [];					0.4362		2170			0.325	0.1	0.575	50		
chrX	152226542	152226542	T	C	hom	222	PNMA3	nonsynonymous SNV	PNMA3:NM_013364:exon2:c.T1130C:p.V377A,	0.91	0.91	0.91	rs6526155 [];	-0.8440	0.0010	1.0000	0.0000	0.8577					0.7625	0.05	0.1875	122		
chrX	152228361	152228361	G	A	hom	222	PNMA3			0.23	0.23	0.23	rs1045069 [];										0.3	0.1	0.6	37		
chrX	152228523	152228523	T	C	hom	222	PNMA3			0.81	0.81	0.81	rs9035 [];							271			0.7	0.05	0.25	76		
chrX	152228778	152228778	T	G	hom	222	PNMA3			0.51	0.51	0.51	rs7122 [];										0.55	0.0625	0.3875	60		
chrX	152727723	152727723	G	A	hom	222	HAUS7			0.5	0.5	0.5	rs762735 [];										0.6	0.05	0.35	61		
chrX	152728155	152728155	T	C	hom	222	HAUS7			0.51	0.51	0.51	rs2980032 [];					0.6853					0.2125	0.05	0.7375	64		
chrX	152760532	152760532	G	T	hom	116	BGN			0.24	0.24	0.24	rs5945197 [];										0.3	0.0375	0.6625	35		
chrX	152760871	152760871	G	A	hom	175	BGN			0.93	0.93	0.93	rs2980045 [];							240			0.9375	0	0.0625	87		
chrX	152770402	152770402	A	G	hom	222	BGN			0.86	0.86	0.86	rs2980053 [];										0.375	0.025	0.6	43		
chrX	152771509	152771509	C	T	hom	222	BGN	synonymous SNV	BGN:NM_001711:exon4:c.C540T:p.S180S,	0.37	0.37	0.37	rs1126499 [];					0.4660					0.425	0.05	0.525	67		
chrX	152772758	152772758	T	C	hom	123	BGN			0.73	0.73	0.73	rs2269404 [];										0.2625	0.05	0.6875	31		
chrX	152774031	152774031	G	A	hom	222	BGN			0.2	0.2	0.2	rs1042103 [];										0.2875	0.0375	0.675	30		
chrX	152774423	152774423	C	A	hom	222	BGN			0.23	0.23	0.23	rs11538656 [];										0.3375	0.05	0.6125	38		
chrX	152774520	152774521	TG	-	het	48.5	BGN			0	0	0								405			0	0.05	0.95	5		
chrX	152774745	152774745	A	G	hom	222	BGN			0.98	0.98	0.98	rs2980054 [];										0.95	0	0.05	95		
chrX	152807425	152807425	G	A	hom	222	ATP2B3			0.62	0.62	0.62	rs762733 [];					0.8594					0.2875	0.0375	0.675	56		
chrX	152807505	152807507	CTT	-	hom	214	ATP2B3			0	0	0	rs10531880 [];										0.35	0.05	0.6	39		
chrX	152807627	152807627	C	-	hom	21.6	ATP2B3			0	0	0	rs5904365 [];										0.35	0	0.65	32		
chrX	152807665	152807665	A	G	hom	125	ATP2B3			0.95	0.95	0.95	rs2980012 [];										0.4375	0	0.5625	44		
chrX	152807923	152807923	G	C	hom	222	ATP2B3			0.99	0.99	0.99	rs2980013 [];					0.9999					0.4375	0	0.5625	219		
chrX	152814373	152814373	T	C	hom	222	ATP2B3			0.42	0.42	0.42	rs2285034 [];										0.1875	0.0875	0.725	29		
chrX	152815089	152815089	A	G	hom	222	ATP2B3	synonymous SNV	ATP2B3:NM_001001344:exon9:c.A1473G:p.G491G,ATP2B3:NM_021949:exon9:c.A1473G:p.G491G,	0.99	0.99	0.99	rs3020949 [];					0.9999					0.9625	0	0.0375	289		
chrX	152821887	152821887	C	T	hom	222	ATP2B3			0.96	0.96	0.96	rs3020957 [];					0.9994					0.4375	0	0.5625	239		
chrX	152825414	152825414	G	T	hom	222	ATP2B3			0.91	0.91	0.91	rs3020959 [];					0.9489					0.4	0.0125	0.5875	212		
chrX	152825433	152825433	A	G	hom	222	ATP2B3			0.99	0.99	0.99	rs2980018 [];					0.9987					0.4375	0	0.5625	74		
chrX	152830322	152830322	A	G	hom	155	ATP2B3			0.94	0.94	0.94	rs4243536 [];										0.4	0.0125	0.5875	42		
chrX	152830684	152830684	C	T	hom	86.3	ATP2B3			0.92	0.92	0.92	rs5987097 [];										0.3	0.0125	0.6875	32		
chrX	152846544	152846544	-	TG	hom	86.5	ATP2B3			0	0	0											0.6625	0.0125	0.325	64		
chrX	152847291	152847291	T	C	hom	222	ATP2B3			0.85	0.85	0.85	rs4898425 [];										0.8125	0.05	0.1375	88		
chrX	152847301	152847301	G	C	hom	222	ATP2B3			0.85	0.85	0.85	rs4898426 [];										0.825	0.05	0.125	89		
chrX	152847488	152847488	T	G	hom	222	ATP2B3			0.85	0.85	0.85	rs5945311 [];										0.825	0.05	0.125	85		
chrX	152848425	152848425	A	C	hom	222	ATP2B3			0.85	0.85	0.85	rs5945312 [];										0.3625	0.05	0.5875	43		
chrX	152848459	152848459	T	G	hom	222	ATP2B3			0.85	0.85	0.85	rs5945313 [];										0.3625	0.05	0.5875	43		
chrX	152864478	152864478	-	C	hom	42.4	FAM58A	unknown	UNKNOWN	0	0	0											0.6375	0	0.3625	120		
chrX	152916023	152916023	T	G	hom	222	DUSP9			1	1	1	rs6643635 [];										0.9375	0	0.0625	92		
chrX	152916113	152916113	-	CACAGGG	hom	214	DUSP9			0	0	0											0.3125	0.0625	0.625	34		
chrX	152916126	152916126	-	CCCGCCCCTGTCCCCAAGT	hom	208	DUSP9			0	0	0											0.175	0.0375	0.7875	19		
chrX	152916238	152916238	-	G	hom	214	DUSP9			0	0	0											0.95	0	0.05	92		
chrX	152935655	152935655	C	T	hom	143	PNCK			0.75	0.75	0.75	rs12848840 [];										0.325	0.0125	0.6625	34		
chrX	152935705	152935705	C	A	hom	187	PNCK			0.77	0.77	0.77	rs5945339 [];										0.2625	0.0125	0.725	29		
chrX	152989830	152989830	A	C	hom	97.5	BCAP31			0	0	0	rs5987137 [];										0.7125	0	0.2875	64		
chrX	153006137	153006137	G	A	het	39	ABCD1	nonsynonymous SNV	ABCD1:NM_000033:exon7:c.G1744A:p.V582I,	0	0	0	rs76180859 [];	-0.3460	0.0001	0.2400	0.0020				300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.325	0.675	43		
chrX	153006141	153006141	T	A	het	47	ABCD1	nonsynonymous SNV	ABCD1:NM_000033:exon7:c.T1748A:p.V583E,	0	0	0	rs79383557 [];	1.7640	0.9995	0.0000	0.9980				300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.3625	0.6375	50		
chrX	153008476	153008476	T	C	het	10.4	ABCD1	nonsynonymous SNV	ABCD1:NM_000033:exon8:c.T1816C:p.S606P [1(haematopoietic_and_lymphoid_tissue)]; 	0	0	0	rs201774661 [];	1.8270	0.9969	0.0000	0.8590		145040 [1(haematopoietic_and_lymphoid_tissue)]; 		300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.75	0.25	139		
chrX	153008483	153008483	G	A	het	6.98	ABCD1	nonsynonymous SNV	ABCD1:NM_000033:exon8:c.G1823A:p.G608D,	0	0	0	rs78993751 [];	2.2830	0.9992	0.0000	0.9990				300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.7625	0.2375	145		
chrX	153008911	153008911	C	T	hom	222	ABCD1			0.58	0.58	0.58	rs4898368 [];					0.6245			300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.2875	0.025	0.6875	75		
chrX	153009197	153009197	G	C	hom	195	ABCD1			0.7	0.7	0.7	rs2229539 [];					0.6915			300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.6125	0.025	0.3625	185		
chrX	153009448	153009448	A	G	het	136	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.6625	0.3375	115		
chrX	153009670	153009670	G	T	het	149	ABCD1			0	0	0	rs199942817 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.775	0.225	127		
chrX	153009719	153009719	G	A	het	222	ABCD1			0	0	0	rs67211405 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.9375	0.0625	146		
chrX	153009876	153009876	G	C	het	193	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.4375	0.5625	101		
chrX	153010059	153010059	G	T	het	128	ABCD1			0	0	0	rs72616452 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.0125	0.9375	0.05	142		
chrX	153010066	153010066	C	T	het	208	ABCD1			0	0	0	rs11803 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.625	0.375	100		
chrX	153010083	153010083	G	A	het	143	ABCD1			0.17	0.17	0.17	rs1055847 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.45	0.55	76		
chrX	153010090	153010090	G	A	het	136	ABCD1			0	0	0	rs75637470 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.95	0.05	137		
chrX	153010092	153010092	G	A	het	125	ABCD1			0	0	0	rs78155328 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.95	0.05	135		
chrX	153010137	153010137	C	T	het	107	ABCD1			0	0	0	rs112109783 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.75	0.25	104		
chrX	153010224	153010224	C	T	hom	222	ABCD1			0.7	0.7	0.7	rs6643782 [];										0.3	0.025	0.675	84		
chrX	153010267	153010267	G	A	het	225	ABCD1			0.61	0.61	0.61	rs6643784 [];										0.1	0.2125	0.6875	31		
chrX	153010314	153010314	G	A	het	36	ABCD1			0	0	0											0	0.225	0.775	20		
chrX	153010320	153010320	-	A	het	34.5	ABCD1			0	0	0											0	0.0875	0.9125	7		
chrX	153038516	153038516	C	G	hom	222	PLXNB3			1	1	1	rs5945161 [];										0.4375	0	0.5625	73		
chrX	153039615	153039615	A	G	hom	105	PLXNB3			1	1	1	rs1543781 [];										0.4375	0	0.5625	69		
chrX	153041132	153041132	C	T	hom	222	PLXNB3			0.18	0.18	0.18	rs5945162 [];					0.2156					0.2125	0.05	0.7375	32		
chrX	153044369	153044369	C	A	hom	147	PLXNB3			0.17	0.17	0.17	rs2071121 [];					0.1902					0.075	0.0625	0.8625	16		
chrX	153048403	153048403	T	C	hom	222	SRPK3			0.55	0.55	0.55	rs916001 [];					0.3425					0.2875	0.075	0.6375	58		
chrX	153049345	153049345	G	A	hom	222	SRPK3			0.16	0.16	0.16	rs4898441 [];					0.1748					0.175	0.05	0.775	35		
chrX	153049354	153049354	A	G	hom	222	SRPK3			0.16	0.16	0.16	rs4898442 [];					0.1730					0.0625	0.05	0.8875	22		
chrX	153049389	153049389	A	G	hom	222	SRPK3			0.59	0.59	0.59	rs3969088 [];					0.3379					0.1125	0.0625	0.825	33		
chrX	153049535	153049535	A	G	hom	222	SRPK3	synonymous SNV	SRPK3:NM_014370:exon10:c.A1014G:p.P338P,SRPK3:NM_001170760:exon10:c.A1011G:p.P337P,	0.54	0.54	0.54	rs4898444 [];					0.3496					0.2875	0.075	0.6375	58		
chrX	153049739	153049739	C	T	hom	222	SRPK3			0.16	0.16	0.16	rs2269366 [];					0.1787					0.0625	0.05	0.8875	20		
chrX	153052661	153052661	A	G	hom	222	IDH3G			0.95	0.95	0.95	rs2269482 [];										0.425	0	0.575	45		
chrX	153053422	153053422	C	T	hom	222	IDH3G			0.11	0.11	0.11	rs12558426 [];					0.0751					0.05	0.0125	0.9375	8		
chrX	153053699	153053699	-	G	hom	214	IDH3G			0	0	0	rs72198906 [];										0.1125	0.0625	0.825	19		
chrX	153055608	153055608	C	T	hom	169	IDH3G			0.11	0.11	0.11	rs2071124 [];					0.0743					0.0375	0.0125	0.95	7		
chrX	153056312	153056312	-	AG	hom	214	IDH3G			0	0	0	rs34761948 [];										0.075	0.025	0.9	14		
chrX	153067740	153067740	C	G	hom	222	PDZD4			0.11	0.11	0.11	rs2269367 [];										0.0625	0.0125	0.925	6		
chrX	153068717	153068718	CA	-	het	10.8	PDZD4			0.03	0.03	0.03								202			0	0.1125	0.8875	10		
chrX	153070999	153070999	G	A	hom	222	PDZD4	synonymous SNV	PDZD4:NM_032512:exon6:c.C612T:p.N204N,	0.1	0.1	0.1	rs3747312 [];					0.0593					0.05	0.0125	0.9375	10		
chrX	153134521	153134521	G	C	hom	192	L1CAM			1	1	1	rs78371277 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.4375	0	0.5625	45		
chrX	153149709	153149709	-	C	hom	214	L1CAM;AVPR2		L1CAM:dist=8310;AVPR2:dist=20820	0	0	0	rs66466703 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.9375	0	0.0625	136		
chrX	153149715	153149715	C	G	hom	222	L1CAM;AVPR2		L1CAM:dist=8316;AVPR2:dist=20814	0	0	0	rs6643650 [];	-2.6770							308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.9375	0	0.0625	135		
chrX	153150929	153150929	G	A	hom	203	L1CAM;AVPR2		L1CAM:dist=9530;AVPR2:dist=19600	0.5	0.5	0.5	rs41311376 [];					0.2120			308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.0875	0.0125	0.9	10		
chrX	153151277	153151277	C	G	hom	31	L1CAM;AVPR2		L1CAM:dist=9878;AVPR2:dist=19252	0	0	0	rs56026845 [];	-0.9550	0.0006	0.0000					308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.0875	0	0.9125	32		
chrX	153168407	153168407	G	A	hom	222	L1CAM;AVPR2		L1CAM:dist=27008;AVPR2:dist=2122	0.5	0.5	0.5	rs3761529 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.0875	0.025	0.8875	11		
chrX	153168449	153168449	T	C	hom	222	L1CAM;AVPR2		L1CAM:dist=27050;AVPR2:dist=2080	0.59	0.59	0.59	rs3761528 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.0875	0.025	0.8875	11		
chrX	153170448	153170448	-	C	hom	214	AVPR2			0	0	0	rs67971735 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.975	0	0.025	95		
chrX	153170980	153170980	T	G	hom	105	AVPR2			1	1	1	rs56689668 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.9125	0	0.0875	169		
chrX	153171993	153171993	A	G	hom	222	AVPR2	synonymous SNV	AVPR2:NM_000054:exon3:c.A927G:p.L309L,	0.6	0.6	0.6	rs5201 [];	0.2580	0.2772	0.0200		0.2999			300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.275	0.0625	0.6625	80		
chrX	153174868	153174868	-	G	hom	181	ARHGAP4			0	0	0	rs34046683 [];										0.4375	0	0.5625	73		
chrX	153175054	153175054	-	C	hom	50.4	ARHGAP4			0	0	0	rs56015121 [];							211			0.4	0	0.6	38		
chrX	153178460	153178460	-	C	hom	165	ARHGAP4			0	0	0	rs5904376 [];										0.425	0	0.575	90		
chrX	153185245	153185245	T	A	het	29.5	ARHGAP4			0.34	0.34	0.34	rs72616464 [];							2336			0.0375	0	0.9625	4		
chrX	153186413	153186413	-	G	hom	214	ARHGAP4			0	0	0	rs34153599 [];										0.4375	0	0.5625	46		
chrX	153186485	153186485	-	C	hom	82.6	ARHGAP4			0	0	0	rs11428457 [];										0.4375	0	0.5625	73		
chrX	153199364	153199364	T	C	hom	222	NAA10			0.01	0.01	0.01	rs146971859 [];					0.0158					0	0	1	0		
chrX	153210184	153210184	-	G	hom	122	RENBP			0	0	0											0.8625	0	0.1375	82		
chrX	153210196	153210196	-	G	hom	21.6	RENBP			0	0	0											0.8625	0	0.1375	82		
chrX	153220358	153220358	G	A	hom	222	HCFC1	synonymous SNV	HCFC1:NM_005334:exon17:c.C3492T:p.S1164S,	0	0	0						0.0011					0	0	1	0		
chrX	153277889	153277889	C	T	hom	140	IRAK1			0.56	0.56	0.56	rs2239673 [];										0.325	0.025	0.65	38		
chrX	153278307	153278307	G	A	hom	201	IRAK1			0.56	0.56	0.56	rs763737 [];										0.3375	0.025	0.6375	38		
chrX	153278829	153278829	G	A	hom	222	IRAK1	nonsynonymous SNV	IRAK1:NM_001569:exon12:c.C1595T:p.S532L,IRAK1:NM_001025243:exon11:c.C1358T:p.S453L,	0.57	0.57	0.57	rs1059703 [];	-0.3780	0.0001	0.3800	0.0000	0.8528					0.7875	0.0375	0.175	133		
chrX	153279841	153279844	AAAA	-	hom	14.2	IRAK1			0	0	0								701			0.075	0.0125	0.9125	8		
chrX	153284192	153284192	A	G	hom	222	IRAK1	nonsynonymous SNV	IRAK1:NM_001569:exon5:c.T587C:p.F196S,IRAK1:NM_001025243:exon5:c.T587C:p.F196S,IRAK1:NM_001025242:exon5:c.T587C:p.F196S,	0.68	0.68	0.68	rs1059702 [];	0.2350	0.0004	0.4400	0.0010	0.8595					0.8	0.0375	0.1625	126		
chrX	153284483	153284483	G	A	hom	222	IRAK1	synonymous SNV	IRAK1:NM_001569:exon4:c.C483T:p.V161V [1(stomach)]; IRAK1:NM_001025243:exon4:c.C483T:p.V161V [1(stomach)]; IRAK1:NM_001025242:exon4:c.C483T:p.V161V [1(stomach)]; 	0.48	0.48	0.48	rs1059701 [];					0.8039	150839 [1(stomach)]; 				0.7125	0.0375	0.25	114		
chrX	153292180	153292180	T	C	hom	222	MECP2			0.67	0.67	0.67	rs2734647 [];								300005 [Methyl-CpG-binding protein-2 - Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked, Lubs type, 300260 (3)];		0.8125	0.0375	0.15	132		
chrX	153294542	153294542	T	C	hom	222	MECP2			0.99	0.99	0.99	rs2853337 [];							200	300005 [Methyl-CpG-binding protein-2 - Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked, Lubs type, 300260 (3)];		0.9375	0	0.0625	155		
chrX	153416537	153416537	A	C	hom	161	OPN1LW			0	0	0	rs78751796 [];										0.4375	0	0.5625	46		
chrX	153553781	153553781	G	A	hom	222	TKTL1			0.27	0.27	0.27	rs4898475 [];					0.1943					0.075	0.0375	0.8875	26		
chrX	153558418	153558418	A	G	hom	222	TKTL1			0.23	0.23	0.23	rs2872817 [];										0.1625	0.0375	0.8	18		
chrX	153577133	153577133	-	CA	hom	214	FLNA			0	0	0									300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.0625	0.025	0.9125	14		
chrX	153578299	153578299	A	G	hom	222	FLNA			0.2	0.2	0.2	rs2070819 [];								300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.05	0.0125	0.9375	6		
chrX	153579448	153579448	A	G	hom	222	FLNA			0.4	0.4	0.4	rs2070822 [];					0.2199			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	27		
chrX	153581932	153581932	A	G	hom	222	FLNA	synonymous SNV	FLNA:NM_001110556:exon36:c.T5850C:p.A1950A,FLNA:NM_001456:exon35:c.T5826C:p.A1942A,	0.21	0.21	0.21	rs2070825 [];					0.1048			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.1	0.025	0.875	28		
chrX	153582198	153582198	T	C	hom	222	FLNA			0.19	0.19	0.19	rs2070826 [];								300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.05	0.0125	0.9375	6		
chrX	153582370	153582370	G	A	hom	222	FLNA	nonsynonymous SNV	FLNA:NM_001110556:exon35:c.C5599T:p.H1867Y,FLNA:NM_001456:exon34:c.C5575T:p.H1859Y,	0	0	0		2.2290	0.9900	0.4600	0.7940				300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0	0	1	0		
chrX	153582703	153582703	G	A	hom	222	FLNA			0.19	0.19	0.19	rs2070827 [];					0.1037			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.05	0.0125	0.9375	13		
chrX	153592315	153592315	C	-	hom	139	FLNA			0.18	0.18	0.18	rs148985076 [];								300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	9		
chrX	153595246	153595246	G	C	hom	222	FLNA			0.19	0.19	0.19	rs4898478 [];					0.1958			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	25		
chrX	153595259	153595259	G	A	hom	209	FLNA			0.18	0.18	0.18	rs4898479 [];					0.1937			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	25		
chrX	153609616	153609616	G	C	hom	184	EMD			0.17	0.17	0.17	rs17426 [];								300384 [Emerin - Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)];		0.15	0.0375	0.8125	35		
chrX	153609617	153609617	C	T	hom	183	EMD			0.17	0.17	0.17	rs17427 [];								300384 [Emerin - Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)];		0.15	0.0375	0.8125	34		
chrX	153609963	153609963	C	T	hom	222	EMD			0.23	0.23	0.23	rs17428 [];										0.075	0.025	0.9	9		
chrX	153626649	153626649	A	C	hom	213	RPL10			0.21	0.21	0.21	rs915941 [];								312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.05	0.0125	0.9375	17		
chrX	153626738	153626738	G	A	hom	222	RPL10			0.18	0.18	0.18	rs915942 [];								312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.1	0.025	0.875	22		
chrX	153664332	153664332	A	G	hom	222	ATP6AP1			0.04	0.04	0.04	rs8425 [];										0.025	0.025	0.95	4		
chrX	153664498	153664498	A	G	hom	222	ATP6AP1			0.08	0.08	0.08	rs8689 [];										0.1	0.0375	0.8625	12		
chrX	153664698	153664698	A	C	hom	222	ATP6AP1			0.26	0.26	0.26	rs6727 [];										0.1125	0.025	0.8625	13		
chrX	153667176	153667176	T	C	hom	222	GDI1	synonymous SNV	GDI1:NM_001493:exon3:c.T219C:p.N73N,	0.25	0.25	0.25	rs4834 [];					0.1284			300104 [GDP dissociation inhibitor 1 - Mental retardation, X-linked nonspecific, 309541 (3)];		0.1125	0.0375	0.85	35		
chrX	153669763	153669764	GG	-	hom	98.7	GDI1			0	0	0									300104 [GDP dissociation inhibitor 1 - Mental retardation, X-linked nonspecific, 309541 (3)];		0.05	0	0.95	5		
chrX	153677700	153677700	T	C	hom	222	FAM50A			0.22	0.22	0.22	rs2070643 [];					0.1062					0.0625	0	0.9375	8		
chrX	153677896	153677896	A	G	hom	166	FAM50A			0.2	0.2	0.2	rs45463798 [];										0.0625	0	0.9375	6		
chrX	153678706	153678706	C	T	hom	222	FAM50A			0.2	0.2	0.2	rs2070644 [];					0.1095					0.0625	0	0.9375	8		
chrX	153734787	153734787	T	A	hom	222	FAM3A			0.27	0.27	0.27	rs7611 [];										0.125	0.0125	0.8625	18		
chrX	153744507	153744507	C	G	hom	86.5	FAM3A			0.3	0.3	0.3	rs9887660 [];										0.075	0.0125	0.9125	8		
chrX	153759858	153759858	T	C	hom	222	G6PD			0.31	0.31	0.31	rs1050757 [];										0.1125	0.0125	0.875	31		
chrX	153760508	153760508	A	G	hom	222	G6PD			0.31	0.31	0.31	rs2071429 [];					0.1327					0.075	0	0.925	27		
chrX	153760654	153760654	G	A	hom	222	G6PD	synonymous SNV	G6PD:NM_000402:exon11:c.C1401T:p.Y467Y,G6PD:NM_001042351:exon11:c.C1311T:p.Y437Y,	0.14	0.14	0.14	rs2230037 [];					0.1133					0.1125	0	0.8875	38		
chrX	153813743	153813743	-	TTCTG	hom	15.6	CTAG1A;CTAG1B		CTAG1A:NM_139250:exon1:c.269+4->TTCTG;CTAG1B:NM_001327:exon1:c.269+4->TTCTG	0	0	0								225	300248 [Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase - Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)];		0.0875	0	0.9125	17		
chrX	153881531	153881531	G	A	hom	222	CTAG2	synonymous SNV	CTAG2:NM_172377:exon1:c.C259T:p.L87L,CTAG2:NM_020994:exon1:c.C259T:p.L87L,	0.03	0.03	0.03	rs148711831 [];					0.0161					0.025	0	0.975	3		
chrX	153928031	153928031	C	T	hom	222	GAB3			0.54	0.54	0.54	rs884840 [];										0.2875	0.0375	0.675	29		
chrX	153994596	153994596	G	T	hom	222	DKC1	synonymous SNV	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T,	0.99	0.99	0.99	rs2728532 [];	-2.1510				1.0000			300126 [Dyskerin - Dyskeratosis congenita-1, 305000 (3); Hoyeraal-Hreidarsson syndrome,300240 (3)];		0.975	0	0.025	210		
chrX	154001559	154001559	C	T	het	11.3	DKC1			0	0	0	rs202203976 [];								300126 [Dyskerin - Dyskeratosis congenita-1, 305000 (3); Hoyeraal-Hreidarsson syndrome,300240 (3)];		0	0	1	1		
chrX	154009603	154009603	-	A	hom	214	MPP1			0	0	0											0	0	1	0		
chrX	154009625	154009625	G	-	hom	78.5	MPP1			0	0	0											0.325	0.0375	0.6375	46		
chrX	154013484	154013484	-	C	hom	8.17	MPP1			0	0	0	rs59913063 [];										0.275	0.05	0.675	27		
chrX	154045229	154045229	G	A	hom	222	MPP1;SMIM9		MPP1:dist=11427;SMIM9:dist=6394	1	1	1	rs113790313 [];										0.9625	0	0.0375	89		
chrX	154064580	154064580	T	C	hom	222	F8			1	1	1	rs1396947 [];								300841 [Coagulation factor VIII, procoagulant component - Hemophilia A, 306700 (3)];		0.95	0	0.05	153		
chrX	154115805	154115805	T	G	hom	7.79	F8A1			0	0	0	rs202084164 [];								300841 [Coagulation factor VIII, procoagulant component - Hemophilia A, 306700 (3)];		0.0375	0.05	0.9125	11		
chrX	154456747	154456747	A	G	hom	222	VBP1	nonsynonymous SNV	VBP1:NM_003372:exon4:c.A367G:p.M123V,	1	1	1	rs572013 [];	1.0640	0.0000	1.0000	0.0000						0.9625	0	0.0375	144		
chrX	154467457	154467457	C	T	hom	222	VBP1			0.43	0.43	0.43	rs11887 [];										0.25	0.05	0.7	34		
chrX	154467737	154467737	T	C	hom	222	VBP1			0.03	0.03	0.03	rs3599 [];										0.0375	0	0.9625	3		
chrX	154488741	154488741	G	A	hom	222	RAB39B			0.04	0.04	0.04	rs17052027 [];								300774 [Ras-associated protein RAB39B - Mental retardation, X-linked-72, 300271 (3)];		0.0375	0	0.9625	11		
chrX	154721357	154721357	G	C	hom	222	TMLHE-AS1			0.56	0.56	0.56	rs150926226 [];					0.6826					0.3125	0.025	0.6625	34		
chrX	154774707	154774707	C	T	hom	219	TMLHE			0.67	0.67	0.67	rs2305518 [];					0.7650		252			0.3375	0.0375	0.625	55		
chrX	154842666	154842666	C	T	hom	178	TMLHE			0.65	0.65	0.65	rs89278 [];										0.3375	0.0375	0.625	34		
chrMT	212	212	C	T	hom	178	TMLHE			0.65	0.65	0.65	rs89278 [];										0.3375	0.0375	0.625	34		